[
  {
    "id": 110274,
    "drug": {
      "current_status": "MARKETED",
      "id": 15154,
      "drug_code": 75617,
      "updated_date": "2025-05-15T02:31:41-04:00",
      "company": {
        "id": 80,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4489,
        "mfr_code": "LEO08",
        "name": "LEO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6 ADELAIDE STREET EAST, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5C 1H6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255402,
          "ingredient": {
            "id": 3242,
            "ingredient_code": 277,
            "en_name": "AZELAIC ACID",
            "fr_name": "Acide azélaïque"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02270811",
      "brand_name": "FINACEA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126787002"
    },
    "created_date": "2020-04-01T13:03:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02270811",
    "company_name": "LEO PHARMA INC",
    "atc_number": "D10AX",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2020-04-10T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-04-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-04-17T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FINACEA",
    "en_drug_common_name": "AZELAIC ACID",
    "fr_drug_brand_name": "FINACEA",
    "fr_drug_common_name": "Azelaic acid",
    "en_ingredients": "AZELAIC ACID",
    "fr_ingredients": "Acide azélaïque",
    "drug_strength": "15%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "50g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110288,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3834,
      "drug_code": 19356,
      "updated_date": "2025-05-15T03:45:28-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8302944,
          "ingredient": {
            "id": 1548,
            "ingredient_code": 5917,
            "en_name": "BRETYLIUM TOSYLATE",
            "fr_name": "Tosylate de brétylium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02185377",
      "brand_name": "BRETYLIUM TOSYLATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81648",
      "number_of_ais": "1",
      "ai_group_no": "0107636001"
    },
    "created_date": "2020-04-01T13:24:57-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02185377",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "discontinuation_date": "2017-11-28T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-01T13:25:45-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "BRETYLIUM TOSYLATE INJECTION USP",
    "en_drug_common_name": "BRETYLIUM TOSYLATE",
    "fr_drug_brand_name": "BRETYLIUM TOSYLATE",
    "fr_drug_common_name": "BRETYLIUM TOSYLATE",
    "fr_ingredients": "BRETYLIUM TOSYLATE",
    "drug_dosage_form_fr": "50mg/ml",
    "drug_route_fr": "Injection",
    "drug_package_quantity": "5 X 10ml",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110297,
    "drug": {
      "current_status": "MARKETED",
      "id": 22336,
      "drug_code": 84736,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257991,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362341",
      "brand_name": "ACETAMINOPHEN CAPLETS 325 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102009001"
    },
    "created_date": "2020-04-01T13:31:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362341",
    "company_name": "APOTEX INC",
    "atc_number": "N02BE",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "actual_start_date": "2020-03-30T00:00:00-04:00",
    "actual_end_date": "2020-05-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-02T12:20:21-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACETAMINOPHEN CAPLETS 325 MG",
    "en_drug_common_name": "APC-ACETAMINOPHEN",
    "fr_drug_brand_name": "ACETAMINOPHEN CAPLETS",
    "fr_drug_common_name": "APC-ACETAMINOPHEN",
    "en_ingredients": "ACETAMINOPHEN",
    "fr_ingredients": "Acétaminophène",
    "drug_strength": "325MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110309,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6018,
      "drug_code": 42145,
      "updated_date": "2025-05-15T03:48:57-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8311839,
          "ingredient": {
            "id": 52,
            "ingredient_code": 8520,
            "en_name": "POLYMYXIN B",
            "fr_name": "Polymyxine B (Sulfate de polymyxine b)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": true
        },
        {
          "id": 8311838,
          "ingredient": {
            "id": 1232,
            "ingredient_code": 8502,
            "en_name": "BACITRACIN",
            "fr_name": "Bacitracine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "01942921",
      "brand_name": "POLYTOPIC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "M2368",
      "number_of_ais": "2",
      "ai_group_no": "0205854001"
    },
    "created_date": "2020-04-01T13:36:49-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "01942921",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "D06AX",
    "atc_description": "ANTIBIOTICS FOR TOPICAL USE",
    "discontinuation_date": "2018-08-14T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-01T13:37:10-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "POLYTOPIC",
    "en_drug_common_name": "PLYTOPIC",
    "fr_drug_brand_name": "POLYTOPIC",
    "fr_drug_common_name": "POLYTOPIC",
    "en_ingredients": "BACITRACIN\r\nPOLYMYXIN B",
    "fr_ingredients": "Bacitracine\r\nPolymyxine B",
    "drug_strength": "500UNIT\r\n10000UNIT",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "15G / 30G",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110315,
    "drug": {
      "current_status": "MARKETED",
      "id": 22338,
      "drug_code": 84737,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257992,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362368",
      "brand_name": "ACETAMINOPHEN CAPLETS 500 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102009002"
    },
    "created_date": "2020-04-01T13:40:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362368",
    "company_name": "APOTEX INC",
    "atc_number": "N02BE",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2020-04-11T00:00:00-04:00",
    "actual_start_date": "2020-03-30T00:00:00-04:00",
    "actual_end_date": "2020-04-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-13T15:24:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACETAMINOPHEN CAPLETS 500 MG",
    "en_drug_common_name": "APC-ACETAMINOPHEN",
    "fr_drug_brand_name": "ACETAMINOPHEN CAPLETS 500 MG",
    "fr_drug_common_name": "APC-ACETAMINOPHEN",
    "en_ingredients": "ACETAMINOPHEN",
    "fr_ingredients": "Acétaminophène",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110324,
    "drug": {
      "current_status": "CANCELLED PRE MARKET",
      "id": 12084,
      "drug_code": 70042,
      "updated_date": "2025-05-15T04:04:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8336485,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "360",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245922",
      "brand_name": "SANDOZ DILTIAZEM T",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863009"
    },
    "created_date": "2020-04-01T13:52:13-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02245922",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "discontinuation_date": "2019-09-28T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-01T13:53:15-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ DILTIAZEM T",
    "en_drug_common_name": "DILTIAZEM T",
    "fr_drug_brand_name": "DILTIAZEM T SR",
    "fr_drug_common_name": "DILTIAZEM T SR",
    "fr_ingredients": "DILTIAZEM T SR",
    "drug_dosage_form_fr": "360MG",
    "drug_route_fr": "Tablet",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110329,
    "drug": {
      "current_status": "MARKETED",
      "id": 22346,
      "drug_code": 84743,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257999,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362422",
      "brand_name": "ACETAMINOPHEN TABLETS USP 325 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102009001"
    },
    "created_date": "2020-04-01T14:07:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362422",
    "company_name": "APOTEX INC",
    "atc_number": "N02BE",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2020-05-29T00:00:00-04:00",
    "actual_start_date": "2020-03-30T00:00:00-04:00",
    "actual_end_date": "2020-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-25T12:34:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACETAMINOPHEN TABLETS USP 325 MG",
    "en_drug_common_name": "APC-ACETAMINOPHEN",
    "fr_drug_brand_name": "ACETAMINOPHEN",
    "fr_drug_common_name": "ACETAMINOPHEN",
    "en_ingredients": "ACETAMINOPHEN",
    "fr_ingredients": "Acétaminophène",
    "drug_strength": "325MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110331,
    "drug": {
      "current_status": "MARKETED",
      "id": 22338,
      "drug_code": 84737,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257992,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362368",
      "brand_name": "ACETAMINOPHEN CAPLETS 500 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102009002"
    },
    "created_date": "2020-04-01T14:09:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362368",
    "company_name": "APOTEX INC",
    "atc_number": "N02BE",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2020-04-13T00:00:00-04:00",
    "actual_start_date": "2020-03-30T00:00:00-04:00",
    "actual_end_date": "2020-03-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-01T14:12:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACETAMINOPHEN CAPLETS 500 MG",
    "en_drug_common_name": "ACETAMINOPHEN",
    "fr_drug_brand_name": "ACETAMINOPHEN",
    "fr_drug_common_name": "ACETAMINOPHEN",
    "en_ingredients": "ACETAMINOPHEN",
    "fr_ingredients": "Acétaminophène",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110339,
    "drug": {
      "current_status": "MARKETED",
      "id": 22328,
      "drug_code": 84726,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257986,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362244",
      "brand_name": "ACETAMINOPHEN TABLETS USP 500 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102009002"
    },
    "created_date": "2020-04-01T14:21:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362244",
    "company_name": "APOTEX INC",
    "atc_number": "N02BE",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2020-06-05T00:00:00-04:00",
    "actual_start_date": "2020-03-30T00:00:00-04:00",
    "actual_end_date": "2020-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-25T12:39:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACETAMINOPHEN TABLETS USP 500 MG",
    "en_drug_common_name": "ACETAMINOPHEN",
    "fr_drug_brand_name": "ACETAMINOPHEN",
    "fr_drug_common_name": "ACETAMINOPHEN",
    "en_ingredients": "ACETAMINOPHEN",
    "fr_ingredients": "Acétaminophène",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110342,
    "drug": {
      "current_status": "MARKETED",
      "id": 29992,
      "drug_code": 92048,
      "updated_date": "2025-05-15T02:34:38-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260916,
          "ingredient": {
            "id": 3728,
            "ingredient_code": 933,
            "en_name": "ZOLPIDEM TARTRATE",
            "fr_name": "Tartrate de zolpidem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02436159",
      "brand_name": "APO-ZOLPIDEM ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122857001"
    },
    "created_date": "2020-04-01T14:31:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02436159",
    "company_name": "APOTEX INC",
    "atc_number": "N05CF",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "estimated_end_date": "2020-05-08T00:00:00-04:00",
    "actual_start_date": "2020-03-30T00:00:00-04:00",
    "actual_end_date": "2020-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-11T12:29:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ZOLPIDEM ODT",
    "en_drug_common_name": "ZOLPIDEM",
    "fr_drug_brand_name": "ZOLPIDEM",
    "fr_drug_common_name": "ZOLPIDEM",
    "en_ingredients": "ZOLPIDEM TARTRATE",
    "fr_ingredients": "Tartrate de zolpidem",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "SUBLINGUAL",
    "drug_route_fr": "Sublinguale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110345,
    "drug": {
      "current_status": "MARKETED",
      "id": 12542,
      "drug_code": 71256,
      "updated_date": "2025-05-15T02:31:24-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8254608,
          "ingredient": {
            "id": 908,
            "ingredient_code": 2446,
            "en_name": "DEFEROXAMINE MESYLATE",
            "fr_name": "Mésylate de déféroxamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02247022",
      "brand_name": "DEFEROXAMINE MESYLATE FOR INJECTION",
      "brand_name_fr": "MÉSILATE DE DÉFÉROXAMINE POUR INJECTION",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109208001"
    },
    "created_date": "2020-04-01T15:38:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247022",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "V03AC",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "actual_start_date": "2020-03-31T00:00:00-04:00",
    "actual_end_date": "2020-05-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-26T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DEFEROXAMINE MESYLATE FOR INJECTION",
    "en_drug_common_name": "Deferoxamine Mesylate for Injection",
    "fr_drug_brand_name": "Mésilate de déféroxamine pour injection",
    "fr_drug_common_name": "Mésilate de déféroxamine pour injection",
    "en_ingredients": "DEFEROXAMINE MESYLATE",
    "fr_ingredients": "Mésylate de déféroxamine",
    "drug_strength": "2G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAPERITONEAL\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntrapéritonéale\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "2g vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110364,
    "drug": {
      "current_status": "MARKETED",
      "id": 5288,
      "drug_code": 3414,
      "updated_date": "2025-05-15T02:30:29-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250512,
          "ingredient": {
            "id": 844,
            "ingredient_code": 10227,
            "en_name": "LITHIUM CARBONATE",
            "fr_name": "Carbonate de lithium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00461733",
      "brand_name": "CARBOLITH",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54281",
      "number_of_ais": "1",
      "ai_group_no": "0101163001"
    },
    "created_date": "2020-04-01T19:27:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00461733",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "N05AN",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2020-03-30T00:00:00-04:00",
    "actual_end_date": "2020-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2020-05-01T20:30:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CARBOLITH",
    "en_drug_common_name": "CARBOLITH",
    "fr_drug_brand_name": "CARBOLITH",
    "fr_drug_common_name": "CARBOLITH",
    "en_ingredients": "LITHIUM CARBONATE",
    "fr_ingredients": "Carbonate de lithium",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "n/a",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110367,
    "drug": {
      "current_status": "MARKETED",
      "id": 25900,
      "drug_code": 88267,
      "updated_date": "2025-12-03T00:32:09-05:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259345,
          "ingredient": {
            "id": 1356,
            "ingredient_code": 10135,
            "en_name": "CHLORTHALIDONE",
            "fr_name": "Chlorthalidone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259344,
          "ingredient": {
            "id": 3782,
            "ingredient_code": 21230,
            "en_name": "AZILSARTAN MEDOXOMIL",
            "fr_name": "Azilsartan Médoxomil (Azilsartan Médoxomil Potassium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02397749",
      "brand_name": "EDARBYCLOR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0253470002"
    },
    "created_date": "2020-04-01T19:31:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02397749",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2020-03-24T00:00:00-04:00",
    "actual_end_date": "2020-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-04-24T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "EDARBYCLOR",
    "en_drug_common_name": "DIN 02397749",
    "fr_drug_brand_name": "EDARBYCLOR",
    "fr_drug_common_name": "EDARBYCLOR",
    "en_ingredients": "CHLORTHALIDONE\r\nAZILSARTAN MEDOXOMIL",
    "fr_ingredients": "Chlorthalidone",
    "drug_strength": "12.5MG\r\n40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28ct",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110370,
    "drug": {
      "current_status": "MARKETED",
      "id": 24096,
      "drug_code": 86721,
      "updated_date": "2025-12-03T00:31:55-05:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258673,
          "ingredient": {
            "id": 3782,
            "ingredient_code": 21230,
            "en_name": "AZILSARTAN MEDOXOMIL",
            "fr_name": "Azilsartan Médoxomil (Azilsartan Médoxomil Potassium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02381389",
      "brand_name": "EDARBI",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153128001"
    },
    "created_date": "2020-04-01T19:34:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02381389",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2020-03-24T00:00:00-04:00",
    "actual_end_date": "2020-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-05-13T19:50:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "EDARBI",
    "en_drug_common_name": "EDARBI",
    "fr_drug_brand_name": "EDARBI",
    "fr_drug_common_name": "EDARBI",
    "en_ingredients": "AZILSARTAN MEDOXOMIL",
    "fr_ingredients": "Azilsartan Medoxomil",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28ct",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110373,
    "drug": {
      "current_status": "MARKETED",
      "id": 23332,
      "drug_code": 85917,
      "updated_date": "2025-05-15T02:33:03-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258412,
          "ingredient": {
            "id": 3742,
            "ingredient_code": 20982,
            "en_name": "COLESEVELAM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de Colésévélam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "625",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02373955",
      "brand_name": "LODALIS",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153000001"
    },
    "created_date": "2020-04-01T19:37:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02373955",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "C10AC",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2020-03-24T00:00:00-04:00",
    "actual_end_date": "2020-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-04-09T21:39:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LODALIS",
    "en_drug_common_name": "LODALIS",
    "fr_drug_brand_name": "LODALIS",
    "fr_drug_common_name": "LODALIS",
    "en_ingredients": "COLESEVELAM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de Colésévélam",
    "drug_strength": "625MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "180's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110376,
    "drug": {
      "current_status": "MARKETED",
      "id": 2358,
      "drug_code": 15525,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252038,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02039524",
      "brand_name": "ZOVIRAX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77218",
      "number_of_ais": "1",
      "ai_group_no": "0115506007"
    },
    "created_date": "2020-04-01T19:40:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02039524",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "D06BB",
    "atc_description": "CHEMOTHERAPEUTICS FOR TOPICAL USE",
    "actual_start_date": "2020-03-23T00:00:00-04:00",
    "actual_end_date": "2020-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-06-03T18:32:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ZOVIRAX",
    "en_drug_common_name": "ZOVIRAX",
    "fr_drug_brand_name": "ZOVIRAX",
    "fr_drug_common_name": "ZOVIRAX",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "5%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "1x5g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110383,
    "drug": {
      "current_status": "MARKETED",
      "id": 23748,
      "drug_code": 86410,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258553,
          "ingredient": {
            "id": 3770,
            "ingredient_code": 20642,
            "en_name": "TAPENTADOL",
            "fr_name": "Tapentadol (Chlorhydrate de tapentadol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378280",
      "brand_name": "NUCYNTA IR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152846006"
    },
    "created_date": "2020-04-01T20:37:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378280",
    "company_name": "ENDO VENTURES LTD",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2020-04-01T00:00:00-04:00",
    "estimated_end_date": "2020-04-30T00:00:00-04:00",
    "actual_end_date": "2020-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-04-16T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Limited Inventory available on allocation",
    "fr_comments": "Inventaire limité en allocation",
    "en_drug_brand_name": "NUCYNTA IR",
    "en_drug_common_name": "Tapentadol",
    "fr_drug_brand_name": "Nucynta IR",
    "fr_drug_common_name": "TAPENTADOL",
    "en_ingredients": "TAPENTADOL",
    "fr_ingredients": "Tapentadol",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110386,
    "drug": {
      "current_status": "MARKETED",
      "id": 27808,
      "drug_code": 90019,
      "updated_date": "2025-12-03T00:32:25-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260108,
          "ingredient": {
            "id": 3770,
            "ingredient_code": 20642,
            "en_name": "TAPENTADOL",
            "fr_name": "Tapentadol (Chlorhydrate de tapentadol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415607",
      "brand_name": "NUCYNTA EXTENDED-RELEASE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152846004"
    },
    "created_date": "2020-04-01T20:39:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02415607",
    "company_name": "ENDO VENTURES LTD",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2020-04-01T00:00:00-04:00",
    "estimated_end_date": "2020-04-30T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-04-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-04-30T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Limited inventory available on allocation",
    "fr_comments": "Inventaire limité en allocation",
    "en_drug_brand_name": "NUCYNTA EXTENDED-RELEASE",
    "en_drug_common_name": "TAPENTADOL",
    "fr_drug_brand_name": "NUCYNTA EXTENDED-RELEASE",
    "fr_drug_common_name": "TAPENTADOL",
    "en_ingredients": "TAPENTADOL",
    "fr_ingredients": "Tapentadol",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110411,
    "drug": {
      "current_status": "MARKETED",
      "id": 10598,
      "drug_code": 66188,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8254015,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242463",
      "brand_name": "MYLAN-ACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506004"
    },
    "created_date": "2020-04-02T13:40:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242463",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2020-04-28T00:00:00-04:00",
    "actual_start_date": "2020-03-12T00:00:00-04:00",
    "actual_end_date": "2020-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-29T12:48:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-ACYCLOVIR",
    "en_drug_common_name": "ACYCLOVIR",
    "fr_drug_brand_name": "MYLAN-ACYCLOVIR",
    "fr_drug_common_name": "ACYCLOVIR",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110438,
    "drug": {
      "current_status": "MARKETED",
      "id": 25354,
      "drug_code": 87823,
      "updated_date": "2025-12-03T00:32:06-05:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259192,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392976",
      "brand_name": "MYLAN-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055004"
    },
    "created_date": "2020-04-02T13:53:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392976",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2020-05-11T00:00:00-04:00",
    "estimated_end_date": "2020-06-23T00:00:00-04:00",
    "actual_end_date": "2020-05-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-05-26T11:39:25-04:00",
    "status": "resolved",
    "en_comments": "Short dated inventory",
    "fr_comments": "short dated inventory",
    "en_drug_brand_name": "MYLAN-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "MYLAN-ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110465,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24172,
      "drug_code": 86795,
      "updated_date": "2025-05-15T04:20:00-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351384,
          "ingredient": {
            "id": 2566,
            "ingredient_code": 11772,
            "en_name": "BUPROPION HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupropion"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02382083",
      "brand_name": "MYLAN-BUPROPION XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131140004"
    },
    "created_date": "2020-04-02T14:17:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382083",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2020-03-30T00:00:00-04:00",
    "actual_end_date": "2020-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-07-01T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-BUPROPION XL",
    "en_drug_common_name": "BUPROPION",
    "fr_drug_brand_name": "MYLAN-BUPROPION XL",
    "fr_drug_common_name": "BUPROPION",
    "en_ingredients": "BUPROPION HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupropion",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90BT, 500BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110472,
    "drug": {
      "current_status": "MARKETED",
      "id": 20720,
      "drug_code": 82506,
      "updated_date": "2025-05-15T02:32:33-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8257333,
          "ingredient": {
            "id": 3218,
            "ingredient_code": 12329,
            "en_name": "GALANTAMINE",
            "fr_name": "Galantamine (Bromhydrate de galantamine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02339447",
      "brand_name": "MYLAN-GALANTAMINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144660004"
    },
    "created_date": "2020-04-02T14:36:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02339447",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2020-05-12T00:00:00-04:00",
    "actual_start_date": "2020-04-09T00:00:00-04:00",
    "actual_end_date": "2020-05-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-12T17:23:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-GALANTAMINE ER",
    "en_drug_common_name": "GALANTAMINE",
    "fr_drug_brand_name": "MYLAN-GALANTMINE ER",
    "fr_drug_common_name": "GALANTMINE",
    "en_ingredients": "GALANTAMINE",
    "fr_ingredients": "GALANTMINE",
    "drug_strength": "16MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BT, 100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110477,
    "drug": {
      "current_status": "MARKETED",
      "id": 10160,
      "drug_code": 64988,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253850,
          "ingredient": {
            "id": 2754,
            "ingredient_code": 1747,
            "en_name": "IFOSFAMIDE",
            "fr_name": "Ifosfamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02241356",
      "brand_name": "IFEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0120706001"
    },
    "created_date": "2020-04-02T14:47:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241356",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "L01AA",
    "atc_description": "ALKYLATINGAGENTS",
    "anticipated_start_date": "2020-04-02T00:00:00-04:00",
    "estimated_end_date": "2020-04-20T00:00:00-04:00",
    "actual_start_date": "2020-04-02T00:00:00-04:00",
    "actual_end_date": "2020-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-04-21T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IFEX (IFOSFAMIDE) 3 G/VIAL",
    "en_drug_common_name": "Ifex",
    "fr_drug_brand_name": "IFEX (IFOSFAMIDE) 3 G/VIAL",
    "fr_drug_common_name": "Ifex",
    "en_ingredients": "IFOSFAMIDE",
    "fr_ingredients": "Ifosfamide",
    "drug_strength": "3G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "3g vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110480,
    "drug": {
      "current_status": "MARKETED",
      "id": 9700,
      "drug_code": 63577,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8253732,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240067",
      "brand_name": "MYLAN-INDAPAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115402002"
    },
    "created_date": "2020-04-02T14:58:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240067",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C03BA",
    "atc_description": "LOW-CEILING DIURETICS, EXCL THIAZIDES",
    "estimated_end_date": "2020-06-16T00:00:00-04:00",
    "actual_start_date": "2020-03-31T00:00:00-04:00",
    "actual_end_date": "2020-06-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-06-17T13:58:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-INDAPAMIDE",
    "en_drug_common_name": "INDAPAMIDE",
    "fr_drug_brand_name": "MYLAN-INDAPAMIDE",
    "fr_drug_common_name": "INDAPAMIDE",
    "en_ingredients": "INDAPAMIDE",
    "fr_ingredients": "Indapamide",
    "drug_strength": "1.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110483,
    "drug": {
      "current_status": "MARKETED",
      "id": 6136,
      "drug_code": 42846,
      "updated_date": "2025-12-03T00:30:36-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252984,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02184435",
      "brand_name": "KADIAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9013",
      "number_of_ais": "1",
      "ai_group_no": "0104545002"
    },
    "created_date": "2020-04-02T15:14:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02184435",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2020-06-16T00:00:00-04:00",
    "actual_start_date": "2020-03-30T00:00:00-04:00",
    "actual_end_date": "2020-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-06-10T17:30:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "KADIAN",
    "en_drug_common_name": "Morphine ER",
    "fr_drug_brand_name": "KADIAN",
    "fr_drug_common_name": "Morphine ER",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110486,
    "drug": {
      "current_status": "MARKETED",
      "id": 6138,
      "drug_code": 42847,
      "updated_date": "2025-12-03T00:30:36-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252985,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02184443",
      "brand_name": "KADIAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9014",
      "number_of_ais": "1",
      "ai_group_no": "0104545006"
    },
    "created_date": "2020-04-02T15:21:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02184443",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2020-05-15T00:00:00-04:00",
    "estimated_end_date": "2020-06-16T00:00:00-04:00",
    "actual_start_date": "2020-04-02T00:00:00-04:00",
    "actual_end_date": "2020-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-06-10T17:31:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "KADIAN",
    "en_drug_common_name": "Morphine ER",
    "fr_drug_brand_name": "KADIAN",
    "fr_drug_common_name": "Morphine ER",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110497,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25046,
      "drug_code": 87552,
      "updated_date": "2025-05-15T04:20:23-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351858,
          "ingredient": {
            "id": 2138,
            "ingredient_code": 11104,
            "en_name": "ONDANSETRON",
            "fr_name": "Ondansétron"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02390051",
      "brand_name": "ONDANSETRON INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVES",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131120004"
    },
    "created_date": "2020-04-02T15:38:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390051",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A04AA",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "estimated_end_date": "2020-06-09T00:00:00-04:00",
    "actual_start_date": "2020-03-30T00:00:00-04:00",
    "actual_end_date": "2020-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-05-06T14:22:37-04:00",
    "status": "resolved",
    "en_comments": "short dated inventory",
    "fr_comments": "short dated inventory",
    "en_drug_brand_name": "ONDANSETRON INJECTION, USP",
    "en_drug_common_name": "ONDANSETRON INJECTION, USP",
    "fr_drug_brand_name": "ONDANSETRON INJECTION, USP",
    "fr_drug_common_name": "ONDANSETRON INJECTION, USP",
    "en_ingredients": "ONDANSETRON",
    "fr_ingredients": "Ondansétron",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "20ML 1VL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110504,
    "drug": {
      "current_status": "MARKETED",
      "id": 55361,
      "drug_code": 94424,
      "updated_date": "2025-05-15T02:35:34-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8262095,
          "ingredient": {
            "id": 2870,
            "ingredient_code": 1893,
            "en_name": "PROPAFENONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propafénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457164",
      "brand_name": "MYLAN-PROPAFENONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116258002"
    },
    "created_date": "2020-04-02T15:50:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457164",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C01BC",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "estimated_end_date": "2020-04-28T00:00:00-04:00",
    "actual_start_date": "2020-03-30T00:00:00-04:00",
    "actual_end_date": "2020-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-29T13:47:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-PROPAFENONE",
    "en_drug_common_name": "PROPAFENONE",
    "fr_drug_brand_name": "MYLAN-PROPAFENONE",
    "fr_drug_common_name": "PROPAFENONE",
    "en_ingredients": "PROPAFENONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propafénone",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110509,
    "drug": {
      "current_status": "MARKETED",
      "id": 4164,
      "drug_code": 20018,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8252595,
          "ingredient": {
            "id": 38,
            "ingredient_code": 10110,
            "en_name": "VERAPAMIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de vérapamil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02210347",
      "brand_name": "MYLAN-VERAPAMIL SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82317",
      "number_of_ais": "1",
      "ai_group_no": "0113846001"
    },
    "created_date": "2020-04-02T16:00:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02210347",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C08DA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "anticipated_start_date": "2020-05-10T00:00:00-04:00",
    "estimated_end_date": "2021-03-02T00:00:00-05:00",
    "actual_start_date": "2020-04-13T00:00:00-04:00",
    "actual_end_date": "2021-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-03-09T16:19:28-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-VERAPAMIL SR",
    "en_drug_common_name": "VERAPAMIL",
    "fr_drug_brand_name": "MYLAN-VERAPAMIL SR",
    "fr_drug_common_name": "VERAPAMIL",
    "en_ingredients": "VERAPAMIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de vérapamil",
    "drug_strength": "120MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110514,
    "drug": {
      "current_status": "MARKETED",
      "id": 25590,
      "drug_code": 88000,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8259247,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394847",
      "brand_name": "ESOMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145162002"
    },
    "created_date": "2020-04-02T16:12:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394847",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2020-06-19T00:00:00-04:00",
    "actual_start_date": "2020-04-02T00:00:00-04:00",
    "actual_end_date": "2020-06-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-06-19T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ESOMEPRAZOLE",
    "en_drug_common_name": "ESOMEPRAZOLE",
    "fr_drug_brand_name": "ESOMEPRAZOLE",
    "fr_drug_common_name": "ESOMEPRAZOLE",
    "en_ingredients": "ESOMEPRAZOLE",
    "fr_ingredients": "ESOMEPRAZOLE",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30,500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110517,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15860,
      "drug_code": 76610,
      "updated_date": "2025-12-03T01:24:19-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8342700,
          "ingredient": {
            "id": 958,
            "ingredient_code": 951,
            "en_name": "CILAZAPRIL",
            "fr_name": "Cilazapril (Monohydrate de Cilazapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02280442",
      "brand_name": "PMS-CILAZAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122806001"
    },
    "created_date": "2020-04-02T17:23:12-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02280442",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2022-01-17T00:00:00-05:00",
    "anticipated_discontinuation_date": "2020-04-02T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-01-18T06:00:03-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-CILAZAPRIL",
    "en_drug_common_name": "CILAZAPRIL",
    "fr_drug_brand_name": "PMS-CILAZAPRIL",
    "fr_drug_common_name": "CILAZAPRIL",
    "en_ingredients": "CILAZAPRIL",
    "fr_ingredients": "Cilazapril",
    "drug_strength": "1.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110528,
    "drug": {
      "current_status": "MARKETED",
      "id": 15600,
      "drug_code": 76285,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255594,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02277204",
      "brand_name": "BIPHENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548012"
    },
    "created_date": "2020-04-02T18:26:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02277204",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2020-04-03T00:00:00-04:00",
    "estimated_end_date": "2020-04-17T00:00:00-04:00",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-15T20:47:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BIPHENTIN",
    "en_drug_common_name": "BIPHENTIN",
    "fr_drug_brand_name": "Biphentin",
    "fr_drug_common_name": "Biphentin",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110531,
    "drug": {
      "current_status": "MARKETED",
      "id": 32008,
      "drug_code": 9509,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251174,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00786543",
      "brand_name": "DILAUDID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68694",
      "number_of_ais": "1",
      "ai_group_no": "0108698005"
    },
    "created_date": "2020-04-02T18:32:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00786543",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2020-04-13T00:00:00-04:00",
    "estimated_end_date": "2020-04-30T00:00:00-04:00",
    "actual_start_date": "2020-04-15T00:00:00-04:00",
    "actual_end_date": "2020-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-04-25T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DILAUDID",
    "en_drug_common_name": "Dilaudid",
    "fr_drug_brand_name": "Dilaudid",
    "fr_drug_common_name": "Dilaudid",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110534,
    "drug": {
      "current_status": "MARKETED",
      "id": 9718,
      "drug_code": 63627,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253737,
          "ingredient": {
            "id": 1624,
            "ingredient_code": 11213,
            "en_name": "DORZOLAMIDE",
            "fr_name": "Dorzolamide (Chlorhydrate de dorzolamide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253736,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02240113",
      "brand_name": "COSOPT",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0237301001"
    },
    "created_date": "2020-04-02T18:43:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240113",
    "company_name": "PURDUE PHARMA",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2020-04-06T00:00:00-04:00",
    "estimated_end_date": "2020-04-24T00:00:00-04:00",
    "actual_start_date": "2020-03-30T00:00:00-04:00",
    "actual_end_date": "2020-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-04-18T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "COSOPT",
    "en_drug_common_name": "COSOPT",
    "fr_drug_brand_name": "Cosopt",
    "fr_drug_common_name": "Cosopt",
    "en_ingredients": "TIMOLOL\r\nDORZOLAMIDE",
    "fr_ingredients": "Timolol \r\nDorzolamide",
    "drug_strength": "5MG\r\n20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "10ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110538,
    "drug": {
      "current_status": "MARKETED",
      "id": 1568,
      "drug_code": 13392,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251762,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01962779",
      "brand_name": "ZOLOFT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74762",
      "number_of_ais": "1",
      "ai_group_no": "0123417002"
    },
    "created_date": "2020-04-02T18:52:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01962779",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-05-05T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-07T14:37:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ZOLOFT CAP 100MG",
    "en_drug_common_name": "Zoloft 100mg",
    "fr_drug_brand_name": "ZOLOFT CAP 100MG",
    "fr_drug_common_name": "Zoloft 100mg",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "Sertraline",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110643,
    "drug": {
      "current_status": "MARKETED",
      "id": 12726,
      "drug_code": 71583,
      "updated_date": "2025-05-15T02:31:25-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254653,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247340",
      "brand_name": "ACT CIPROFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123207001"
    },
    "created_date": "2020-04-02T20:51:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247340",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-21T18:41:46-04:00",
    "status": "resolved",
    "en_comments": "Allocating to 100% of our market.",
    "fr_comments": "Allocating to 100% of our market.",
    "en_drug_brand_name": "ACT CIPROFLOXACIN",
    "en_drug_common_name": "CIPROFLOXACIN 500MG  FC TAB",
    "fr_drug_brand_name": "ACT-CIPROFLOXACIN 500MG  FC TAB",
    "fr_drug_common_name": "CIPROFLOXACIN 500MG  FC TAB",
    "en_ingredients": "CIPROFLOXACIN",
    "fr_ingredients": "Ciprofloxacine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110646,
    "drug": {
      "current_status": "MARKETED",
      "id": 12728,
      "drug_code": 71584,
      "updated_date": "2025-05-15T02:31:25-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254654,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247341",
      "brand_name": "ACT CIPROFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123207002"
    },
    "created_date": "2020-04-02T20:52:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247341",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2020-09-30T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-09-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-03T17:59:05-04:00",
    "status": "resolved",
    "en_comments": "Allocating to 100% of our market.",
    "fr_comments": "Allocating to 100% of our market.",
    "en_drug_brand_name": "ACT CIPROFLOXACIN",
    "en_drug_common_name": "CIPROFLOXACIN 750MG FC TAB",
    "fr_drug_brand_name": "CO-CIPROFLOXACIN 750MG FC TAB",
    "fr_drug_common_name": "CIPROFLOXACIN 750MG FC TAB",
    "en_ingredients": "CIPROFLOXACIN",
    "fr_ingredients": "Ciprofloxacine",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110649,
    "drug": {
      "current_status": "MARKETED",
      "id": 14218,
      "drug_code": 74297,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255132,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "850",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02257734",
      "brand_name": "TEVA-METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773002"
    },
    "created_date": "2020-04-02T20:54:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02257734",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2020-07-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-14T17:49:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT METFORMIN",
    "en_drug_common_name": "METFORMIN 850MG FC TAB",
    "fr_drug_brand_name": "ACT-METFORMIN 850MG FC TAB",
    "fr_drug_common_name": "METFORMIN 850MG FC TAB",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "850MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110652,
    "drug": {
      "current_status": "MARKETED",
      "id": 18832,
      "drug_code": 80096,
      "updated_date": "2025-12-03T00:31:21-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256582,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02315424",
      "brand_name": "TEVA-LEVOFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663003"
    },
    "created_date": "2020-04-02T20:55:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02315424",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2020-07-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-07-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-07-23T14:03:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT LEVOFLOXACIN",
    "en_drug_common_name": "LEVOFLOXACIN 250MG FC TAB",
    "fr_drug_brand_name": "ACT-LEVOFLOXACIN 250MG FC TAB",
    "fr_drug_common_name": "LEVOFLOXACIN 250MG FC TAB",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110655,
    "drug": {
      "current_status": "MARKETED",
      "id": 18836,
      "drug_code": 80098,
      "updated_date": "2025-12-03T00:31:21-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256584,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02315440",
      "brand_name": "TEVA-LEVOFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663005"
    },
    "created_date": "2020-04-02T20:56:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02315440",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2020-09-30T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-14T17:50:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT LEVOFLOXACIN",
    "en_drug_common_name": "LEVOFLOXACIN 750MG FC TAB",
    "fr_drug_brand_name": "ACT-LEVOFLOXACIN 750MG FC TAB",
    "fr_drug_common_name": "LEVOFLOXACIN 750MG FC TAB",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110658,
    "drug": {
      "current_status": "MARKETED",
      "id": 4350,
      "drug_code": 20329,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252725,
          "ingredient": {
            "id": 550,
            "ingredient_code": 6492,
            "en_name": "PSEUDOEPHEDRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de pseudoéphédrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252724,
          "ingredient": {
            "id": 98,
            "ingredient_code": 9131,
            "en_name": "CODEINE PHOSPHATE",
            "fr_name": "Phosphate de codéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252723,
          "ingredient": {
            "id": 1154,
            "ingredient_code": 6494,
            "en_name": "TRIPROLIDINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de triprolidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02169126",
      "brand_name": "TEVA-COTRIDIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82637",
      "number_of_ais": "3",
      "ai_group_no": "0304415002"
    },
    "created_date": "2020-04-02T20:57:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02169126",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "R05DA",
    "atc_description": "COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2024-12-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-02-20T15:46:58-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-COTRIDIN",
    "en_drug_common_name": "COTRIDIN SYRUP",
    "fr_drug_brand_name": "TEVA-COTRIDIN SYRUP",
    "fr_drug_common_name": "COTRIDIN SYRUP",
    "en_ingredients": "PSEUDOEPHEDRINE HYDROCHLORIDE\r\nTRIPROLIDINE HYDROCHLORIDE\r\nCODEINE PHOSPHATE",
    "fr_ingredients": "Chlorhydrate de pseudoéphédrine\r\nChlorhydrate de triprolidine\r\nPhosphate de codéine",
    "drug_strength": "30MG\r\n2MG\r\n10MG",
    "drug_dosage_form": "SYRUP",
    "drug_dosage_form_fr": "Sirop",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "2L",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110661,
    "drug": {
      "current_status": "MARKETED",
      "id": 8374,
      "drug_code": 5778,
      "updated_date": "2025-05-15T02:30:35-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250825,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250824,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00608165",
      "brand_name": "TEVA-OXYCOCET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61498",
      "number_of_ais": "2",
      "ai_group_no": "0215596001"
    },
    "created_date": "2020-04-02T20:58:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00608165",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2020-07-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-07-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-07-23T14:03:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OXYCOCET",
    "en_drug_common_name": "OXYCOCET TABS 5MG/325MG",
    "fr_drug_brand_name": "TEVA-OXYCOCET TABS 5MG/325MG",
    "fr_drug_common_name": "OXYCOCET TABS 5MG/325MG",
    "en_ingredients": "ACETAMINOPHEN\r\nOXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Acétaminophène\r\nChlorhydrate d'oxycodone",
    "drug_strength": "325MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110664,
    "drug": {
      "current_status": "MARKETED",
      "id": 9630,
      "drug_code": 63322,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253721,
          "ingredient": {
            "id": 2674,
            "ingredient_code": 1400,
            "en_name": "AMIODARONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amiodarone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239835",
      "brand_name": "TEVA-AMIODARONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118593001"
    },
    "created_date": "2020-04-02T20:59:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239835",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C01BD",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-14T17:10:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-AMIODARONE",
    "en_drug_common_name": "AMIODARONE 200MG TAB",
    "fr_drug_brand_name": "TEVA-AMIODARONE 200MG TAB",
    "fr_drug_common_name": "AMIODARONE 200MG TAB",
    "en_ingredients": "AMIODARONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amiodarone",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110667,
    "drug": {
      "current_status": "MARKETED",
      "id": 5184,
      "drug_code": 3264,
      "updated_date": "2025-12-03T00:30:21-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250498,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00406724",
      "brand_name": "NOVAMOXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "53654",
      "number_of_ais": "1",
      "ai_group_no": "0131314001"
    },
    "created_date": "2020-04-02T21:01:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00406724",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01CA",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2020-07-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-08-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-08-14T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NOVAMOXIN",
    "en_drug_common_name": "AMOXICILLIN 250MG CAP",
    "fr_drug_brand_name": "TEVA-AMOXICILLIN 250MG CAP",
    "fr_drug_common_name": "AMOXICILLIN 250MG CAP",
    "en_ingredients": "AMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "250MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110670,
    "drug": {
      "current_status": "MARKETED",
      "id": 18732,
      "drug_code": 80009,
      "updated_date": "2025-05-15T02:32:13-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256548,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "18",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02314568",
      "brand_name": "TEVA-ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434002"
    },
    "created_date": "2020-04-02T21:02:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314568",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2021-04-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-04-15T19:06:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE 18MG CAP",
    "fr_drug_brand_name": "TEVA-ATOMOXETINE 18MG CAP",
    "fr_drug_common_name": "ATOMOXETINE 18MG CAP",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "ATOMOXETINE",
    "drug_strength": "18MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110673,
    "drug": {
      "current_status": "MARKETED",
      "id": 14884,
      "drug_code": 75288,
      "updated_date": "2025-05-15T02:31:40-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255332,
          "ingredient": {
            "id": 3044,
            "ingredient_code": 1218,
            "en_name": "BISOPROLOL FUMARATE",
            "fr_name": "Fumarate de bisoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02267470",
      "brand_name": "TEVA-BISOPROLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122418001"
    },
    "created_date": "2020-04-02T21:03:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02267470",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-21T18:42:27-04:00",
    "status": "resolved",
    "en_comments": "Allocating to 100% of our market.",
    "fr_comments": "Allocating to 100% of our market.",
    "en_drug_brand_name": "TEVA-BISOPROLOL",
    "en_drug_common_name": "BISOPROLOL FUMARATE 5MG TAB",
    "fr_drug_brand_name": "TEVA-BISOPROLOL FUMARATE 5MG TAB",
    "fr_drug_common_name": "BISOPROLOL FUMARATE 5MG TAB",
    "en_ingredients": "BISOPROLOL FUMARATE",
    "fr_ingredients": "Fumarate de bisoprolol",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110676,
    "drug": {
      "current_status": "MARKETED",
      "id": 15100,
      "drug_code": 75561,
      "updated_date": "2025-05-15T02:31:41-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255395,
          "ingredient": {
            "id": 1586,
            "ingredient_code": 141,
            "en_name": "BICALUTAMIDE",
            "fr_name": "Bicalutamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02270226",
      "brand_name": "TEVA-BICALUTAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127996001"
    },
    "created_date": "2020-04-02T21:04:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02270226",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L02BB",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2020-09-30T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-09-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-03T18:00:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-BICALUTAMIDE",
    "en_drug_common_name": "BICALUTAMIDE 50MG TAB",
    "fr_drug_brand_name": "TEVA-BICALUTAMIDE 50MG TAB",
    "fr_drug_common_name": "BICALUTAMIDE 50MG TAB",
    "en_ingredients": "BICALUTAMIDE",
    "fr_ingredients": "Bicalutamide",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110679,
    "drug": {
      "current_status": "MARKETED",
      "id": 55425,
      "drug_code": 95418,
      "updated_date": "2025-05-15T02:35:55-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262596,
          "ingredient": {
            "id": 198,
            "ingredient_code": 7581,
            "en_name": "BUDESONIDE",
            "fr_name": "Budésonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02465957",
      "brand_name": "TEVA-BUDESONIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116807011"
    },
    "created_date": "2020-04-02T21:05:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02465957",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-04T18:49:29-04:00",
    "status": "resolved",
    "en_comments": "Allocating to 100% of our market.",
    "fr_comments": "Allocating to 100% of our market.",
    "en_drug_brand_name": "TEVA-BUDESONIDE",
    "en_drug_common_name": "BUDESONIDE INH 0.5MG/ML 2ML",
    "fr_drug_brand_name": "TEVA-BUDESONIDE INH 0.5MG/ML 2ML",
    "fr_drug_common_name": "BUDESONIDE INH 0.5MG/ML 2ML",
    "en_ingredients": "BUDESONIDE",
    "fr_ingredients": "Budésonide",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "20",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110682,
    "drug": {
      "current_status": "MARKETED",
      "id": 10668,
      "drug_code": 66289,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254043,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242538",
      "brand_name": "TEVA-DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863004"
    },
    "created_date": "2020-04-02T21:06:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242538",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2020-04-30T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-16T19:05:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DILTIAZEM CD",
    "en_drug_common_name": "DILTIAZEM CD 120MG CAPS",
    "fr_drug_brand_name": "TEVA-DILTIAZEM CD 120MG CAPS",
    "fr_drug_common_name": "DILTIAZEM CD 120MG CAPS",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "120MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110685,
    "drug": {
      "current_status": "MARKETED",
      "id": 10670,
      "drug_code": 66290,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254044,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "180",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242539",
      "brand_name": "TEVA-DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863007"
    },
    "created_date": "2020-04-02T21:07:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242539",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-14T17:10:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DILTIAZEM CD",
    "en_drug_common_name": "TEVA-DILTIAZEM CD 180MG CAPS",
    "fr_drug_brand_name": "TEVA-DILTIAZEM CD 180MG CAPS",
    "fr_drug_common_name": "DILTIAZEM CD 180MG CAPS",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "180MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110688,
    "drug": {
      "current_status": "MARKETED",
      "id": 19114,
      "drug_code": 80368,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256696,
          "ingredient": {
            "id": 3198,
            "ingredient_code": 13585,
            "en_name": "ESCITALOPRAM",
            "fr_name": "Escitalopram (Oxalate d'escitalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02318180",
      "brand_name": "TEVA-ESCITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150435002"
    },
    "created_date": "2020-04-02T21:08:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02318180",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-08T19:35:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ESCITALOPRAM",
    "en_drug_common_name": "ESCITALOPRAM 10MG TAB",
    "fr_drug_brand_name": "TEVA-ESCITALOPRAM 10MG TAB",
    "fr_drug_common_name": "ESCITALOPRAM 10MG TAB",
    "en_ingredients": "ESCITALOPRAM",
    "fr_ingredients": "Escitalopram",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110691,
    "drug": {
      "current_status": "MARKETED",
      "id": 60492,
      "drug_code": 94743,
      "updated_date": "2025-05-15T02:35:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262256,
          "ingredient": {
            "id": 3098,
            "ingredient_code": 13276,
            "en_name": "FULVESTRANT",
            "fr_name": "Fulvestrant"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02460130",
      "brand_name": "TEVA-FULVESTRANT INJECTION",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE, PRE-FILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149744001"
    },
    "created_date": "2020-04-02T21:09:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02460130",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L02BA",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-01T17:21:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FULVESTRANT INJECTION",
    "en_drug_common_name": "FULVESTRANT INJECTION 50MG/ML",
    "fr_drug_brand_name": "TEVA-FULVESTRANT INJECTION 50MG/ML",
    "fr_drug_common_name": "FULVESTRANT INJECTION 50MG/ML",
    "en_ingredients": "FULVESTRANT",
    "fr_ingredients": "Fulvestrant",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "5ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110694,
    "drug": {
      "current_status": "MARKETED",
      "id": 12734,
      "drug_code": 71589,
      "updated_date": "2025-05-15T02:31:25-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254655,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "800",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247346",
      "brand_name": "TEVA-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "800MG",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929005"
    },
    "created_date": "2020-04-02T21:10:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247346",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2020-04-30T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-01T17:21:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-GABAPENTIN",
    "en_drug_common_name": "TEVA-GABAPENTIN 800MG TAB",
    "fr_drug_brand_name": "TEVA-GABAPENTIN 800MG TAB",
    "fr_drug_common_name": "GABAPENTIN 800MG TAB",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "800MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110697,
    "drug": {
      "current_status": "MARKETED",
      "id": 16820,
      "drug_code": 778,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250187,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00021474",
      "brand_name": "TEVA-HYDROCHLOROTHIAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "29610",
      "number_of_ais": "1",
      "ai_group_no": "0101048002"
    },
    "created_date": "2020-04-02T21:11:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00021474",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C03AA",
    "atc_description": "LOW-CEILING DIURETICS, THIAZIDES",
    "estimated_end_date": "2020-08-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-08T19:35:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-HYDROCHLOROTHIAZIDE",
    "en_drug_common_name": "HYDROCHLOROTHIAZIDE 25MG TABS",
    "fr_drug_brand_name": "TEVA-HYDROCHLOROTHIAZIDE 25MG TABS",
    "fr_drug_common_name": "HYDROCHLOROTHIAZIDE 25MG TABS",
    "en_ingredients": "HYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110700,
    "drug": {
      "current_status": "MARKETED",
      "id": 16820,
      "drug_code": 778,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250187,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00021474",
      "brand_name": "TEVA-HYDROCHLOROTHIAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "29610",
      "number_of_ais": "1",
      "ai_group_no": "0101048002"
    },
    "created_date": "2020-04-02T21:12:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00021474",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C03AA",
    "atc_description": "LOW-CEILING DIURETICS, THIAZIDES",
    "estimated_end_date": "2020-08-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-08T19:36:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-HYDROCHLOROTHIAZIDE",
    "en_drug_common_name": "HYDROCHLOROTHIAZIDE 25MG TABS",
    "fr_drug_brand_name": "TEVA-HYDROCHLOROTHIAZIDE 25MG TABS",
    "fr_drug_common_name": "HYDROCHLOROTHIAZIDE 25MG TABS",
    "en_ingredients": "HYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110703,
    "drug": {
      "current_status": "MARKETED",
      "id": 55824,
      "drug_code": 95216,
      "updated_date": "2025-05-15T02:35:51-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262506,
          "ingredient": {
            "id": 1286,
            "ingredient_code": 232,
            "en_name": "PERINDOPRIL ERBUMINE",
            "fr_name": "Périndopril erbumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8262505,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02464020",
      "brand_name": "TEVA-PERINDOPRIL/INDAPAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0248401001"
    },
    "created_date": "2020-04-02T21:14:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02464020",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-14T18:09:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PERINDOPRIL/INDAPAMIDE",
    "en_drug_common_name": "PERIN/INDA 4MG/1.25MG TAB",
    "fr_drug_brand_name": "TEVA-PERIN/INDA 4MG/1.25MG TAB",
    "fr_drug_common_name": "PERIN/INDA 4MG/1.25MG TAB",
    "en_ingredients": "PERINDOPRIL ERBUMINE\r\nINDAPAMIDE",
    "fr_ingredients": "Périndopril erbumine\r\nIndapamide",
    "drug_strength": "4MG\r\n1.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110706,
    "drug": {
      "current_status": "MARKETED",
      "id": 15280,
      "drug_code": 75820,
      "updated_date": "2025-05-15T02:31:42-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255454,
          "ingredient": {
            "id": 124,
            "ingredient_code": 2585,
            "en_name": "SALBUTAMOL",
            "fr_name": "Salbutamol (Sulfate de salbutamol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "2.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8255453,
          "ingredient": {
            "id": 1298,
            "ingredient_code": 1945,
            "en_name": "IPRATROPIUM BROMIDE",
            "fr_name": "Bromure d'ipratropium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "2.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02272695",
      "brand_name": "TEVA-COMBO STERINEBS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0232902001"
    },
    "created_date": "2020-04-02T21:15:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02272695",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "R03AL",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2020-07-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-07-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-07-30T16:55:11-04:00",
    "status": "resolved",
    "en_comments": "Allocating to 100% of our market.",
    "fr_comments": "Allocating to 100% of our market.",
    "en_drug_brand_name": "TEVA-COMBO STERINEBS",
    "en_drug_common_name": "IPRATROP SALB 0.5/2.5MG",
    "fr_drug_brand_name": "IPRATROP SALB 0.5/2.5MG",
    "fr_drug_common_name": "TEVA-IPRATROP SALB 0.5/2.5MG",
    "en_ingredients": "IPRATROPIUM BROMIDE\r\nSALBUTAMOL",
    "fr_ingredients": "Bromure d'ipratropium\r\nSalbutamol",
    "drug_strength": "0.5MG\r\n2.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "20x 2.5ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110709,
    "drug": {
      "current_status": "MARKETED",
      "id": 28342,
      "drug_code": 90485,
      "updated_date": "2025-05-15T02:34:12-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260276,
          "ingredient": {
            "id": 2666,
            "ingredient_code": 11852,
            "en_name": "MODAFINIL",
            "fr_name": "Modafinil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420260",
      "brand_name": "TEVA-MODAFINIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136083001"
    },
    "created_date": "2020-04-02T21:16:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420260",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2020-07-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-14T17:50:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-MODAFINIL",
    "en_drug_common_name": "MODAFINIL 100MG TABS",
    "fr_drug_brand_name": "ALERTEC - MODAFINIL 100MG TABS",
    "fr_drug_common_name": "MODAFINIL 100MG TABS",
    "en_ingredients": "MODAFINIL",
    "fr_ingredients": "Modafinil",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110712,
    "drug": {
      "current_status": "MARKETED",
      "id": 17724,
      "drug_code": 78808,
      "updated_date": "2025-12-03T00:31:16-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256228,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02302764",
      "brand_name": "TEVA-MORPHINE SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545009"
    },
    "created_date": "2020-04-02T21:18:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02302764",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-08T19:37:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-MORPHINE SR",
    "en_drug_common_name": "MORPHINE SR 15MG TAB",
    "fr_drug_brand_name": "TEVA-MORPHINE SR 15MG TAB",
    "fr_drug_common_name": "MORPHINE SR 15MG TAB",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110716,
    "drug": {
      "current_status": "MARKETED",
      "id": 17726,
      "drug_code": 78809,
      "updated_date": "2025-12-03T00:31:16-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256229,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02302772",
      "brand_name": "TEVA-MORPHINE SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545011"
    },
    "created_date": "2020-04-02T21:19:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02302772",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2020-08-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-08T19:37:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-MORPHINE SR",
    "en_drug_common_name": "MORPHINE SR 30MG TAB",
    "fr_drug_brand_name": "TEVA-MORPHINE SR 30MG TAB",
    "fr_drug_common_name": "MORPHINE SR 30MG TAB",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110719,
    "drug": {
      "current_status": "MARKETED",
      "id": 17726,
      "drug_code": 78809,
      "updated_date": "2025-12-03T00:31:16-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256229,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02302772",
      "brand_name": "TEVA-MORPHINE SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545011"
    },
    "created_date": "2020-04-02T21:20:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02302772",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2020-08-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-09T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-MORPHINE SR",
    "en_drug_common_name": "MORPHINE SR 30MG TAB",
    "fr_drug_brand_name": "TEVA-MORPHINE SR 30MG TAB",
    "fr_drug_common_name": "MORPHINE SR 30MG TAB",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110722,
    "drug": {
      "current_status": "MARKETED",
      "id": 17728,
      "drug_code": 78810,
      "updated_date": "2025-12-03T00:31:16-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256230,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02302780",
      "brand_name": "TEVA-MORPHINE SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545010"
    },
    "created_date": "2020-04-02T21:22:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02302780",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-23T18:30:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-MORPHINE SR",
    "en_drug_common_name": "MORPHINE SR 60MG TAB",
    "fr_drug_brand_name": "TEVA-MORPHINE SR 60MG TAB",
    "fr_drug_common_name": "MORPHINE SR 60MG TAB",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "50's & 100's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110725,
    "drug": {
      "current_status": "MARKETED",
      "id": 17730,
      "drug_code": 78811,
      "updated_date": "2025-12-03T00:31:16-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256231,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02302799",
      "brand_name": "TEVA-MORPHINE SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545012"
    },
    "created_date": "2020-04-02T21:23:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02302799",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2020-07-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-08T19:38:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-MORPHINE SR",
    "en_drug_common_name": "MORPHINE SR 100MG TAB",
    "fr_drug_brand_name": "TEVA-MORPHINE SR 100MG TAB",
    "fr_drug_common_name": "MORPHINE SR 100MG TAB",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110746,
    "drug": {
      "current_status": "MARKETED",
      "id": 1582,
      "drug_code": 13416,
      "updated_date": "2025-12-03T00:30:31-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8251763,
          "ingredient": {
            "id": 880,
            "ingredient_code": 331,
            "en_name": "ZINC",
            "fr_name": "Zinc (Oxyde de zinc, Sulfate de zinc)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "00787000",
      "brand_name": "MICRO ZN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74799",
      "number_of_ais": "1",
      "ai_group_no": "0109299013"
    },
    "created_date": "2020-04-03T13:39:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00787000",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A12CB",
    "atc_description": "OTHER MINERAL SUPPLEMENTS",
    "estimated_end_date": "2020-06-12T00:00:00-04:00",
    "actual_start_date": "2020-04-02T00:00:00-04:00",
    "actual_end_date": "2020-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-06-22T16:05:49-04:00",
    "status": "resolved",
    "en_comments": "Product is on allocation at Baxter Canada at 50% of customer historical usage.",
    "fr_comments": "Produit en allocation chez Baxter Canada à 50% de l'utilisation historique du client.",
    "en_drug_brand_name": "MICRO ZN",
    "en_drug_common_name": "MICRO Zinc",
    "fr_drug_brand_name": "MICRO ZN",
    "fr_drug_common_name": "MICRO Zinc",
    "en_ingredients": "ZINC",
    "fr_ingredients": "Zinc",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 10 ml vials",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110749,
    "drug": {
      "current_status": "MARKETED",
      "id": 7596,
      "drug_code": 5036,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250702,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00565350",
      "brand_name": "TEVA-NAPROXEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59483",
      "number_of_ais": "1",
      "ai_group_no": "0109634001"
    },
    "created_date": "2020-04-03T14:11:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00565350",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-08T19:39:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-NAPROXEN",
    "en_drug_common_name": "NAPROXEN 250MG TAB",
    "fr_drug_brand_name": "TEVA-NAPROXEN 250MG TAB",
    "fr_drug_common_name": "NAPROXEN 250MG TAB",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110752,
    "drug": {
      "current_status": "MARKETED",
      "id": 1772,
      "drug_code": 13848,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251815,
          "ingredient": {
            "id": 40,
            "ingredient_code": 2037,
            "en_name": "NAPROXEN SODIUM",
            "fr_name": "Naproxène sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "550",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02026600",
      "brand_name": "TEVA-NAPROXEN SODIUM DS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75311",
      "number_of_ais": "1",
      "ai_group_no": "0113934002"
    },
    "created_date": "2020-04-03T14:12:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02026600",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-04-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-09T20:00:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-NAPROXEN SODIUM DS",
    "en_drug_common_name": "NAPROXEN SODIUM DS 550MG TAB",
    "fr_drug_brand_name": "TEVA-NAPROXEN SODIUM DS 550MG TAB",
    "fr_drug_common_name": "NAPROXEN SODIUM DS 550MG TAB",
    "en_ingredients": "NAPROXEN SODIUM",
    "fr_ingredients": "Naproxène sodique",
    "drug_strength": "550MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110755,
    "drug": {
      "current_status": "MARKETED",
      "id": 15572,
      "drug_code": 76242,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255583,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02276747",
      "brand_name": "TEVA-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2020-04-03T14:13:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02276747",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-29T19:03:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OLANZAPINE",
    "en_drug_common_name": "TEVA-OLANZAPINE 10MG TAB",
    "fr_drug_brand_name": "TEVA-OLANZAPINE 10MG TAB",
    "fr_drug_common_name": "OLANZAPINE 10MG TAB",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110758,
    "drug": {
      "current_status": "MARKETED",
      "id": 57534,
      "drug_code": 87938,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259222,
          "ingredient": {
            "id": 3136,
            "ingredient_code": 13326,
            "en_name": "PEMETREXED",
            "fr_name": "Pémétrexed (Pémétrexed disodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02394227",
      "brand_name": "PEMETREXED DISODIUM FOR INJECTION",
      "brand_name_fr": "PEMETREXED DISODIQUE POUR INJECTION",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150104001"
    },
    "created_date": "2020-04-03T14:14:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394227",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01BA",
    "atc_description": "ANTIMETABOLITES",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-23T18:31:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PEMETREXED DISODIUM FOR INJECTION",
    "en_drug_common_name": "PEMETREXED DISODIUM FOR INJ 500MG",
    "fr_drug_brand_name": "PEMETREXED DISODIUM FOR INJ 500MG",
    "fr_drug_common_name": "PEMETREXED DISODIUM FOR INJ 500MG",
    "en_ingredients": "PEMETREXED",
    "fr_ingredients": "PEMETREXED DISODIUM",
    "drug_strength": "500MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110761,
    "drug": {
      "current_status": "MARKETED",
      "id": 55832,
      "drug_code": 95320,
      "updated_date": "2025-05-15T02:35:53-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262552,
          "ingredient": {
            "id": 1286,
            "ingredient_code": 232,
            "en_name": "PERINDOPRIL ERBUMINE",
            "fr_name": "Périndopril erbumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02464993",
      "brand_name": "TEVA-PERINDOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127178002"
    },
    "created_date": "2020-04-03T14:15:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02464993",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-08T19:40:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PERINDOPRIL",
    "en_drug_common_name": "PERINDOPRIL 4MG TAB",
    "fr_drug_brand_name": "TEVA-PERINDOPRIL 4MG TAB",
    "fr_drug_common_name": "PERINDOPRIL 4MG TAB",
    "en_ingredients": "PERINDOPRIL ERBUMINE",
    "fr_ingredients": "Périndopril erbumine",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110764,
    "drug": {
      "current_status": "MARKETED",
      "id": 6080,
      "drug_code": 4256,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250615,
          "ingredient": {
            "id": 1222,
            "ingredient_code": 10127,
            "en_name": "PROPRANOLOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propranolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00496502",
      "brand_name": "TEVA-PROPRANOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57112",
      "number_of_ais": "1",
      "ai_group_no": "0101831002"
    },
    "created_date": "2020-04-03T14:16:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00496502",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2020-04-15T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-09-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-03T15:07:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PROPRANOLOL",
    "en_drug_common_name": "TEVA-PROPRANOLOL 80MG TAB",
    "fr_drug_brand_name": "TEVA-PROPRANOLOL 80MG TAB",
    "fr_drug_common_name": "PROPRANOLOL 80MG TAB",
    "en_ingredients": "PROPRANOLOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propanolol",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110767,
    "drug": {
      "current_status": "MARKETED",
      "id": 22222,
      "drug_code": 84628,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257954,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "225",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02361221",
      "brand_name": "TEVA-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121007"
    },
    "created_date": "2020-04-03T14:19:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02361221",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-08T19:40:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PREGABALIN",
    "en_drug_common_name": "PREGABALIN 225MG CAP",
    "fr_drug_brand_name": "TEVA-PREGABALIN 225MG CAP",
    "fr_drug_common_name": "PREGABALIN 225MG CAP",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "225MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110770,
    "drug": {
      "current_status": "MARKETED",
      "id": 7712,
      "drug_code": 507,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250155,
          "ingredient": {
            "id": 714,
            "ingredient_code": 7566,
            "en_name": "PREDNISONE",
            "fr_name": "Prednisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00021695",
      "brand_name": "TEVA-PREDNISONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "20724",
      "number_of_ais": "1",
      "ai_group_no": "0106321001"
    },
    "created_date": "2020-04-03T14:20:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00021695",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-21T18:43:06-04:00",
    "status": "resolved",
    "en_comments": "Allocating to 100% of our market.",
    "fr_comments": "Allocating to 100% of our market.",
    "en_drug_brand_name": "TEVA-PREDNISONE",
    "en_drug_common_name": "TEVA-PREDNISONE 5MG TAB",
    "fr_drug_brand_name": "TEVA-PREDNISONE 5MG TAB",
    "fr_drug_common_name": "PREDNISONE 5MG TAB",
    "en_ingredients": "PREDNISONE",
    "fr_ingredients": "Prednisone",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110773,
    "drug": {
      "current_status": "MARKETED",
      "id": 1284,
      "drug_code": 1286,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250254,
          "ingredient": {
            "id": 714,
            "ingredient_code": 7566,
            "en_name": "PREDNISONE",
            "fr_name": "Prednisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00232378",
      "brand_name": "TEVA-PREDNISONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "38522",
      "number_of_ais": "1",
      "ai_group_no": "0106321002"
    },
    "created_date": "2020-04-03T14:21:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00232378",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "estimated_end_date": "2020-07-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-21T18:45:49-04:00",
    "status": "resolved",
    "en_comments": "Allocating to 100% of our market.",
    "fr_comments": "Allocating to 100% of our market.",
    "en_drug_brand_name": "TEVA-PREDNISONE",
    "en_drug_common_name": "PREDNISONE 50MG TAB",
    "fr_drug_brand_name": "TEVA-PREDNISONE 50MG TAB",
    "fr_drug_common_name": "PREDNISONE 50MG TAB",
    "en_ingredients": "PREDNISONE",
    "fr_ingredients": "Prednisone",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110776,
    "drug": {
      "current_status": "MARKETED",
      "id": 17322,
      "drug_code": 78369,
      "updated_date": "2025-05-15T02:31:58-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256100,
          "ingredient": {
            "id": 2640,
            "ingredient_code": 11819,
            "en_name": "RISEDRONATE SODIUM",
            "fr_name": "Risédronate sodique (Hémipentahydrate de risédronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "35",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02298392",
      "brand_name": "TEVA-RISEDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135301003"
    },
    "created_date": "2020-04-03T14:22:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02298392",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-04-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-09T20:01:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-RISEDRONATE",
    "en_drug_common_name": "RISEDRONATE 35MG TABS",
    "fr_drug_brand_name": "TEVA-RISEDRONATE 35MG TABS",
    "fr_drug_common_name": "RISEDRONATE 35MG TABS",
    "en_ingredients": "RISEDRONATE SODIUM",
    "fr_ingredients": "Risédronate sodique",
    "drug_strength": "35MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110779,
    "drug": {
      "current_status": "MARKETED",
      "id": 4692,
      "drug_code": 2447,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250414,
          "ingredient": {
            "id": 564,
            "ingredient_code": 10091,
            "en_name": "FUROSEMIDE",
            "fr_name": "Furosémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00337749",
      "brand_name": "TEVA-FUROSEMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "49660",
      "number_of_ais": "1",
      "ai_group_no": "0101944001"
    },
    "created_date": "2020-04-03T14:23:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00337749",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C03CA",
    "atc_description": "HIGH-CEILING DIURETICS",
    "estimated_end_date": "2020-04-30T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-23T18:31:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FUROSEMIDE",
    "en_drug_common_name": "FUROSEMIDE 40MG TAB",
    "fr_drug_brand_name": "TEVA-FUROSEMIDE 40MG TAB",
    "fr_drug_common_name": "FUROSEMIDE 40MG TAB",
    "en_ingredients": "FUROSEMIDE",
    "fr_ingredients": "Furosémide",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110782,
    "drug": {
      "current_status": "MARKETED",
      "id": 18174,
      "drug_code": 79437,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256373,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02308754",
      "brand_name": "TEVA-SILDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261003"
    },
    "created_date": "2020-04-03T14:25:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02308754",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2020-12-31T00:00:00-05:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-04-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-09T20:01:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SILDENAFIL",
    "en_drug_common_name": "SILDENAFIL 100MG TAB",
    "fr_drug_brand_name": "TEVA-SILDENAFIL 100MG TAB",
    "fr_drug_common_name": "SILDENAFIL 100MG TAB",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "SILDENAFIL",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110785,
    "drug": {
      "current_status": "MARKETED",
      "id": 8418,
      "drug_code": 5858,
      "updated_date": "2025-05-15T02:30:35-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250842,
          "ingredient": {
            "id": 1010,
            "ingredient_code": 7408,
            "en_name": "SPIRONOLACTONE",
            "fr_name": "Spironolactone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250841,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00613231",
      "brand_name": "TEVA-SPIRONOLACTONE/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61643",
      "number_of_ais": "2",
      "ai_group_no": "0201064001"
    },
    "created_date": "2020-04-03T14:26:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00613231",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C03EA",
    "atc_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-04T18:49:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SPIRONOLACTONE/HCTZ",
    "en_drug_common_name": "SPIRONOLACTONE HCTZ 25/25MG TAB",
    "fr_drug_brand_name": "TEVA-SPIRONOLACTONE HCTZ 25/25MG TAB",
    "fr_drug_common_name": "SPIRONOLACTONE HCTZ 25/25MG TAB",
    "en_ingredients": "SPIRONOLACTONE\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Spironolactone\r\nHydrochlorothiazide",
    "drug_strength": "25MG\r\n25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110788,
    "drug": {
      "current_status": "MARKETED",
      "id": 23846,
      "drug_code": 86513,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258582,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258581,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379252",
      "brand_name": "TEVA-TELMISARTAN HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0244783002"
    },
    "created_date": "2020-04-03T14:28:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379252",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-14T17:51:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TELMISARTAN HCTZ",
    "en_drug_common_name": "TELMISARTAN/HCTZ 80/25MG TAB",
    "fr_drug_brand_name": "TEVA-TELMISARTAN/HCTZ 80/25MG TAB",
    "fr_drug_common_name": "TELMISARTAN/HCTZ 80/25MG TAB",
    "en_ingredients": "TELMISARTAN\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Telmisartan\r\nHydrochlorothiazide",
    "drug_strength": "80.0MG\r\n25.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 & UD 30's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110791,
    "drug": {
      "current_status": "MARKETED",
      "id": 6840,
      "drug_code": 4523,
      "updated_date": "2025-05-15T02:30:31-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250648,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250647,
          "ingredient": {
            "id": 2256,
            "ingredient_code": 10190,
            "en_name": "TRIAMTERENE",
            "fr_name": "Triamtérène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00532657",
      "brand_name": "TEVA-TRIAMTERENE/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57941",
      "number_of_ais": "2",
      "ai_group_no": "0201052001"
    },
    "created_date": "2020-04-03T14:29:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00532657",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C03EA",
    "atc_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-01T17:22:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TRIAMTERENE/HCTZ",
    "en_drug_common_name": "TRIAMTERENE HCTZ 50/25MG TABS",
    "fr_drug_brand_name": "TEVA-TRIAMTERENE HCTZ 50/25MG TABS",
    "fr_drug_common_name": "TRIAMTERENE HCTZ 50/25MG TABS",
    "en_ingredients": "TRIAMTERENE\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Triamtérène\r\nHydrochlorothiazide",
    "drug_strength": "50MG\r\n25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110794,
    "drug": {
      "current_status": "MARKETED",
      "id": 6840,
      "drug_code": 4523,
      "updated_date": "2025-05-15T02:30:31-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250648,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250647,
          "ingredient": {
            "id": 2256,
            "ingredient_code": 10190,
            "en_name": "TRIAMTERENE",
            "fr_name": "Triamtérène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00532657",
      "brand_name": "TEVA-TRIAMTERENE/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57941",
      "number_of_ais": "2",
      "ai_group_no": "0201052001"
    },
    "created_date": "2020-04-03T14:30:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00532657",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C03EA",
    "atc_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-05-14T15:20:23-04:00",
    "status": "resolved",
    "en_comments": "Item is discontinued",
    "fr_comments": "Item is discontinued",
    "en_drug_brand_name": "TEVA-TRIAMTERENE/HCTZ",
    "en_drug_common_name": "TEVA-TRIAMTERENE HCTZ 50/25MG TABS",
    "fr_drug_brand_name": "TEVA-TRIAMTERENE HCTZ 50/25MG TABS",
    "fr_drug_common_name": "TRIAMTERENE HCTZ 50/25MG TABS",
    "en_ingredients": "TRIAMTERENE\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Triamtérène\r\nHydrochlorothiazide",
    "drug_strength": "50MG\r\n25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110797,
    "drug": {
      "current_status": "MARKETED",
      "id": 30356,
      "drug_code": 92406,
      "updated_date": "2025-12-03T00:32:47-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261094,
          "ingredient": {
            "id": 2566,
            "ingredient_code": 11772,
            "en_name": "BUPROPION HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupropion"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439662",
      "brand_name": "TEVA-BUPROPION XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131140004"
    },
    "created_date": "2020-04-03T15:10:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439662",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-08T19:52:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT BUPROPION XL",
    "en_drug_common_name": "BUPROPION XL 300MG SR TAB",
    "fr_drug_brand_name": "ACT-BUPROPION XL 300MG SR TAB",
    "fr_drug_common_name": "BUPROPION XL 300MG SR TAB",
    "en_ingredients": "BUPROPION HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupropion",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110800,
    "drug": {
      "current_status": "MARKETED",
      "id": 14216,
      "drug_code": 74296,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255131,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02257726",
      "brand_name": "TEVA-METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2020-04-03T15:14:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02257726",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-04T18:49:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT METFORMIN",
    "en_drug_common_name": "METFORMIN 500MG FC TAB",
    "fr_drug_brand_name": "ACT-METFORMIN 500MG FC TAB",
    "fr_drug_common_name": "METFORMIN 500MG FC TAB",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110803,
    "drug": {
      "current_status": "MARKETED",
      "id": 14216,
      "drug_code": 74296,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255131,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02257726",
      "brand_name": "TEVA-METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2020-04-03T15:15:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02257726",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2020-07-31T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-14T17:48:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT METFORMIN",
    "en_drug_common_name": "METFORMIN 500MG FC TAB",
    "fr_drug_brand_name": "ACT-METFORMIN 500MG FC TAB",
    "fr_drug_common_name": "METFORMIN 500MG FC TAB",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "360",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110806,
    "drug": {
      "current_status": "MARKETED",
      "id": 14216,
      "drug_code": 74296,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255131,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02257726",
      "brand_name": "TEVA-METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2020-04-03T15:16:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02257726",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2020-04-30T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-23T18:30:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT METFORMIN",
    "en_drug_common_name": "METFORMIN 500MG FC TAB",
    "fr_drug_brand_name": "ACT-METFORMIN 500MG FC TAB",
    "fr_drug_common_name": "METFORMIN 500MG FC TAB",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110817,
    "drug": {
      "current_status": "MARKETED",
      "id": 20830,
      "drug_code": 82711,
      "updated_date": "2025-05-15T02:32:34-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257366,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02341611",
      "brand_name": "REVATIO",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261005"
    },
    "created_date": "2020-04-03T16:29:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02341611",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "C02KX",
    "atc_description": "OTHER ANTIHYPERTENSIVES",
    "estimated_end_date": "2020-08-07T00:00:00-04:00",
    "actual_start_date": "2020-04-02T00:00:00-04:00",
    "actual_end_date": "2020-08-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-08-07T13:51:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "REVATIO",
    "en_drug_common_name": "Revatio",
    "fr_drug_brand_name": "Revatio",
    "fr_drug_common_name": "Revatio",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "Sildenafil",
    "drug_strength": "0.8MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1x 12.5ml Vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110831,
    "drug": {
      "current_status": "MARKETED",
      "id": 6904,
      "drug_code": 46718,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8253199,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00884359",
      "brand_name": "ZOCOR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "Y9291",
      "number_of_ais": "1",
      "ai_group_no": "0122415002"
    },
    "created_date": "2020-04-03T19:29:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00884359",
    "company_name": "MERCK CANADA INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2020-04-03T00:00:00-04:00",
    "estimated_end_date": "2020-04-10T00:00:00-04:00",
    "actual_start_date": "2020-04-02T00:00:00-04:00",
    "actual_end_date": "2020-04-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-04-09T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ZOCOR",
    "en_drug_common_name": "simvastatin tablets",
    "fr_drug_brand_name": "ZOCOR",
    "fr_drug_common_name": "comprimés de simvastatine",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110834,
    "drug": {
      "current_status": "MARKETED",
      "id": 10804,
      "drug_code": 66635,
      "updated_date": "2025-05-15T02:31:12-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8254082,
          "ingredient": {
            "id": 2312,
            "ingredient_code": 9011,
            "en_name": "SCOPOLAMINE HYDROBROMIDE",
            "fr_name": "Bromhydrate de scopolamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242810",
      "brand_name": "SCOPOLAMINE HYDROBROMIDE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104674001"
    },
    "created_date": "2020-04-03T19:42:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242810",
    "company_name": "OMEGA LABORATORIES LTD",
    "atc_number": "N05CM",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "estimated_end_date": "2020-06-08T00:00:00-04:00",
    "actual_start_date": "2020-04-02T00:00:00-04:00",
    "actual_end_date": "2020-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-06-09T19:51:58-04:00",
    "status": "resolved",
    "en_comments": "On Allocation (Covid-19)",
    "fr_comments": "En Allocation (Covid-19)",
    "en_drug_brand_name": "SCOPOLAMINE HYDROBROMIDE INJECTION",
    "en_drug_common_name": "Scopolamine Hydrobromide Injection",
    "fr_drug_brand_name": "Injection de bromhydrate de scopolamine",
    "fr_drug_common_name": "Injection de bromhydrate de scopolamine",
    "en_ingredients": "SCOPOLAMINE HYDROBROMIDE",
    "fr_ingredients": "Bromhydrate de scopolamine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée\r\nIntramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10 x 1mL vial /fiole",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110839,
    "drug": {
      "current_status": "MARKETED",
      "id": 10806,
      "drug_code": 66636,
      "updated_date": "2025-05-15T02:31:12-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8254083,
          "ingredient": {
            "id": 2312,
            "ingredient_code": 9011,
            "en_name": "SCOPOLAMINE HYDROBROMIDE",
            "fr_name": "Bromhydrate de scopolamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242811",
      "brand_name": "SCOPOLAMINE HYDROBROMIDE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104674004"
    },
    "created_date": "2020-04-03T19:46:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242811",
    "company_name": "OMEGA LABORATORIES LTD",
    "atc_number": "N05CM",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2020-04-02T00:00:00-04:00",
    "actual_end_date": "2020-09-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-09-18T14:59:37-04:00",
    "status": "resolved",
    "en_comments": "On Allocation (Covid-19)",
    "fr_comments": "En Allocation (Covid-19)",
    "en_drug_brand_name": "SCOPOLAMINE HYDROBROMIDE INJECTION",
    "en_drug_common_name": "Scopolamine Hydrobromide Injection",
    "fr_drug_brand_name": "Injection de bromhydrate de scopolamine",
    "fr_drug_common_name": "Injection de bromhydrate de scopolamine",
    "en_ingredients": "SCOPOLAMINE HYDROBROMIDE",
    "fr_ingredients": "Bromhydrate de scopolamine",
    "drug_strength": "0.6MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée\r\nIntramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10 x 1mL vial /fiole",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110842,
    "drug": {
      "current_status": "MARKETED",
      "id": 22364,
      "drug_code": 84760,
      "updated_date": "2025-12-03T00:31:44-05:00",
      "company": {
        "id": 17393,
        "created_date": "2025-12-03T00:30:14-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 22004,
        "mfr_code": "",
        "name": "JUNO PHARMA CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258008,
          "ingredient": {
            "id": 1166,
            "ingredient_code": 1076,
            "en_name": "POTASSIUM ACETATE",
            "fr_name": "Acétate de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "39.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02362597",
      "brand_name": "POTASSIUM ACETATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "POTASSIUM 4MMOL/ML. 50ML SINGLE USE VIALS.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107304002"
    },
    "created_date": "2020-04-03T19:48:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362597",
    "company_name": "OMEGA LABORATORIES LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-19T14:04:54-04:00",
    "status": "resolved",
    "en_comments": "On Allocation",
    "fr_comments": "En Allocation",
    "en_drug_brand_name": "POTASSIUM ACETATE INJECTION USP",
    "en_drug_common_name": "Potassium Acetate Injection",
    "fr_drug_brand_name": "Acétate de potassium injection",
    "fr_drug_common_name": "Acétate de potassium injection",
    "en_ingredients": "POTASSIUM ACETATE",
    "fr_ingredients": "Acétate de potassium",
    "drug_strength": "39.2%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 50mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110845,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 80,
      "drug_code": 10169,
      "updated_date": "2025-05-15T03:36:52-04:00",
      "company": {
        "id": 30,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 3574,
        "mfr_code": "ALL07",
        "name": "ALLERGAN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "300",
        "street_name": "1380 RODICK ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MARKHAM",
        "postal_code": "L3R 4G5",
        "post_office_box": "",
        "contact_information": "Company contact information;\r\nTelephone number: 800-668-6424\r\nEmail address: MR-GENERAL_INQUIRY@allergan.com\r\nWebsite address: allergan.ca\r\nPostal address:  500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5"
      },
      "drug_ingredients": [
        {
          "id": 8286365,
          "ingredient": {
            "id": 70,
            "ingredient_code": 7617,
            "en_name": "PREDNISOLONE ACETATE",
            "fr_name": "Acétate de prednisolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8286364,
          "ingredient": {
            "id": 72,
            "ingredient_code": 8145,
            "en_name": "SULFACETAMIDE SODIUM",
            "fr_name": "Sulfacétamide sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00807788",
      "brand_name": "BLEPHAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69880",
      "number_of_ais": "2",
      "ai_group_no": "0206094001"
    },
    "created_date": "2020-04-03T19:58:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00807788",
    "company_name": "ALLERGAN INC",
    "atc_number": "S01CA",
    "atc_description": "ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB",
    "anticipated_start_date": "2020-04-03T00:00:00-04:00",
    "estimated_end_date": "2020-04-20T00:00:00-04:00",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-07T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BLEPHAMIDE",
    "en_drug_common_name": "sulfacetamide/prednisolone",
    "fr_drug_brand_name": "BLEPHAMIDE",
    "fr_drug_common_name": "sulfacetamide/prednisolone",
    "en_ingredients": "SULFACETAMIDE SODIUM\r\nPREDNISOLONE ACETATE",
    "fr_ingredients": "Sulfacétamide sodique\r\nAcétate de prednisolone",
    "drug_strength": "10%\r\n0.2%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "10ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110849,
    "drug": {
      "current_status": "MARKETED",
      "id": 10008,
      "drug_code": 64426,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253808,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        },
        {
          "id": 8253807,
          "ingredient": {
            "id": 2000,
            "ingredient_code": 11282,
            "en_name": "SALMETEROL",
            "fr_name": "Salmétérol (Xinafoate de salmétérol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02240835",
      "brand_name": "ADVAIR 100 DISKUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0238341001"
    },
    "created_date": "2020-04-03T20:42:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240835",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03AK",
    "atc_description": "ADRENERGICS, INHALANTS",
    "actual_start_date": "2020-04-02T00:00:00-04:00",
    "actual_end_date": "2020-05-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-05-13T14:39:53-04:00",
    "status": "resolved",
    "en_comments": "Re-supply is ongoing with inventory allocated to 100% of regular demand",
    "fr_comments": "Un réapprovisionnement est en cours avec une allocation des stocks à 100 % de la demande régulière.",
    "en_drug_brand_name": "ADVAIR 100 DISKUS",
    "en_drug_common_name": "fluticasone propionate and salmeterol inhalation powder",
    "fr_drug_brand_name": "ADVAIR 100 DISKUS",
    "fr_drug_common_name": "propionate de fluticasone et salmétérol en poudre pour inhalation",
    "en_ingredients": "SALMETEROL\r\nFLUTICASONE PROPIONATE",
    "fr_ingredients": "Propionate de fluticasone",
    "drug_strength": "50MCG\r\n100MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110852,
    "drug": {
      "current_status": "MARKETED",
      "id": 28148,
      "drug_code": 90298,
      "updated_date": "2025-05-15T02:34:11-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8260227,
          "ingredient": {
            "id": 3868,
            "ingredient_code": 22120,
            "en_name": "VILANTEROL",
            "fr_name": "Vilantérol (Trifénatate de vilantérol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        },
        {
          "id": 8260226,
          "ingredient": {
            "id": 3936,
            "ingredient_code": 22230,
            "en_name": "UMECLIDINIUM",
            "fr_name": "Uméclidinium (Bromure d'uméclidinium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "62.5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02418401",
      "brand_name": "ANORO ELLIPTA",
      "brand_name_fr": "",
      "descriptor": "POWDER FOR ORAL INHALATION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0255171002"
    },
    "created_date": "2020-04-03T20:54:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02418401",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03AL",
    "atc_description": "ADRENERGICS, INHALANTS",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-04-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-04-22T15:58:47-04:00",
    "status": "resolved",
    "en_comments": "Re-supply is ongoing with inventory allocated to 50% of regular demand.",
    "fr_comments": "Un réapprovisionnement est en cours avec une allocation des stocks à 50 % de la demande régulière.",
    "en_drug_brand_name": "ANORO ELLIPTA",
    "en_drug_common_name": "umeclidinium (as bromide) and vilanterol (as trifenatate) dry powder for oral inhalation",
    "fr_drug_brand_name": "ANORO ELLIPTA",
    "fr_drug_common_name": "uméclidinium (sous forme de bromure) et vilantérol (sous forme de trifénatate) en poudre",
    "en_ingredients": "VILANTEROL\r\nUMECLIDINIUM",
    "fr_ingredients": "Vilantérol (Vilanterol trifenatate) Uméclidinium (Umeclidinium bromide)",
    "drug_strength": "25MCG\r\n62.5MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110855,
    "drug": {
      "current_status": "MARKETED",
      "id": 9254,
      "drug_code": 62268,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253612,
          "ingredient": {
            "id": 1116,
            "ingredient_code": 11247,
            "en_name": "CLAVULANIC ACID",
            "fr_name": "Acide clavulanique (Clavulinate potassique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "57",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253611,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02238830",
      "brand_name": "CLAVULIN 400",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0234720004"
    },
    "created_date": "2020-04-03T21:06:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238830",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J01CR",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-06-03T14:22:34-04:00",
    "status": "resolved",
    "en_comments": "Re-supply is ongoing with inventory allocated to 100% of regular demand.",
    "fr_comments": "Un réapprovisionnement est en cours avec une allocation des stocks à 100 % de la demande régulière.",
    "en_drug_brand_name": "CLAVULIN 400",
    "en_drug_common_name": "amoxicillin / clavulanate potassium for oral suspension",
    "fr_drug_brand_name": "CLAVULIN 400",
    "fr_drug_common_name": "amoxicilline et clavulanate de potassium pour suspension orale",
    "en_ingredients": "CLAVULANIC ACID\r\nAMOXICILLIN",
    "fr_ingredients": "Amoxicilline (AMOXICILLIN TRIHYDRATE); Acide clavulanique (CLAVULANATE POTASSIUM)",
    "drug_strength": "57MG\r\n400MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "70mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110860,
    "drug": {
      "current_status": "MARKETED",
      "id": 8696,
      "drug_code": 60565,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253507,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02237245",
      "brand_name": "FLOVENT DISKUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124685007"
    },
    "created_date": "2020-04-03T21:21:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237245",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "actual_start_date": "2020-04-02T00:00:00-04:00",
    "actual_end_date": "2020-05-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-05-27T14:18:29-04:00",
    "status": "resolved",
    "en_comments": "For emergency supply, contact GSK Customer Service 1-800-387-7374.",
    "fr_comments": "Pour un approvisionnement d’urgence, communiquez avec le Service à la clientèle de GSK au 1-800-387-7374.",
    "en_drug_brand_name": "FLOVENT DISKUS",
    "en_drug_common_name": "fluticasone propionate powder for inhalation",
    "fr_drug_brand_name": "FLOVENT DISKUS",
    "fr_drug_common_name": "propionate de fluticasone en poudre pour inhalation",
    "en_ingredients": "FLUTICASONE PROPIONATE",
    "fr_ingredients": "Propionate de fluticasone",
    "drug_strength": "100MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "60's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110863,
    "drug": {
      "current_status": "MARKETED",
      "id": 7294,
      "drug_code": 49290,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253268,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02230420",
      "brand_name": "IMITREX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238005"
    },
    "created_date": "2020-04-03T21:32:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230420",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-04-30T16:54:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX NASAL SPRAY",
    "en_drug_common_name": "sumatriptan nasal spray",
    "fr_drug_brand_name": "IMITREX NASAL SPRAY",
    "fr_drug_common_name": "vaporisation nasale de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "Sumatriptan",
    "drug_strength": "20MG",
    "drug_dosage_form": "SPRAY",
    "drug_dosage_form_fr": "Pulvérisation",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "2's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110866,
    "drug": {
      "current_status": "MARKETED",
      "id": 10224,
      "drug_code": 65137,
      "updated_date": "2025-12-03T00:30:43-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253867,
          "ingredient": {
            "id": 124,
            "ingredient_code": 2585,
            "en_name": "SALBUTAMOL",
            "fr_name": "Salbutamol (Sulfate de salbutamol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02241497",
      "brand_name": "VENTOLIN HFA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108887003"
    },
    "created_date": "2020-04-03T21:39:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241497",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03AC",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2020-07-15T00:00:00-04:00",
    "actual_start_date": "2020-04-02T00:00:00-04:00",
    "actual_end_date": "2020-07-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-07-03T14:51:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VENTOLIN HFA",
    "en_drug_common_name": "salbutamol sulfate inhalation aerosol",
    "fr_drug_brand_name": "VENTOLIN HFA",
    "fr_drug_common_name": "sulfate de salbutamol en aérosol pour inhalation",
    "en_ingredients": "SALBUTAMOL",
    "fr_ingredients": "Salbutamol (Sulfate de salbutamol)",
    "drug_strength": "100MCG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "1x200",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110875,
    "drug": {
      "current_status": "MARKETED",
      "id": 10904,
      "drug_code": 66825,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 598,
        "created_date": "2017-03-09T13:22:57-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11314,
        "mfr_code": "TPT08",
        "name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254109,
          "ingredient": {
            "id": 2848,
            "ingredient_code": 7509,
            "en_name": "HYDROCORTISONE VALERATE",
            "fr_name": "Valérate d'hydrocortisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242985",
      "brand_name": "HYDROVAL OINTMENT 0.2%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112513001"
    },
    "created_date": "2020-04-03T22:00:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242985",
    "company_name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
    "atc_number": "D07AA",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2020-10-02T00:00:00-04:00",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-07T19:20:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HYDROVAL OINTMENT 0.2%",
    "en_drug_common_name": "HYDROVAL OINTMENT 0.2%",
    "fr_drug_brand_name": "HYDROVAL OINTMENT 0.2%",
    "fr_drug_common_name": "HYDROVAL OINTMENT 0.2%",
    "en_ingredients": "HYDROCORTISONE VALERATE",
    "fr_ingredients": "Valérate d'hydrocortisone",
    "drug_strength": "0.2%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "60 g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110912,
    "drug": {
      "current_status": "MARKETED",
      "id": 53021,
      "drug_code": 94454,
      "updated_date": "2025-05-15T02:35:34-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262117,
          "ingredient": {
            "id": 2586,
            "ingredient_code": 11787,
            "en_name": "CAPECITABINE",
            "fr_name": "Capécitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457490",
      "brand_name": "TARO-CAPECITABINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134120001"
    },
    "created_date": "2020-04-03T22:09:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457490",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "estimated_end_date": "2020-05-15T00:00:00-04:00",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-27T10:32:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CAPECITABINE",
    "en_drug_common_name": "TARO-CAPECITABINE",
    "fr_drug_brand_name": "TARO-CAPECITABINE",
    "fr_drug_common_name": "TARO-CAPECITABINE",
    "en_ingredients": "CAPECITABINE",
    "fr_ingredients": "Capécitabine",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 bottle",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110915,
    "drug": {
      "current_status": "MARKETED",
      "id": 10734,
      "drug_code": 66472,
      "updated_date": "2025-05-15T02:31:11-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254062,
          "ingredient": {
            "id": 704,
            "ingredient_code": 9054,
            "en_name": "WARFARIN SODIUM",
            "fr_name": "Warfarine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02242682",
      "brand_name": "TARO-WARFARIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104597005"
    },
    "created_date": "2020-04-03T22:10:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242682",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "B01AA",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2020-04-24T00:00:00-04:00",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-04-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-01T09:37:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-WARFARIN",
    "en_drug_common_name": "WARFARIN",
    "fr_drug_brand_name": "TARO-WARFARIN",
    "fr_drug_common_name": "WARFARIN",
    "en_ingredients": "WARFARIN SODIUM",
    "fr_ingredients": "Warfarine sodique",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "250",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110920,
    "drug": {
      "current_status": "MARKETED",
      "id": 24992,
      "drug_code": 87502,
      "updated_date": "2025-12-03T00:32:03-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259037,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389517",
      "brand_name": "SPC-MONTELUKAST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823002"
    },
    "created_date": "2020-04-03T22:13:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389517",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "R03DC",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "estimated_end_date": "2020-07-03T00:00:00-04:00",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-07-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-07-03T19:54:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-MONTELUKAST",
    "en_drug_common_name": "MONTELUKAST",
    "fr_drug_brand_name": "RAN-MONTELUKAST",
    "fr_drug_common_name": "MONTELUKAST",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "MONTELUKAST",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110933,
    "drug": {
      "current_status": "MARKETED",
      "id": 18350,
      "drug_code": 79614,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256434,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310511",
      "brand_name": "TARO-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858004"
    },
    "created_date": "2020-04-03T22:16:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310511",
    "company_name": "SUN PHARMA CANADA INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2020-04-24T00:00:00-04:00",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-21T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL",
    "fr_drug_brand_name": "TARO-RAMIPRIL",
    "fr_drug_common_name": "RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110950,
    "drug": {
      "current_status": "MARKETED",
      "id": 29386,
      "drug_code": 91393,
      "updated_date": "2025-12-03T00:32:39-05:00",
      "company": {
        "id": 80,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4489,
        "mfr_code": "LEO08",
        "name": "LEO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6 ADELAIDE STREET EAST, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5C 1H6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260661,
          "ingredient": {
            "id": 1538,
            "ingredient_code": 619,
            "en_name": "TINZAPARIN SODIUM",
            "fr_name": "Tinzaparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "0.6",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02429470",
      "brand_name": "INNOHEP",
      "brand_name_fr": "",
      "descriptor": "UNIT DOSE 0.6ML PRE-FILLED SYRINGES. 20000 ANTI-XA IU/ML. PRESERVATIVE FREE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124929003"
    },
    "created_date": "2020-04-04T12:43:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429470",
    "company_name": "LEO PHARMA INC",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2020-05-15T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-23T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "INNOHEP",
    "en_drug_common_name": "tinzaparin sodium",
    "fr_drug_brand_name": "Innohep",
    "fr_drug_common_name": "Tinzaparine sodique",
    "en_ingredients": "TINZAPARIN SODIUM",
    "fr_ingredients": "Tinzaparine sodique",
    "drug_strength": "12000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "10 x 0.6mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110953,
    "drug": {
      "current_status": "MARKETED",
      "id": 13336,
      "drug_code": 7293,
      "updated_date": "2025-12-03T00:30:24-05:00",
      "company": {
        "id": 430,
        "created_date": "2017-03-09T13:22:46-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15812,
        "mfr_code": "",
        "name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ZIEGELHOF 24",
        "province": "MECKLENBURG - WEST POMERANIA",
        "country": "GERMANY",
        "city": "GREIFSWALD",
        "postal_code": "17489",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251002,
          "ingredient": {
            "id": 2696,
            "ingredient_code": 4892,
            "en_name": "ALFACALCIDOL",
            "fr_name": "Alfacalcidol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00474525",
      "brand_name": "ONE-ALPHA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "65089",
      "number_of_ais": "1",
      "ai_group_no": "0135700002"
    },
    "created_date": "2020-04-04T16:02:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00474525",
    "company_name": "LEO PHARMA INC",
    "atc_number": "A11CC",
    "atc_description": "VIT A AND D, INCL COMBINATIONS OF THE TWO",
    "estimated_end_date": "2020-05-15T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-05-16T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ONE ALPHA CAPS 1MCG",
    "en_drug_common_name": "alphacalcidol",
    "fr_drug_brand_name": "ONE-ALPHA",
    "fr_drug_common_name": "Alfacalcidol",
    "en_ingredients": "ALFACALCIDOL",
    "fr_ingredients": "Alfacalcidol",
    "drug_strength": "1MCG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "10 x 10 blisters",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110956,
    "drug": {
      "current_status": "DORMANT",
      "id": 59269,
      "drug_code": 96746,
      "updated_date": "2025-05-15T06:56:01-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369549,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02476614",
      "brand_name": "APO-HYDROMORPHONE CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698002"
    },
    "created_date": "2020-04-05T00:45:24-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02476614",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2019-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-05T00:46:09-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "APO-HYDROMORPHONE CR",
    "en_drug_common_name": "HYDROMORPHONE CR",
    "fr_drug_brand_name": "APO-HYDROMORPHONE CR",
    "fr_drug_common_name": "HYDROMORPHONE CR",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "3MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 btl",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110959,
    "drug": {
      "current_status": "DORMANT",
      "id": 59273,
      "drug_code": 96748,
      "updated_date": "2025-05-15T06:56:01-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369551,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02476630",
      "brand_name": "APO-HYDROMORPHONE CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698010"
    },
    "created_date": "2020-04-05T00:47:49-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02476630",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2019-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-05T00:48:15-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "APO-HYDROMORPHONE CR",
    "en_drug_common_name": "HYDROMORPHONE CR",
    "fr_drug_brand_name": "APO-HYDROMORPHONE CR",
    "fr_drug_common_name": "HYDROMORPHONE CR",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "6MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110962,
    "drug": {
      "current_status": "DORMANT",
      "id": 59735,
      "drug_code": 96750,
      "updated_date": "2025-05-15T06:56:01-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369553,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02476657",
      "brand_name": "APO-HYDROMORPHONE CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698011"
    },
    "created_date": "2020-04-05T00:49:13-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02476657",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2019-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-05T00:49:39-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "APO-HYDROMORPHONE CR",
    "en_drug_common_name": "HYDROMORPHONE CR",
    "fr_drug_brand_name": "APO-HYDROMORPHONE CR",
    "fr_drug_common_name": "HYDROMORPHONE CR",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "12MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110965,
    "drug": {
      "current_status": "DORMANT",
      "id": 59277,
      "drug_code": 96751,
      "updated_date": "2025-05-15T06:56:01-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369554,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "18",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02476665",
      "brand_name": "APO-HYDROMORPHONE CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698015"
    },
    "created_date": "2020-04-05T00:50:47-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02476665",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2019-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-05T00:51:19-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "APO-HYDROMORPHONE CR",
    "en_drug_common_name": "HYDROMORPHONE CR",
    "fr_drug_brand_name": "APO-HYDROMORPHONE CR",
    "fr_drug_common_name": "HYDROMORPHONE CR",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "18MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110968,
    "drug": {
      "current_status": "DORMANT",
      "id": 59279,
      "drug_code": 96752,
      "updated_date": "2025-05-15T06:56:01-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369555,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "24",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02476673",
      "brand_name": "APO-HYDROMORPHONE CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698012"
    },
    "created_date": "2020-04-05T00:52:25-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02476673",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2019-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-05T00:52:51-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "APO-HYDROMORPHONE CR",
    "en_drug_common_name": "HYDROMORPHONE CR",
    "fr_drug_brand_name": "APO-HYDROMORPHONE CR",
    "fr_drug_common_name": "HYDROMORPHONE CR",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "24MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110971,
    "drug": {
      "current_status": "DORMANT",
      "id": 59281,
      "drug_code": 96753,
      "updated_date": "2025-05-15T06:56:01-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369556,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02476681",
      "brand_name": "APO-HYDROMORPHONE CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698013"
    },
    "created_date": "2020-04-05T00:53:51-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02476681",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2019-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-05T00:54:12-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "APO-HYDROMORPHONE CR",
    "en_drug_common_name": "HYDROMORPHONE CR",
    "fr_drug_brand_name": "APO-HYDROMORPHONE CR",
    "fr_drug_common_name": "HYDROMORPHONE CR",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110974,
    "drug": {
      "current_status": "DORMANT",
      "id": 59271,
      "drug_code": 96747,
      "updated_date": "2025-05-15T06:56:01-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369550,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02476622",
      "brand_name": "APO-HYDROMORPHONE CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698018"
    },
    "created_date": "2020-04-05T00:55:03-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02476622",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2019-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-05T00:55:25-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "APO-HYDROMORPHONE CR",
    "en_drug_common_name": "HYDROMORPHONE CR",
    "fr_drug_brand_name": "APO-HYDROMORPHONE CR",
    "fr_drug_common_name": "HYDROMORPHONE CR",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "4.5MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 110977,
    "drug": {
      "current_status": "DORMANT",
      "id": 59275,
      "drug_code": 96749,
      "updated_date": "2025-05-15T06:56:01-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369552,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02476649",
      "brand_name": "APO-HYDROMORPHONE CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698019"
    },
    "created_date": "2020-04-05T00:56:14-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02476649",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2019-12-30T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-05T00:56:38-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "APO-HYDROMORPHONE CR",
    "en_drug_common_name": "HYDROMORPHONE CR",
    "fr_drug_brand_name": "APO-HYDROMORPHONE CR",
    "fr_drug_common_name": "HYDROMORPHONE CR",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "9MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111002,
    "drug": {
      "current_status": "MARKETED",
      "id": 2592,
      "drug_code": 16195,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252098,
          "ingredient": {
            "id": 1238,
            "ingredient_code": 11220,
            "en_name": "BROMOCRIPTINE",
            "fr_name": "Bromocriptine (Mésylate de bromocriptine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02087324",
      "brand_name": "BROMOCRIPTINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77983",
      "number_of_ais": "1",
      "ai_group_no": "0111278001"
    },
    "created_date": "2020-04-06T13:04:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02087324",
    "company_name": "AA PHARMA INC",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2020-04-04T00:00:00-04:00",
    "estimated_end_date": "2020-07-04T00:00:00-04:00",
    "actual_start_date": "2020-04-04T00:00:00-04:00",
    "actual_end_date": "2020-07-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-07-24T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BROMOCRIPTINE",
    "en_drug_common_name": "BROMOCRIPTINE",
    "fr_drug_brand_name": "BROMOCRIPTINE",
    "fr_drug_common_name": "BROMOCRIPTINE",
    "en_ingredients": "BROMOCRIPTINE",
    "fr_ingredients": "BROMOCRIPTINE MESYLATE",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111006,
    "drug": {
      "current_status": "DORMANT",
      "id": 10932,
      "drug_code": 6687,
      "updated_date": "2025-05-15T06:55:21-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366423,
          "ingredient": {
            "id": 206,
            "ingredient_code": 8618,
            "en_name": "ERYTHROMYCIN",
            "fr_name": "Érythromycine (Stéarate d'érythromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00682020",
      "brand_name": "ERYTHRO-BASE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63846",
      "number_of_ais": "1",
      "ai_group_no": "0105708003"
    },
    "created_date": "2020-04-06T13:07:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00682020",
    "company_name": "AA PHARMA INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2021-03-01T00:00:00-05:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2021-02-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-02-20T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ERYTHRO-BASE",
    "en_drug_common_name": "ERYTHRO-BASE",
    "fr_drug_brand_name": "ERYTHRO-BASE",
    "fr_drug_common_name": "ERYTHRO-BASE",
    "en_ingredients": "ERYTHROMYCIN",
    "fr_ingredients": "Érythromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111031,
    "drug": {
      "current_status": "MARKETED",
      "id": 12576,
      "drug_code": 71309,
      "updated_date": "2025-05-15T02:31:24-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254614,
          "ingredient": {
            "id": 6333,
            "ingredient_code": 1915,
            "en_name": "CYCLOSPORINE",
            "fr_name": "Cyclosporine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247074",
      "brand_name": "SANDOZ CYCLOSPORINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115996003"
    },
    "created_date": "2020-04-06T13:30:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247074",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L04AD",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2020-05-15T00:00:00-04:00",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-05-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-05-11T14:30:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ CYCLOSPORINE",
    "en_drug_common_name": "Cyclosporine",
    "fr_drug_brand_name": "Cyclosporine",
    "fr_drug_common_name": "Cyclosporine",
    "en_ingredients": "CYCLOSPORINE",
    "fr_ingredients": "Cyclosporine",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111034,
    "drug": {
      "current_status": "MARKETED",
      "id": 13882,
      "drug_code": 73813,
      "updated_date": "2025-05-15T02:31:36-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254990,
          "ingredient": {
            "id": 590,
            "ingredient_code": 4922,
            "en_name": "VITAMIN D3",
            "fr_name": "Vitamine D3"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02253178",
      "brand_name": "SANDOZ D 10 000",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108524005"
    },
    "created_date": "2020-04-06T13:34:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02253178",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A11CC",
    "atc_description": "VIT A AND D, INCL COMBINATIONS OF THE TWO",
    "estimated_end_date": "2020-05-06T00:00:00-04:00",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-05-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-05-11T14:35:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "EURO D 10 000",
    "en_drug_common_name": "EURO D",
    "fr_drug_brand_name": "EURO D",
    "fr_drug_common_name": "EURO D",
    "en_ingredients": "VITAMIN D3",
    "fr_ingredients": "Vitamine D3",
    "drug_strength": "10000UNIT",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111042,
    "drug": {
      "current_status": "MARKETED",
      "id": 2664,
      "drug_code": 16473,
      "updated_date": "2025-05-15T02:30:56-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8252125,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00884340",
      "brand_name": "ZOCOR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78364",
      "number_of_ais": "1",
      "ai_group_no": "0122415003"
    },
    "created_date": "2020-04-06T13:47:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00884340",
    "company_name": "MERCK CANADA INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2020-04-06T00:00:00-04:00",
    "estimated_end_date": "2020-04-17T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-04-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-04-17T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ZOCOR",
    "en_drug_common_name": "simvastatin tablets",
    "fr_drug_brand_name": "ZOCOR",
    "fr_drug_common_name": "comprimés de simvastatine",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111045,
    "drug": {
      "current_status": "MARKETED",
      "id": 962,
      "drug_code": 12256,
      "updated_date": "2025-05-15T02:30:52-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251604,
          "ingredient": {
            "id": 466,
            "ingredient_code": 2322,
            "en_name": "DOPAMINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de dopamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251603,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00761850",
      "brand_name": "DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73323",
      "number_of_ais": "2",
      "ai_group_no": "0217918001"
    },
    "created_date": "2020-04-06T13:56:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00761850",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "C01CA",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "anticipated_start_date": "2020-04-06T00:00:00-04:00",
    "estimated_end_date": "2020-05-01T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-05-02T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Baxter products Dopamine Hydrochloride and 5% Dextrose USP – 400mg/250mL bags (DIN 00761826) and 800mg/250mL bags (DIN 00761834) are available as alternatives if they align with clinical practice.",
    "fr_comments": "Les produits Baxter, Dopamine Hydrochloride et 5% Dextrose USP – 400mg/250mL (DIN 00761826) et 800mg/250mL (DIN 00761834)  peut être utilisé comme alternatives s'ils correspondent à la pratique clinique.",
    "en_drug_brand_name": "DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP",
    "en_drug_common_name": "Dopamine",
    "fr_drug_brand_name": "DOPAMINE HCL 0.8MG/ML DEXTROSE 5% INJ USP",
    "fr_drug_common_name": "Dopamine",
    "en_ingredients": "DOPAMINE HYDROCHLORIDE\r\nDEXTROSE",
    "fr_ingredients": "Chlorhydrate de dopamine\r\nDextrose",
    "drug_strength": ".8MG\r\n50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "250mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111051,
    "drug": {
      "current_status": "MARKETED",
      "id": 5544,
      "drug_code": 36945,
      "updated_date": "2025-12-03T00:30:35-05:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252868,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02213192",
      "brand_name": "ELTROXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4371",
      "number_of_ais": "1",
      "ai_group_no": "0107794001"
    },
    "created_date": "2020-04-06T14:08:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02213192",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "H03AA",
    "atc_description": "THYROID PREPARATIONS",
    "estimated_end_date": "2020-04-15T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-04-23T14:23:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ELTROXIN",
    "en_drug_common_name": "levothyroxine sodium",
    "fr_drug_brand_name": "ELTROXIN",
    "fr_drug_common_name": "levothyroxine sodium",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "50MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 Tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111060,
    "drug": {
      "current_status": "MARKETED",
      "id": 30822,
      "drug_code": 92924,
      "updated_date": "2025-05-15T02:35:05-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261386,
          "ingredient": {
            "id": 2142,
            "ingredient_code": 20300,
            "en_name": "NALTREXONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de naltrexone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02444275",
      "brand_name": "APO-NALTREXONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118591001"
    },
    "created_date": "2020-04-06T14:22:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02444275",
    "company_name": "APOTEX INC",
    "atc_number": "N07BB",
    "atc_description": "DRUGS USED IN ADDICTIVE DISORDERS",
    "estimated_end_date": "2020-05-22T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-05-04T13:11:07-04:00",
    "status": "resolved",
    "en_comments": "very limited inventory is available",
    "fr_comments": "very limited inventory is available",
    "en_drug_brand_name": "APO-NALTREXONE",
    "en_drug_common_name": "NALTREXONE",
    "fr_drug_brand_name": "APO-NALTREXONE",
    "fr_drug_common_name": "NALTREXONE",
    "en_ingredients": "NALTREXONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de naltrexone",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111063,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15860,
      "drug_code": 76610,
      "updated_date": "2025-12-03T01:24:19-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8342700,
          "ingredient": {
            "id": 958,
            "ingredient_code": 951,
            "en_name": "CILAZAPRIL",
            "fr_name": "Cilazapril (Monohydrate de Cilazapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02280442",
      "brand_name": "PMS-CILAZAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122806001"
    },
    "created_date": "2020-04-06T14:50:20-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02280442",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2020-04-06T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-27T15:49:32-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-CILAZAPRIL",
    "en_drug_common_name": "CILAZAPRIL",
    "fr_drug_brand_name": "PMS-CILAZAPRIL",
    "fr_drug_common_name": "CILAZAPRIL",
    "en_ingredients": "CILAZAPRIL",
    "fr_ingredients": "Cilazapril",
    "drug_strength": "1.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111066,
    "drug": {
      "current_status": "DORMANT",
      "id": 31386,
      "drug_code": 93679,
      "updated_date": "2025-05-15T06:55:56-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369355,
          "ingredient": {
            "id": 2536,
            "ingredient_code": 11714,
            "en_name": "NADROPARIN CALCIUM",
            "fr_name": "Nadroparine calcique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9500",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02450631",
      "brand_name": "FRAXIPARINE",
      "brand_name_fr": "",
      "descriptor": "0.6 ML (5700 IU) PREFILLED SYRINGE - BROWN",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131662001"
    },
    "created_date": "2020-04-06T14:51:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02450631",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2020-05-07T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-05-19T19:19:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FRAXIPARINE",
    "en_drug_common_name": "FRAXIPARINE 0.6ml 10SPR 5700 IU",
    "fr_drug_brand_name": "FRAXIPARINE",
    "fr_drug_common_name": "FRAXIPARINE 0.6ml 10SPR 5700 IU",
    "en_ingredients": "NADROPARIN CALCIUM",
    "fr_ingredients": "Nadroparine calcique",
    "drug_strength": "9500UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intraveineuse\r\nSous-cutanée\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111069,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15862,
      "drug_code": 76611,
      "updated_date": "2025-12-03T01:24:19-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8342701,
          "ingredient": {
            "id": 958,
            "ingredient_code": 951,
            "en_name": "CILAZAPRIL",
            "fr_name": "Cilazapril (Monohydrate de Cilazapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02280450",
      "brand_name": "PMS-CILAZAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122806004"
    },
    "created_date": "2020-04-06T14:51:54-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02280450",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2020-04-06T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-27T15:50:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-CILAZAPRIL",
    "en_drug_common_name": "CILAZAPRIL",
    "fr_drug_brand_name": "PMS-CILAZAPRIL",
    "fr_drug_common_name": "CILAZAPRIL",
    "en_ingredients": "CILAZAPRIL",
    "fr_ingredients": "Cilazapril",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111072,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15864,
      "drug_code": 76612,
      "updated_date": "2025-12-03T01:24:19-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8342702,
          "ingredient": {
            "id": 958,
            "ingredient_code": 951,
            "en_name": "CILAZAPRIL",
            "fr_name": "Cilazapril (Monohydrate de Cilazapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02280469",
      "brand_name": "PMS-CILAZAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122806002"
    },
    "created_date": "2020-04-06T14:53:38-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02280469",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2020-04-06T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-27T15:51:08-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-CILAZAPRIL",
    "en_drug_common_name": "CILAZAPRIL",
    "fr_drug_brand_name": "PMS-CILAZAPRIL",
    "fr_drug_common_name": "CILAZAPRIL",
    "en_ingredients": "CILAZAPRIL",
    "fr_ingredients": "Cilazapril",
    "drug_strength": "5.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111075,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15864,
      "drug_code": 76612,
      "updated_date": "2025-12-03T01:24:19-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8342702,
          "ingredient": {
            "id": 958,
            "ingredient_code": 951,
            "en_name": "CILAZAPRIL",
            "fr_name": "Cilazapril (Monohydrate de Cilazapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02280469",
      "brand_name": "PMS-CILAZAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122806002"
    },
    "created_date": "2020-04-06T14:55:04-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02280469",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2020-04-06T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-27T15:51:43-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-CILAZAPRIL",
    "en_drug_common_name": "CILAZAPRIL",
    "fr_drug_brand_name": "PMS-CILAZAPRIL",
    "fr_drug_common_name": "CILAZAPRIL",
    "en_ingredients": "CILAZAPRIL",
    "fr_ingredients": "Cilazapril",
    "drug_strength": "5.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111078,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 16796,
      "drug_code": 77757,
      "updated_date": "2025-12-03T01:24:50-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8343934,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292211",
      "brand_name": "PMS-LISINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121550001"
    },
    "created_date": "2020-04-06T14:56:02-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02292211",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2020-04-06T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-27T16:45:11-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-LISINOPRIL",
    "en_drug_common_name": "LISINOPRIL",
    "fr_drug_brand_name": "PMS-LISINOPRIL",
    "fr_drug_common_name": "LISINOPRIL",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30, 100, 500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111081,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12980,
      "drug_code": 72227,
      "updated_date": "2025-12-03T01:22:12-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8338628,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247918",
      "brand_name": "PMS-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858003"
    },
    "created_date": "2020-04-06T15:00:18-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02247918",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2020-04-06T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Product to be discontinued. Transitioned to phama-RAMIPRIL DIN (02469073)",
    "fr_discontinuation_comments": "produit sera discontinue, on fera la transition au pharma-Ramipril din 0469073",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-27T16:57:33-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL",
    "fr_drug_brand_name": "PMS-RAMIPRIL",
    "fr_drug_common_name": "RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111084,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12982,
      "drug_code": 72228,
      "updated_date": "2025-12-03T01:22:12-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8338629,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247919",
      "brand_name": "PMS-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858002"
    },
    "created_date": "2020-04-06T15:02:49-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02247919",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2020-04-06T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-04-06T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Product to be discontinued. Transitioned to phama-RAMIPRIL DIN (02469081)",
    "fr_discontinuation_comments": "Product to be discontinued. Transitioned to phama-RAMIPRIL DIN (02469081)",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-27T16:57:59-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL",
    "fr_drug_brand_name": "PMS-RAMIPRIL",
    "fr_drug_common_name": "RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111090,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 54588,
      "drug_code": 95581,
      "updated_date": "2025-12-03T00:33:30-05:00",
      "company": {
        "id": 1864,
        "created_date": "2017-03-09T13:26:05-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 13936,
        "mfr_code": "",
        "name": "MANTRA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1000 RUE DU LUX SUITE 201",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BROSSARD",
        "postal_code": "J4Y 0E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262684,
          "ingredient": {
            "id": 3046,
            "ingredient_code": 12754,
            "en_name": "EZETIMIBE",
            "fr_name": "Ézétimibe"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02467437",
      "brand_name": "M-EZETIMIBE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149164001"
    },
    "created_date": "2020-04-06T15:17:21-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02467437",
    "company_name": "MANTRA PHARMA INC",
    "atc_number": "C10AX",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2020-04-07T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-04-10T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Transfer to new format (Blister 30)",
    "fr_discontinuation_comments": "Transfert vers Format Blister 30",
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-04-08T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "M-EZETIMIBE",
    "en_drug_common_name": "Ezetimibe (10 mg ) 100",
    "fr_drug_brand_name": "M-Ezetimibe",
    "fr_drug_common_name": "Ezetimibe (10 mg 100)",
    "en_ingredients": "EZETIMIBE",
    "fr_ingredients": "Ézétimibe",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111093,
    "drug": {
      "current_status": "MARKETED",
      "id": 62853,
      "drug_code": 97419,
      "updated_date": "2025-05-15T02:37:16-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8263789,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02483890",
      "brand_name": "AZITHROMYCIN FOR INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072006"
    },
    "created_date": "2020-04-06T15:20:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02483890",
    "company_name": "STERIMAX INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "actual_start_date": "2020-03-30T00:00:00-04:00",
    "actual_end_date": "2020-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-04-08T00:01:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AZITHROMYCIN FOR INJECTION USP",
    "en_drug_common_name": "AZYTHROMYCIN FOR INJECTION USP",
    "fr_drug_brand_name": "AZITHROMYCINE POUR INJECTION USP",
    "fr_drug_common_name": "AZITHROMYCINE POUR INJECTION USP",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "500MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 VIALS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111103,
    "drug": {
      "current_status": "MARKETED",
      "id": 14450,
      "drug_code": 74714,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255207,
          "ingredient": {
            "id": 954,
            "ingredient_code": 1205,
            "en_name": "DICLOFENAC POTASSIUM",
            "fr_name": "Diclofénac potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02261774",
      "brand_name": "SANDOZ DICLOFENAC RAPIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122516001"
    },
    "created_date": "2020-04-06T16:46:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02261774",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2020-04-27T00:00:00-04:00",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-05-05T15:33:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ DICLOFENAC RAPIDE",
    "en_drug_common_name": "Diclofenac rapide",
    "fr_drug_brand_name": "Diclofenac rapide",
    "fr_drug_common_name": "Diclofenac rapide",
    "en_ingredients": "DICLOFENAC POTASSIUM",
    "fr_ingredients": "Diclofénac potassique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111112,
    "drug": {
      "current_status": "MARKETED",
      "id": 51283,
      "drug_code": 94884,
      "updated_date": "2025-05-15T02:35:44-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262336,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461331",
      "brand_name": "SANDOZ GLICLAZIDE MR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934003"
    },
    "created_date": "2020-04-06T17:01:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02461331",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2020-08-07T00:00:00-04:00",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-08-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-08-24T14:32:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ GLICLAZIDE MR",
    "en_drug_common_name": "Gliclazide MR",
    "fr_drug_brand_name": "Gliclazide",
    "fr_drug_common_name": "Gliclazide",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111116,
    "drug": {
      "current_status": "MARKETED",
      "id": 51283,
      "drug_code": 94884,
      "updated_date": "2025-05-15T02:35:44-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262336,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461331",
      "brand_name": "SANDOZ GLICLAZIDE MR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934003"
    },
    "created_date": "2020-04-06T17:05:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02461331",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2020-08-07T00:00:00-04:00",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-08-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-08-24T14:32:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ GLICLAZIDE MR",
    "en_drug_common_name": "Gliclazide",
    "fr_drug_brand_name": "Gliclazide",
    "fr_drug_common_name": "Gliclazide",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111150,
    "drug": {
      "current_status": "MARKETED",
      "id": 18616,
      "drug_code": 79888,
      "updated_date": "2025-05-15T02:32:12-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256518,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313359",
      "brand_name": "SANDOZ LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971002"
    },
    "created_date": "2020-04-06T17:22:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313359",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-08-28T00:00:00-04:00",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-08-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-09-15T15:26:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LOSARTAN",
    "en_drug_common_name": "Losartan",
    "fr_drug_brand_name": "Losartan",
    "fr_drug_common_name": "Losartan",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111153,
    "drug": {
      "current_status": "MARKETED",
      "id": 18614,
      "drug_code": 79887,
      "updated_date": "2025-05-15T02:32:12-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256517,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313340",
      "brand_name": "SANDOZ LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971003"
    },
    "created_date": "2020-04-06T17:24:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313340",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-08-07T00:00:00-04:00",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-08-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-08-17T12:34:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LOSARTAN",
    "en_drug_common_name": "Losartan",
    "fr_drug_brand_name": "Losartan",
    "fr_drug_common_name": "Losartan",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111166,
    "drug": {
      "current_status": "MARKETED",
      "id": 22006,
      "drug_code": 84365,
      "updated_date": "2025-05-15T02:32:49-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257872,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "SACHET",
          "base": false
        }
      ],
      "din": "02358611",
      "brand_name": "SANDOZ MONTELUKAST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823003"
    },
    "created_date": "2020-04-06T17:35:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02358611",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "R03DC",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "estimated_end_date": "2020-06-12T00:00:00-04:00",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-05-25T14:24:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ MONTELUKAST GRANULES",
    "en_drug_common_name": "Montelakast",
    "fr_drug_brand_name": "Montelakast",
    "fr_drug_common_name": "Montelakast",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "Montelakast",
    "drug_strength": "4MG",
    "drug_dosage_form": "GRANULES",
    "drug_dosage_form_fr": "Granules",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "300",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111183,
    "drug": {
      "current_status": "MARKETED",
      "id": 876,
      "drug_code": 1193,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250241,
          "ingredient": {
            "id": 534,
            "ingredient_code": 10153,
            "en_name": "CHLORAMBUCIL",
            "fr_name": "Chlorambucil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00004626",
      "brand_name": "LEUKERAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "37209",
      "number_of_ais": "1",
      "ai_group_no": "0101769001"
    },
    "created_date": "2020-04-07T00:21:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00004626",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "L01AA",
    "atc_description": "ALKYLATINGAGENTS",
    "anticipated_start_date": "2020-07-06T00:00:00-04:00",
    "estimated_end_date": "2020-08-24T00:00:00-04:00",
    "actual_start_date": "2020-07-08T00:00:00-04:00",
    "actual_end_date": "2020-08-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-08-26T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "QA",
    "fr_comments": "QA",
    "en_drug_brand_name": "LEUKERAN",
    "en_drug_common_name": "chlorambucil",
    "fr_drug_brand_name": "LEUKERAN 2MG TAB BOT 25 CA ASP",
    "fr_drug_common_name": "Chlorambucil",
    "en_ingredients": "CHLORAMBUCIL",
    "fr_ingredients": "Chlorambucil",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "25 Tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111224,
    "drug": {
      "current_status": "MARKETED",
      "id": 22470,
      "drug_code": 84906,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258069,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02364123",
      "brand_name": "APO-HYDROMORPHONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698003"
    },
    "created_date": "2020-04-07T13:54:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02364123",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2020-05-22T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-05-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-22T13:38:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-HYDROMORPHONE",
    "en_drug_common_name": "HYDROMORPHONE",
    "fr_drug_brand_name": "APO-HYDROMORPHONE",
    "fr_drug_common_name": "HYDROMORPHONE",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111239,
    "drug": {
      "current_status": "MARKETED",
      "id": 59699,
      "drug_code": 92374,
      "updated_date": "2025-12-03T00:32:47-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261082,
          "ingredient": {
            "id": 2292,
            "ingredient_code": 11081,
            "en_name": "ROPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de ropivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02439379",
      "brand_name": "ROPIVACAINE HYDROCHLORIDE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133273001"
    },
    "created_date": "2020-04-07T15:12:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439379",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2020-04-01T00:00:00-04:00",
    "estimated_end_date": "2020-04-20T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-04-25T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ROPIVACAINE HYDROCHLORIDE INJECTION, USP",
    "en_drug_common_name": "Ropivacaine Hydrochloride Injection, USP, 2 mg/mL freeflex® Bag 100 mL",
    "fr_drug_brand_name": "Chlorhydrate de ropivacaïne injectable, USP, 2 mg/mL, sacs freeflexMD 100 mL",
    "fr_drug_common_name": "Chlorhydrate de ropivacaïne injectable, USP, 2 mg/mL, sacs freeflexMD 100 mL",
    "en_ingredients": "ROPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de ropivacaïne",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nINFILTRATION\r\nINFILTRATION\r\nEPIDURAL",
    "drug_route_fr": "Épidurale\r\nINFILTRATION\r\nINFILTRATION\r\nÉpidurale",
    "drug_package_quantity": "100 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111260,
    "drug": {
      "current_status": "MARKETED",
      "id": 14752,
      "drug_code": 75095,
      "updated_date": "2025-12-03T00:31:02-05:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8255299,
          "ingredient": {
            "id": 1318,
            "ingredient_code": 238,
            "en_name": "LAMOTRIGINE",
            "fr_name": "Lamotrigine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02265494",
      "brand_name": "MYLAN-LAMOTRIGINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127134003"
    },
    "created_date": "2020-04-07T15:58:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02265494",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2020-04-30T00:00:00-04:00",
    "estimated_end_date": "2020-05-26T00:00:00-04:00",
    "actual_end_date": "2020-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-06T13:46:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-LAMOTRIGINE",
    "en_drug_common_name": "LAMOTRIGINE",
    "fr_drug_brand_name": "MYLAN-LAMOTRIGINE",
    "fr_drug_common_name": "LAMOTRIGINE",
    "en_ingredients": "LAMOTRIGINE",
    "fr_ingredients": "Lamotrigine",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111263,
    "drug": {
      "current_status": "MARKETED",
      "id": 14754,
      "drug_code": 75096,
      "updated_date": "2025-12-03T00:31:02-05:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8255300,
          "ingredient": {
            "id": 1318,
            "ingredient_code": 238,
            "en_name": "LAMOTRIGINE",
            "fr_name": "Lamotrigine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02265508",
      "brand_name": "MYLAN-LAMOTRIGINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127134001"
    },
    "created_date": "2020-04-07T15:59:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02265508",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2020-06-05T00:00:00-04:00",
    "estimated_end_date": "2020-06-15T00:00:00-04:00",
    "actual_end_date": "2020-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-29T13:08:44-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MYLAN-LAMOTRIGINE",
    "en_drug_common_name": "LAMOTRIGINE",
    "fr_drug_brand_name": "MYLAN-LAMOTRIGINE",
    "fr_drug_common_name": "LAMOTRIGINE",
    "en_ingredients": "LAMOTRIGINE",
    "fr_ingredients": "Lamotrigine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT, 500BT",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111282,
    "drug": {
      "current_status": "MARKETED",
      "id": 29846,
      "drug_code": 91887,
      "updated_date": "2025-05-15T02:34:35-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8260821,
          "ingredient": {
            "id": 3162,
            "ingredient_code": 13352,
            "en_name": "CINACALCET",
            "fr_name": "Cinacalcet (Chlorhydrate de cinacalcet)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02434547",
      "brand_name": "MYLAN-CINACALCET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150282002"
    },
    "created_date": "2020-04-07T17:06:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02434547",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "H05BX",
    "atc_description": "ANTI-PARATHYROID HORMONES",
    "anticipated_start_date": "2020-07-06T00:00:00-04:00",
    "estimated_end_date": "2020-08-25T00:00:00-04:00",
    "actual_end_date": "2020-07-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-07-10T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Short dated inventory",
    "fr_comments": "short dated inventory",
    "en_drug_brand_name": "MYLAN-CINACALCET",
    "en_drug_common_name": "CINACALCET",
    "fr_drug_brand_name": "MYLAN-CINACALCET",
    "fr_drug_common_name": "CINACALCET",
    "en_ingredients": "CINACALCET",
    "fr_ingredients": "CINACALCET",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111339,
    "drug": {
      "current_status": "MARKETED",
      "id": 4016,
      "drug_code": 197,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 252,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 3893,
        "mfr_code": "CHU08",
        "name": "CHURCH & DWIGHT CANADA CORP",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "635 SECRETARIAT COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5S 0A5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250129,
          "ingredient": {
            "id": 622,
            "ingredient_code": 9782,
            "en_name": "DIMENHYDRINATE",
            "fr_name": "Diménhydrinate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00013579",
      "brand_name": "GRAVOL IM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "07159",
      "number_of_ais": "1",
      "ai_group_no": "0102747004"
    },
    "created_date": "2020-04-07T17:26:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00013579",
    "company_name": "CHURCH & DWIGHT CANADA CORP",
    "atc_number": "R06AA",
    "atc_description": "ANTIHISTAMINES FOR SYSTEMIC USE",
    "estimated_end_date": "2020-12-22T00:00:00-05:00",
    "actual_start_date": "2020-10-09T00:00:00-04:00",
    "actual_end_date": "2020-12-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-08-16T13:35:40-04:00",
    "status": "resolved",
    "en_comments": "Due to the current situation (Covid-19) we are not able to pull forward any production. Therefore we can no longer meet demand of any of our clients.",
    "fr_comments": "En raison de la situation actuelle (Covid-19), nous ne sommes pas en mesure de faire avancer la production. Par conséquent, nous ne pouvons plus répondre à la demande de tous nos clients.",
    "en_drug_brand_name": "GRAVOL IM",
    "en_drug_common_name": "DIMENHYDRINATE INJECTION",
    "fr_drug_brand_name": "GRAVOL IM",
    "fr_drug_common_name": "INJECTION DE DIMENHYDRINATE",
    "en_ingredients": "DIMENHYDRINATE",
    "fr_ingredients": "Diménhydrinate",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "10 X 1 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111341,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 30662,
      "drug_code": 92699,
      "updated_date": "2025-05-15T04:23:59-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8355966,
          "ingredient": {
            "id": 2680,
            "ingredient_code": 11865,
            "en_name": "CELECOXIB",
            "fr_name": "Célécoxib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442647",
      "brand_name": "SDZ CELECOXIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137043002"
    },
    "created_date": "2020-04-07T17:30:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02442647",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "M01AH",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "hc_updated_date": "2023-11-17T18:27:59-05:00",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-11-17T18:28:01-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "SDZ CELECOXIB",
    "en_drug_common_name": "Celecoxib",
    "fr_drug_brand_name": "Celecoxib",
    "fr_drug_common_name": "Celecoxib",
    "en_ingredients": "CELECOXIB",
    "fr_ingredients": "Célécoxib",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111347,
    "drug": {
      "current_status": "MARKETED",
      "id": 27542,
      "drug_code": 89784,
      "updated_date": "2025-05-15T02:34:04-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259954,
          "ingredient": {
            "id": 3280,
            "ingredient_code": 12477,
            "en_name": "TRAVOPROST",
            "fr_name": "Travoprost"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.004",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02413167",
      "brand_name": "SANDOZ TRAVOPROST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145801001"
    },
    "created_date": "2020-04-07T17:34:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02413167",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01EE",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2020-06-19T00:00:00-04:00",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-05-04T13:46:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TRAVOPROST",
    "en_drug_common_name": "Travoprost",
    "fr_drug_brand_name": "Travoprost",
    "fr_drug_common_name": "Travoprost",
    "en_ingredients": "TRAVOPROST",
    "fr_ingredients": "Travoprost",
    "drug_strength": "0.004%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5ml btl",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111352,
    "drug": {
      "current_status": "MARKETED",
      "id": 53479,
      "drug_code": 95068,
      "updated_date": "2025-12-03T00:33:21-05:00",
      "company": {
        "id": 1760,
        "created_date": "2017-03-09T13:25:38-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 15083,
        "mfr_code": "",
        "name": "DR REDDY'S LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "SURVEY NOS. 42, 45, 46 & 54, INNOVATION PLAZA, BACHUPALLY",
        "province": "TELANGANA",
        "country": "INDIA",
        "city": "MEDCHAL-MALKAJGIRI",
        "postal_code": "500090",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262434,
          "ingredient": {
            "id": 3608,
            "ingredient_code": 20554,
            "en_name": "AZACITIDINE",
            "fr_name": "Azacitidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02462826",
      "brand_name": "AZACITIDINE FOR INJECTION",
      "brand_name_fr": "AZACITIDINE POUR INJECTION",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152665001"
    },
    "created_date": "2020-04-07T18:15:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02462826",
    "company_name": "DR REDDY'S LABORATORIES LTD",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2020-07-15T00:00:00-04:00",
    "estimated_end_date": "2020-08-31T00:00:00-04:00",
    "actual_start_date": "2020-07-15T00:00:00-04:00",
    "actual_end_date": "2020-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-06-30T21:55:53-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "AZACITIDINE FOR INJECTION",
    "en_drug_common_name": "AZACITIDINE FOR INJECTION",
    "fr_drug_brand_name": "AZACITIDINE POUR INJECTION",
    "fr_drug_common_name": "AZACITIDINE POUR INJECTION",
    "en_ingredients": "AZACITIDINE",
    "fr_ingredients": "Azacitidine",
    "drug_strength": "100MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "1 vial / carton",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111364,
    "drug": {
      "current_status": "MARKETED",
      "id": 8588,
      "drug_code": 60218,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253479,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02236926",
      "brand_name": "ACYCLOVIR SODIUM INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506007"
    },
    "created_date": "2020-04-07T20:03:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02236926",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-08-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2020-08-15T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "On 50% Allocation effective April 1, 2020\r\nOur stock of Acyclovir Sodium Injection 50 mg/mL, 10 mL and 20 mL vials is expected to deplete by August 14, 2020. The product will remain on reduced allocation until stock is depleted.",
    "fr_comments": "Sous allocation à 50 % dès le 1er avril 2020\r\nNos stocks d’Acyclovir sodique injectable à 50 mg / mL en fioles de 10 mL et de 20 mL devraient arriver à épuisement d’ici le\r\n14 août 2020. Le produit demeurera sous allocation réduite jusqu’à l’épuisement des stocks.",
    "en_drug_brand_name": "ACYCLOVIR SODIUM INJECTION",
    "en_drug_common_name": "Acyclovir Sodium Injection",
    "fr_drug_brand_name": "Acyclovir sodique injectable",
    "fr_drug_common_name": "Acyclovir sodique injectable",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "Vial 10 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111367,
    "drug": {
      "current_status": "MARKETED",
      "id": 8588,
      "drug_code": 60218,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253479,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02236926",
      "brand_name": "ACYCLOVIR SODIUM INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506007"
    },
    "created_date": "2020-04-07T20:05:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02236926",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-08-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2020-08-17T14:09:24-04:00",
    "status": "resolved",
    "en_comments": "Our stock of Acyclovir Sodium Injection 50 mg/mL, 10 mL and 20 mL vials is expected to deplete by August 14, 2020. The product will remain on reduced allocation until stock is depleted.",
    "fr_comments": "Sous allocation à 25 % dès le 1er avril 2020",
    "en_drug_brand_name": "ACYCLOVIR SODIUM INJECTION",
    "en_drug_common_name": "Acyclovir Sodium Injection",
    "fr_drug_brand_name": "Acyclovir sodique injectable",
    "fr_drug_common_name": "Acyclovir sodique injectable",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "Vial 20 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111372,
    "drug": {
      "current_status": "MARKETED",
      "id": 3562,
      "drug_code": 18937,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252402,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "234",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139510",
      "brand_name": "SODIUM CHLORIDE INJECTION, USP",
      "brand_name_fr": "CHLORURE DE SODIUM INJECTABLE, USP",
      "descriptor": "SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "81223",
      "number_of_ais": "1",
      "ai_group_no": "0100053008"
    },
    "created_date": "2020-04-07T20:13:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139510",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "estimated_end_date": "2020-06-15T00:00:00-04:00",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-06-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-23T14:17:18-04:00",
    "status": "resolved",
    "en_comments": "Backorder Resolved\r\nOff Allocation\r\nNow Available",
    "fr_comments": "Rupture résolue\r\nAllocation retirée\r\nMaintenant disponible",
    "en_drug_brand_name": "SODIUM CHLORIDE INJECTION, USP",
    "en_drug_common_name": "Sodium Chloride Injection",
    "fr_drug_brand_name": "Chlorure de sodium injectable",
    "fr_drug_common_name": "Chlorure de sodium injectable",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "234MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "200 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111381,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2470,
      "drug_code": 15897,
      "updated_date": "2025-12-03T01:07:26-05:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8295939,
          "ingredient": {
            "id": 1108,
            "ingredient_code": 2282,
            "en_name": "DANAZOL",
            "fr_name": "Danazol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02018144",
      "brand_name": "CYCLOMEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77660",
      "number_of_ais": "1",
      "ai_group_no": "0110952003"
    },
    "created_date": "2020-04-07T21:54:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02018144",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "G03XA",
    "atc_description": "OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM",
    "anticipated_start_date": "2020-04-30T00:00:00-04:00",
    "estimated_end_date": "2020-08-07T00:00:00-04:00",
    "actual_end_date": "2020-07-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-07-29T19:35:26-04:00",
    "status": "resolved",
    "en_comments": "The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.",
    "fr_comments": "La date de disponibilité est la date de disponibilité estimée au niveau du centre de distribution principal de Sanofi. La date de disponibilité au niveau du centre de distribution du grossiste habituel d’un client peut varier. Les pharmacies sont invitées à communiquer directement avec leur grossiste pour avoir une date de disponibilité pour le produit. Les patients sont invités à communiquer directement avec leur pharmacie pour obtenir plus de détails à propos de la disponibilité du produit.",
    "en_drug_brand_name": "CYCLOMEN",
    "en_drug_common_name": "Cyclomen",
    "fr_drug_brand_name": "CYCLOMEN",
    "fr_drug_common_name": "Cyclomen",
    "en_ingredients": "DANAZOL",
    "fr_ingredients": "Danazol",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111384,
    "drug": {
      "current_status": "MARKETED",
      "id": 5652,
      "drug_code": 37363,
      "updated_date": "2025-12-03T00:30:35-05:00",
      "company": {
        "id": 430,
        "created_date": "2017-03-09T13:22:46-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15812,
        "mfr_code": "",
        "name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ZIEGELHOF 24",
        "province": "MECKLENBURG - WEST POMERANIA",
        "country": "GERMANY",
        "city": "GREIFSWALD",
        "postal_code": "17489",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252903,
          "ingredient": {
            "id": 54,
            "ingredient_code": 8523,
            "en_name": "GRAMICIDIN",
            "fr_name": "Gramicidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252902,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252901,
          "ingredient": {
            "id": 1292,
            "ingredient_code": 8626,
            "en_name": "FRAMYCETIN SULFATE",
            "fr_name": "Sulfate de framycétine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02224623",
      "brand_name": "SOFRACORT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4890",
      "number_of_ais": "3",
      "ai_group_no": "0305701001"
    },
    "created_date": "2020-04-07T21:58:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02224623",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "S03CA",
    "atc_description": "CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION",
    "anticipated_start_date": "2020-06-30T00:00:00-04:00",
    "estimated_end_date": "2020-09-14T00:00:00-04:00",
    "actual_end_date": "2020-09-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-09-08T18:15:55-04:00",
    "status": "resolved",
    "en_comments": "Delay in production\r\nThe availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.",
    "fr_comments": "Délai d'approvisionnement\r\nLa date de disponibilité est la date de disponibilité estimée au niveau du centre de distribution principal de Sanofi. La date de disponibilité au niveau du centre de distribution du grossiste habituel d’un client peut varier. Les pharmacies sont invitées à communiquer directement avec leur grossiste pour avoir une date de disponibilité pour le produit. Les patients sont invités à communiquer directement avec leur pharmacie pour obtenir plus de détails à propos de la disponibilité du produit.",
    "en_drug_brand_name": "SOFRACORT",
    "en_drug_common_name": "Sofracort",
    "fr_drug_brand_name": "CYLCOMEN",
    "fr_drug_common_name": "Cyclomen",
    "en_ingredients": "FRAMYCETIN SULFATE\r\nDEXAMETHASONE\r\nGRAMICIDIN",
    "fr_ingredients": "Sulfate de framycétine\r\nDexaméthasone\r\nGramicidine",
    "drug_strength": "5MG\r\n0.5MG\r\n0.05MG",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC\r\nOTIC\r\nOPHTHALMIC\r\nOTIC",
    "drug_route_fr": "Ophtalmique\r\nOtique\r\nOphtalmique\r\nOtique",
    "drug_package_quantity": "8ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111387,
    "drug": {
      "current_status": "MARKETED",
      "id": 7728,
      "drug_code": 50758,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8253390,
          "ingredient": {
            "id": 62,
            "ingredient_code": 9412,
            "en_name": "NITROGLYCERIN",
            "fr_name": "Nitroglycérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02231441",
      "brand_name": "NITROLINGUAL PUMPSPRAY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103615009"
    },
    "created_date": "2020-04-07T22:02:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231441",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "C01DA",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "anticipated_start_date": "2020-04-06T00:00:00-04:00",
    "estimated_end_date": "2020-04-17T00:00:00-04:00",
    "actual_end_date": "2020-04-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-04-15T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Production delay\r\nThe availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.",
    "fr_comments": "Délai d'approvisionnement\r\nLa date de disponibilité est la date de disponibilité estimée au niveau du centre de distribution principal de Sanofi. La date de disponibilité au niveau du centre de distribution du grossiste habituel d’un client peut varier. Les pharmacies sont invitées à communiquer directement avec leur grossiste pour avoir une date de disponibilité pour le produit. Les patients sont invités à communiquer directement avec leur pharmacie pour obtenir plus de détails à propos de la disponibilité du produit.",
    "en_drug_brand_name": "NITROLINGUAL PUMPSPRAY",
    "en_drug_common_name": "Nitrolingual",
    "fr_drug_brand_name": "NITROLINGUAL",
    "fr_drug_common_name": "Nitrolingual",
    "en_ingredients": "NITROGLYCERIN",
    "fr_ingredients": "Nitroglycérine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "METERED-DOSE PUMP",
    "drug_dosage_form_fr": "Pompe à dose mesurée",
    "drug_route": "SUBLINGUAL\r\nSUBLINGUAL",
    "drug_route_fr": "Sublinguale\r\nSublinguale",
    "drug_package_quantity": "1",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111392,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8938,
      "drug_code": 61288,
      "updated_date": "2025-12-03T01:17:15-05:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8325715,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237923",
      "brand_name": "AVAPRO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700001"
    },
    "created_date": "2020-04-07T22:12:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237923",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2020-05-12T00:00:00-04:00",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_end_date": "2020-06-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-06-30T01:13:23-04:00",
    "status": "resolved",
    "en_comments": "Production Delay\r\nThe availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.",
    "fr_comments": "Délai d'approvisionnement",
    "en_drug_brand_name": "AVAPRO",
    "en_drug_common_name": "Avapro",
    "fr_drug_brand_name": "AVAPRO",
    "fr_drug_common_name": "Avapro",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111399,
    "drug": {
      "current_status": "MARKETED",
      "id": 1908,
      "drug_code": 14049,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8251857,
          "ingredient": {
            "id": 1012,
            "ingredient_code": 763,
            "en_name": "ENOXAPARIN SODIUM",
            "fr_name": "Énoxaparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.3",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02012472",
      "brand_name": "LOVENOX",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE PRE-FILLED SYRINGE 30MG/0.3ML",
      "pediatric_flag": false,
      "accession_number": "75556",
      "number_of_ais": "1",
      "ai_group_no": "0131860001"
    },
    "created_date": "2020-04-07T22:20:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02012472",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2020-04-15T00:00:00-04:00",
    "estimated_end_date": "2020-04-24T00:00:00-04:00",
    "actual_end_date": "2020-04-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-04-20T15:40:48-04:00",
    "status": "resolved",
    "en_comments": "The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.",
    "fr_comments": "La date de disponibilité est la date de disponibilité estimée au niveau du centre de distribution principal de Sanofi. La date de disponibilité au niveau du centre de distribution du grossiste habituel d’un client peut varier. Les pharmacies sont invitées à communiquer directement avec leur grossiste pour avoir une date de disponibilité pour le produit. Les patients sont invités à communiquer directement avec leur pharmacie pour obtenir plus de détails à propos de la disponibilité du produit.",
    "en_drug_brand_name": "LOVENOX",
    "en_drug_common_name": "Lovenox",
    "fr_drug_brand_name": "LOVENOX",
    "fr_drug_common_name": "Lovenox",
    "en_ingredients": "ENOXAPARIN SODIUM",
    "fr_ingredients": "Énoxaparine sodique",
    "drug_strength": "30MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111402,
    "drug": {
      "current_status": "MARKETED",
      "id": 23762,
      "drug_code": 86422,
      "updated_date": "2025-05-15T02:33:10-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8258561,
          "ingredient": {
            "id": 1012,
            "ingredient_code": 763,
            "en_name": "ENOXAPARIN SODIUM",
            "fr_name": "Énoxaparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.6",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02378426",
      "brand_name": "LOVENOX",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE PRE-FILLED SYRINGE 60MG/0.6ML",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131860001"
    },
    "created_date": "2020-04-07T22:24:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378426",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2020-04-02T00:00:00-04:00",
    "estimated_end_date": "2020-04-24T00:00:00-04:00",
    "actual_end_date": "2020-04-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-04-20T15:42:31-04:00",
    "status": "resolved",
    "en_comments": "The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.",
    "fr_comments": "La date de disponibilité est la date de disponibilité estimée au niveau du centre de distribution principal de Sanofi. La date de disponibilité au niveau du centre de distribution du grossiste habituel d’un client peut varier. Les pharmacies sont invitées à communiquer directement avec leur grossiste pour avoir une date de disponibilité pour le produit. Les patients sont invités à communiquer directement avec leur pharmacie pour obtenir plus de détails à propos de la disponibilité du produit.",
    "en_drug_brand_name": "LOVENOX",
    "en_drug_common_name": "Lovenox",
    "fr_drug_brand_name": "LOVENOX",
    "fr_drug_common_name": "Lovenox",
    "en_ingredients": "ENOXAPARIN SODIUM",
    "fr_ingredients": "Énoxaparine sodique",
    "drug_strength": "60MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111405,
    "drug": {
      "current_status": "MARKETED",
      "id": 10746,
      "drug_code": 66484,
      "updated_date": "2025-05-15T02:31:11-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8254068,
          "ingredient": {
            "id": 1012,
            "ingredient_code": 763,
            "en_name": "ENOXAPARIN SODIUM",
            "fr_name": "Énoxaparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.8",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242692",
      "brand_name": "LOVENOX HP",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE PRE-FILLED SYRINGE 120MG/0.8ML",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131860002"
    },
    "created_date": "2020-04-07T22:27:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242692",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2020-04-13T00:00:00-04:00",
    "estimated_end_date": "2020-04-24T00:00:00-04:00",
    "actual_end_date": "2020-04-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-04-15T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.",
    "fr_comments": "La date de disponibilité est la date de disponibilité estimée au niveau du centre de distribution principal de Sanofi. La date de disponibilité au niveau du centre de distribution du grossiste habituel d’un client peut varier. Les pharmacies sont invitées à communiquer directement avec leur grossiste pour avoir une date de disponibilité pour le produit. Les patients sont invités à communiquer directement avec leur pharmacie pour obtenir plus de détails à propos de la disponibilité du produit.",
    "en_drug_brand_name": "LOVENOX HP",
    "en_drug_common_name": "Lovenox HP",
    "fr_drug_brand_name": "LOVENOX HP",
    "fr_drug_common_name": "Lovenox HP",
    "en_ingredients": "ENOXAPARIN SODIUM",
    "fr_ingredients": "Énoxaparine sodique",
    "drug_strength": "120MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111453,
    "drug": {
      "current_status": "MARKETED",
      "id": 1872,
      "drug_code": 13998,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8251846,
          "ingredient": {
            "id": 502,
            "ingredient_code": 7588,
            "en_name": "TRIAMCINOLONE ACETONIDE",
            "fr_name": "Acétonide  de triamcinolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01977563",
      "brand_name": "TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75495",
      "number_of_ais": "1",
      "ai_group_no": "0106310006"
    },
    "created_date": "2020-04-08T12:34:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01977563",
    "company_name": "STERIMAX INC",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "actual_start_date": "2020-03-09T00:00:00-04:00",
    "actual_end_date": "2020-09-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-09-10T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TRIAMCINOLONE ACETONIDE SUSPENSION",
    "en_drug_common_name": "TRIAMCINOLONE ACETONIDE SUSPENSION",
    "fr_drug_brand_name": "SUSPENSION STÉRILE D'ACÉTONIDE DE TRIAMCINOLONE USP",
    "fr_drug_common_name": "SUSPENSION STÉRILE D'ACÉTONIDE DE TRIAMCINOLONE USP",
    "en_ingredients": "TRIAMCINOLONE ACETONIDE",
    "fr_ingredients": "Acétonide  de triamcinolone",
    "drug_strength": "40MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRA-ARTICULAR\r\nINTRAMUSCULAR\r\nINTRA-ARTICULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intra-articulaire\r\nIntramusculaire\r\nIntra-articulaire\r\nIntramusculaire",
    "drug_package_quantity": "1 VIAL 1 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111456,
    "drug": {
      "current_status": "MARKETED",
      "id": 1872,
      "drug_code": 13998,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8251846,
          "ingredient": {
            "id": 502,
            "ingredient_code": 7588,
            "en_name": "TRIAMCINOLONE ACETONIDE",
            "fr_name": "Acétonide  de triamcinolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01977563",
      "brand_name": "TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75495",
      "number_of_ais": "1",
      "ai_group_no": "0106310006"
    },
    "created_date": "2020-04-08T12:36:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01977563",
    "company_name": "STERIMAX INC",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "actual_start_date": "2020-03-09T00:00:00-04:00",
    "actual_end_date": "2020-08-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-08-08T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Product is available at McKesson.",
    "fr_comments": "Produit est disponible chez McKesson.",
    "en_drug_brand_name": "TRIAMCINOLONE ACETONIDE SUSPENSION",
    "en_drug_common_name": "TRIAMCINOLONE ACETONIDE SUSPENSION",
    "fr_drug_brand_name": "SUSPENSION STÉRILE D'ACÉTONIDE DE TRIAMCINOLONE USP",
    "fr_drug_common_name": "SUSPENSION STÉRILE D'ACÉTONIDE DE TRIAMCINOLONE USP",
    "en_ingredients": "TRIAMCINOLONE ACETONIDE",
    "fr_ingredients": "Acétonide  de triamcinolone",
    "drug_strength": "40MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRA-ARTICULAR\r\nINTRAMUSCULAR\r\nINTRA-ARTICULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intra-articulaire\r\nIntramusculaire\r\nIntra-articulaire\r\nIntramusculaire",
    "drug_package_quantity": "1 VIAL 5ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111459,
    "drug": {
      "current_status": "MARKETED",
      "id": 62853,
      "drug_code": 97419,
      "updated_date": "2025-05-15T02:37:16-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8263789,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02483890",
      "brand_name": "AZITHROMYCIN FOR INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072006"
    },
    "created_date": "2020-04-08T12:40:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02483890",
    "company_name": "STERIMAX INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "actual_start_date": "2020-03-30T00:00:00-04:00",
    "actual_end_date": "2020-07-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-07-09T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AZITHROMYCIN FOR INJECTION USP",
    "en_drug_common_name": "AZITHROMYCIN FOR INJECTION USP",
    "fr_drug_brand_name": "AZYTHROMYCINE POUR INJECTION USP",
    "fr_drug_common_name": "AZYTHROMYCINE POUR INJECTION USP",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "500MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 VIALS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111480,
    "drug": {
      "current_status": "MARKETED",
      "id": 11530,
      "drug_code": 68312,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8254298,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8254297,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244344",
      "brand_name": "MICARDIS PLUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0244783001"
    },
    "created_date": "2020-04-08T14:22:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244344",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "anticipated_start_date": "2020-05-26T00:00:00-04:00",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-05-26T00:00:00-04:00",
    "actual_end_date": "2020-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-12-04T15:23:17-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MICARDIS PLUS",
    "en_drug_common_name": "Micardis Plus",
    "fr_drug_brand_name": "Micardis Plus",
    "fr_drug_common_name": "Micardis Plus",
    "en_ingredients": "TELMISARTAN\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Telmisartan\r\nHydrochlorothiazide",
    "drug_strength": "80MG\r\n12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28s",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111483,
    "drug": {
      "current_status": "MARKETED",
      "id": 23026,
      "drug_code": 85612,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8258325,
          "ingredient": {
            "id": 3734,
            "ingredient_code": 20882,
            "en_name": "LINAGLIPTIN",
            "fr_name": "Linagliptine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02370921",
      "brand_name": "TRAJENTA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152946001"
    },
    "created_date": "2020-04-08T14:26:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02370921",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "A10BH",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2020-05-11T00:00:00-04:00",
    "actual_start_date": "2020-05-04T00:00:00-04:00",
    "actual_end_date": "2020-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-05-13T17:32:11-04:00",
    "status": "avoided_shortage",
    "en_comments": "Shipment arrived before running out of stock",
    "en_drug_brand_name": "TRAJENTA",
    "en_drug_common_name": "Trajenta",
    "fr_drug_brand_name": "Trajenta",
    "fr_drug_common_name": "Trajeta",
    "en_ingredients": "LINAGLIPTIN",
    "fr_ingredients": "Linagliptine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30s",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111486,
    "drug": {
      "current_status": "MARKETED",
      "id": 30786,
      "drug_code": 92872,
      "updated_date": "2025-12-03T00:32:52-05:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8261357,
          "ingredient": {
            "id": 4090,
            "ingredient_code": 22629,
            "en_name": "EMPAGLIFLOZIN",
            "fr_name": "EMPAGLIFLOZINE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443945",
      "brand_name": "JARDIANCE",
      "brand_name_fr": "JARDIANCE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0157150002"
    },
    "created_date": "2020-04-08T15:37:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443945",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "A10BK",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2020-05-15T00:00:00-04:00",
    "estimated_end_date": "2020-06-01T00:00:00-04:00",
    "actual_end_date": "2020-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-13T17:34:45-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "JARDIANCE",
    "en_drug_common_name": "Jardiance",
    "fr_drug_brand_name": "Jardiance",
    "fr_drug_common_name": "Jardiance",
    "en_ingredients": "EMPAGLIFLOZIN",
    "fr_ingredients": "EMPAGLIFLOZINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30s",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111489,
    "drug": {
      "current_status": "MARKETED",
      "id": 30786,
      "drug_code": 92872,
      "updated_date": "2025-12-03T00:32:52-05:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8261357,
          "ingredient": {
            "id": 4090,
            "ingredient_code": 22629,
            "en_name": "EMPAGLIFLOZIN",
            "fr_name": "EMPAGLIFLOZINE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443945",
      "brand_name": "JARDIANCE",
      "brand_name_fr": "JARDIANCE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0157150002"
    },
    "created_date": "2020-04-08T15:41:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443945",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "A10BK",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2020-04-28T00:00:00-04:00",
    "estimated_end_date": "2020-04-29T00:00:00-04:00",
    "actual_end_date": "2020-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-22T18:41:30-04:00",
    "status": "avoided_shortage",
    "en_comments": "Product arrival date improved, expected to arrive before running out of stock",
    "fr_comments": "La date d'arrivée du produit s'est améliorée, devrait arriver avant épuisement du stock Le rapport de pénurie sera clôturé avec la \"date de fin réelle\" lorsque le produit arrivera",
    "en_drug_brand_name": "JARDIANCE",
    "en_drug_common_name": "Jardiance 90's",
    "fr_drug_brand_name": "Jardiance",
    "fr_drug_common_name": "Jardiance 90s",
    "en_ingredients": "EMPAGLIFLOZIN",
    "fr_ingredients": "EMPAGLIFLOZINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90's",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111492,
    "drug": {
      "current_status": "MARKETED",
      "id": 30784,
      "drug_code": 92871,
      "updated_date": "2025-12-03T00:32:52-05:00",
      "company": {
        "id": 192,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 3617,
        "mfr_code": "BOE07",
        "name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5180 SOUTH SERVICE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BURLINGTON",
        "postal_code": "L7L 5H4",
        "post_office_box": "",
        "contact_information": "1800 263 2425"
      },
      "drug_ingredients": [
        {
          "id": 8261356,
          "ingredient": {
            "id": 4090,
            "ingredient_code": 22629,
            "en_name": "EMPAGLIFLOZIN",
            "fr_name": "EMPAGLIFLOZINE"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443937",
      "brand_name": "JARDIANCE",
      "brand_name_fr": "JARDIANCE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0157150001"
    },
    "created_date": "2020-04-08T15:43:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443937",
    "company_name": "BOEHRINGER INGELHEIM (CANADA) LTD LTEE",
    "atc_number": "A10BK",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2020-05-29T00:00:00-04:00",
    "estimated_end_date": "2020-06-08T00:00:00-04:00",
    "actual_end_date": "2020-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-13T17:35:25-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "JARDIANCE",
    "en_drug_common_name": "Jardiance 90s",
    "fr_drug_brand_name": "Jardiance",
    "fr_drug_common_name": "Jardiance 90s",
    "en_ingredients": "EMPAGLIFLOZIN",
    "fr_ingredients": "EMPAGLIFLOZINE",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90s",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111501,
    "drug": {
      "current_status": "MARKETED",
      "id": 24904,
      "drug_code": 87424,
      "updated_date": "2025-05-15T02:33:33-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259007,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388715",
      "brand_name": "CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220003"
    },
    "created_date": "2020-04-08T19:12:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388715",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2020-05-09T00:00:00-04:00",
    "actual_end_date": "2020-07-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-07-24T19:54:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111508,
    "drug": {
      "current_status": "MARKETED",
      "id": 2216,
      "drug_code": 1471,
      "updated_date": "2025-12-03T00:30:19-05:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250269,
          "ingredient": {
            "id": 1104,
            "ingredient_code": 20261,
            "en_name": "ETHAMBUTOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'éthambutol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00247960",
      "brand_name": "ETIBI",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "40558",
      "number_of_ais": "1",
      "ai_group_no": "0108662001"
    },
    "created_date": "2020-04-08T19:50:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00247960",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "J04AK",
    "atc_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
    "anticipated_start_date": "2020-05-08T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2020-05-07T20:23:19-04:00",
    "status": "avoided_shortage",
    "en_comments": "currently on manual allocation",
    "en_drug_brand_name": "ETIBI",
    "en_drug_common_name": "ETIBI",
    "fr_drug_brand_name": "ETIBI",
    "fr_drug_common_name": "ETIBI",
    "en_ingredients": "ETHAMBUTOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'éthambutol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111515,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21216,
      "drug_code": 83602,
      "updated_date": "2025-05-15T04:16:59-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348855,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02350815",
      "brand_name": "MORPHINE SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545009"
    },
    "created_date": "2020-04-08T21:00:08-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02350815",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2020-06-12T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-05-27T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-06-13T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MORPHINE SR",
    "en_drug_common_name": "MORPHINE",
    "fr_drug_brand_name": "MORPHINE SR",
    "fr_drug_common_name": "MORPHINE",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111518,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21220,
      "drug_code": 83608,
      "updated_date": "2025-05-15T04:17:00-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348860,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02350890",
      "brand_name": "MORPHINE SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545011"
    },
    "created_date": "2020-04-08T21:01:39-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02350890",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_discontinuation_date": "2020-08-27T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-08T21:01:55-04:00",
    "status": "to_be_discontinued",
    "en_drug_brand_name": "MORPHINE SR",
    "en_drug_common_name": "MORPHINE",
    "fr_drug_brand_name": "MORPHINE SR",
    "fr_drug_common_name": "MORPHINE",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": true,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111521,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21222,
      "drug_code": 83610,
      "updated_date": "2025-05-15T04:17:00-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348861,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02350912",
      "brand_name": "MORPHINE SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104545010"
    },
    "created_date": "2020-04-08T21:02:38-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02350912",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_discontinuation_date": "2021-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-06-03T16:59:47-04:00",
    "status": "to_be_discontinued",
    "en_drug_brand_name": "MORPHINE SR",
    "en_drug_common_name": "MORPHINE",
    "fr_drug_brand_name": "MORPHINE SR",
    "fr_drug_common_name": "MORPHINE",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": true,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111524,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 29100,
      "drug_code": 91136,
      "updated_date": "2025-05-15T04:22:43-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8354864,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8354863,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02426803",
      "brand_name": "TRAMADOL/ACET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250601001"
    },
    "created_date": "2020-04-08T21:03:50-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02426803",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2020-07-06T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-07-07T05:00:07-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TRAMADOL/ACET",
    "en_drug_common_name": "TRAMADOL/ACET",
    "fr_drug_brand_name": "TRAMADOL/ACET",
    "fr_drug_common_name": "TRAMADOL/ACET",
    "en_ingredients": "ACETAMINOPHEN\r\nTRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Acétaminophène\r\nChlorhydrate de tramadol",
    "drug_strength": "325MG\r\n37.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111527,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22230,
      "drug_code": 84644,
      "updated_date": "2025-05-15T04:17:50-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8349749,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8349748,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02361361",
      "brand_name": "OXYCODONE/ACET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0215596001"
    },
    "created_date": "2020-04-08T21:05:05-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02361361",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2020-06-08T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-11-15T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-06-09T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "OXYCODONE/ACET",
    "en_drug_common_name": "OXYCODONE/ACET",
    "fr_drug_brand_name": "OXYCODONE/ACET",
    "fr_drug_common_name": "OXYCODONE/ACET",
    "en_ingredients": "OXYCODONE HYDROCHLORIDE\r\nACETAMINOPHEN",
    "fr_ingredients": "Chlorhydrate d'oxycodone\r\nAcétaminophène",
    "drug_strength": "5MG\r\n325MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111531,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22230,
      "drug_code": 84644,
      "updated_date": "2025-05-15T04:17:50-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8349749,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8349748,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02361361",
      "brand_name": "OXYCODONE/ACET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0215596001"
    },
    "created_date": "2020-04-08T21:06:42-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02361361",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2020-06-08T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-07-16T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-06-09T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "OXYCODONE/ACET",
    "en_drug_common_name": "OXYCODONE/ACET",
    "fr_drug_brand_name": "OXYCODONE/ACET",
    "fr_drug_common_name": "OXYCODONE/ACET",
    "en_ingredients": "OXYCODONE HYDROCHLORIDE\r\nACETAMINOPHEN",
    "fr_ingredients": "Chlorhydrate d'oxycodone\r\nAcétaminophène",
    "drug_strength": "5MG\r\n325MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111537,
    "drug": {
      "current_status": "MARKETED",
      "id": 65776,
      "drug_code": 97283,
      "updated_date": "2025-05-15T02:36:54-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8263692,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02482363",
      "brand_name": "AURO-AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072002"
    },
    "created_date": "2020-04-08T21:12:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02482363",
    "company_name": "AURO PHARMA INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "actual_start_date": "2020-04-07T00:00:00-04:00",
    "actual_end_date": "2020-08-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-08-14T20:57:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-AZITHROMYCIN",
    "en_drug_common_name": "Azithromycin",
    "fr_drug_brand_name": "AURO-AZITHROMYCIN",
    "fr_drug_common_name": "Azithromycine",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "100MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "15 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111550,
    "drug": {
      "current_status": "MARKETED",
      "id": 25542,
      "drug_code": 87965,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8259226,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394499",
      "brand_name": "AURO-LISINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121550002"
    },
    "created_date": "2020-04-08T21:21:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394499",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "actual_start_date": "2020-04-07T00:00:00-04:00",
    "actual_end_date": "2020-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-07-06T20:44:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-LISINOPRIL",
    "en_drug_common_name": "Lisinopril",
    "fr_drug_brand_name": "AURO-LISINOPRIL",
    "fr_drug_common_name": "Lisinopril",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111553,
    "drug": {
      "current_status": "MARKETED",
      "id": 30216,
      "drug_code": 92264,
      "updated_date": "2025-05-15T02:34:41-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8261037,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02438275",
      "brand_name": "AURO-METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2020-04-08T21:25:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02438275",
    "company_name": "AURO PHARMA INC",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "actual_start_date": "2020-04-07T00:00:00-04:00",
    "actual_end_date": "2020-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-04-23T13:02:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-METFORMIN",
    "en_drug_common_name": "Metformin Hydrochloride",
    "fr_drug_brand_name": "AURO-METFORMIN",
    "fr_drug_common_name": "Chlorhydrate de metformine",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100, 360 & 500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111556,
    "drug": {
      "current_status": "MARKETED",
      "id": 57164,
      "drug_code": 94613,
      "updated_date": "2025-05-15T02:35:40-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8262198,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02458977",
      "brand_name": "AURO-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563001"
    },
    "created_date": "2020-04-08T21:37:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02458977",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2020-04-07T00:00:00-04:00",
    "actual_end_date": "2025-02-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-02-19T17:24:51-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-PRAVASTATIN",
    "en_drug_common_name": "Pravastatin Sodium",
    "fr_drug_brand_name": "AURO-PRAVASTATIN",
    "fr_drug_common_name": "Pravastatine sodique",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111559,
    "drug": {
      "current_status": "MARKETED",
      "id": 57166,
      "drug_code": 94614,
      "updated_date": "2025-05-15T02:35:40-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8262199,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02458985",
      "brand_name": "AURO-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563002"
    },
    "created_date": "2020-04-08T21:39:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02458985",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2020-04-07T00:00:00-04:00",
    "actual_end_date": "2025-02-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-02-19T17:25:16-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-PRAVASTATIN",
    "en_drug_common_name": "Pravastatin Sodium",
    "fr_drug_brand_name": "AURO-PRAVASTATIN",
    "fr_drug_common_name": "Pravastatine sodique",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111564,
    "drug": {
      "current_status": "MARKETED",
      "id": 57168,
      "drug_code": 94615,
      "updated_date": "2025-05-15T02:35:40-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8262200,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02458993",
      "brand_name": "AURO-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2020-04-08T21:41:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02458993",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2020-04-07T00:00:00-04:00",
    "actual_end_date": "2025-02-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2025-02-19T17:25:40-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-PRAVASTATIN",
    "en_drug_common_name": "Pravastatin Sodium",
    "fr_drug_brand_name": "AURO-PRAVASTATIN",
    "fr_drug_common_name": "Pravastatine sodique",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111592,
    "drug": {
      "current_status": "MARKETED",
      "id": 29790,
      "drug_code": 91827,
      "updated_date": "2025-05-15T02:34:35-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8260800,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02433885",
      "brand_name": "AURO-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121003"
    },
    "created_date": "2020-04-09T14:24:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02433885",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-09-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-09-04T21:44:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-PREGABALIN",
    "en_drug_common_name": "Pregabalin",
    "fr_drug_brand_name": "AURO-PREGABALIN",
    "fr_drug_common_name": "Prégabaline",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111595,
    "drug": {
      "current_status": "MARKETED",
      "id": 31552,
      "drug_code": 93870,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261797,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452324",
      "brand_name": "MAR-AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072001"
    },
    "created_date": "2020-04-09T14:34:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452324",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "anticipated_start_date": "2020-04-10T00:00:00-04:00",
    "estimated_end_date": "2022-08-28T00:00:00-04:00",
    "actual_start_date": "2020-04-10T00:00:00-04:00",
    "actual_end_date": "2023-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-06-22T18:02:10-04:00",
    "status": "resolved",
    "en_comments": "Business reasons",
    "fr_comments": "Business reasons",
    "en_drug_brand_name": "MAR-AZITHROMYCIN",
    "en_drug_common_name": "AZITHROMYCIN",
    "fr_drug_brand_name": "MAR-AZITHROMYCIN",
    "fr_drug_common_name": "AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 Tablet",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111598,
    "drug": {
      "current_status": "MARKETED",
      "id": 25056,
      "drug_code": 87570,
      "updated_date": "2025-05-15T02:33:37-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8259081,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02390256",
      "brand_name": "AURO-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858005"
    },
    "created_date": "2020-04-09T14:39:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390256",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-07-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-07-31T20:13:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-QUETIAPINE",
    "en_drug_common_name": "Quetiapine",
    "fr_drug_brand_name": "AURO-QUETIAPINE",
    "fr_drug_common_name": "QUÉTIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUÉTIAPINE",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 & 500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111601,
    "drug": {
      "current_status": "MARKETED",
      "id": 25124,
      "drug_code": 87630,
      "updated_date": "2025-05-15T02:33:39-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8259105,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02390914",
      "brand_name": "AURO-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417001"
    },
    "created_date": "2020-04-09T14:43:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390914",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-10-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-10-29T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-SERTRALINE",
    "en_drug_common_name": "Sertraline",
    "fr_drug_brand_name": "AURO-SERTRALINE",
    "fr_drug_common_name": "Sertraline",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "Sertraline",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111604,
    "drug": {
      "current_status": "MARKETED",
      "id": 31032,
      "drug_code": 93172,
      "updated_date": "2025-05-15T02:35:06-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8261465,
          "ingredient": {
            "id": 3272,
            "ingredient_code": 18175,
            "en_name": "SOLIFENACIN SUCCINATE",
            "fr_name": "Succinate de solifénacine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02446383",
      "brand_name": "AURO-SOLIFENACIN",
      "brand_name_fr": "AURO-SOLIFÉNACINE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151584002"
    },
    "created_date": "2020-04-09T14:55:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02446383",
    "company_name": "AURO PHARMA INC",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-07-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-07-17T21:19:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-SOLIFENACIN",
    "en_drug_common_name": "Solifenacin Succinate",
    "fr_drug_brand_name": "AURO-SOLIFENACIN",
    "fr_drug_common_name": "Succinate de solifénacine",
    "en_ingredients": "SOLIFENACIN SUCCINATE",
    "fr_ingredients": "Succinate de solifénacine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 & 100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111607,
    "drug": {
      "current_status": "MARKETED",
      "id": 27658,
      "drug_code": 89887,
      "updated_date": "2025-05-15T02:34:04-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8260011,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02414201",
      "brand_name": "AURO-VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885003"
    },
    "created_date": "2020-04-09T15:21:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02414201",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2021-02-28T00:00:00-05:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2021-02-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-02-18T20:34:08-05:00",
    "status": "resolved",
    "en_comments": "Auro-Valsartan 40mg (100's) available as of February 17, 2021\r\nAuro-Valsartan 40mg (30's) -Replaceable with Auro-Valsartan 40mg (100's)",
    "en_drug_brand_name": "AURO-VALSARTAN",
    "en_drug_common_name": "Valsartan",
    "fr_drug_brand_name": "AURO-VALSARTAN",
    "fr_drug_common_name": "Valsartan",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 & 100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111618,
    "drug": {
      "current_status": "MARKETED",
      "id": 32218,
      "drug_code": 9973,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251251,
          "ingredient": {
            "id": 136,
            "ingredient_code": 8508,
            "en_name": "NYSTATIN",
            "fr_name": "Nystatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00792667",
      "brand_name": "PMS-NYSTATIN SUSPENSION 100000 UNIT/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69548",
      "number_of_ais": "1",
      "ai_group_no": "0105858002"
    },
    "created_date": "2020-04-09T17:09:06-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00792667",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A07AA",
    "atc_description": "INTESTINALANTIINFECTIVES",
    "discontinuation_date": "2020-04-09T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-10T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-NYSTATIN SUSPENSION 100000 UNIT/ML",
    "en_drug_common_name": "NYSTATIN",
    "fr_drug_brand_name": "PMS-NYSTATIN SUSPENSION 100000 UNIT/ML",
    "fr_drug_common_name": "NYSTATIN",
    "en_ingredients": "NYSTATIN",
    "fr_ingredients": "Nystatine",
    "drug_strength": "100000UNIT",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "48mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111759,
    "drug": {
      "current_status": "MARKETED",
      "id": 4568,
      "drug_code": 227,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250133,
          "ingredient": {
            "id": 1728,
            "ingredient_code": 8833,
            "en_name": "SUCCINYLCHOLINE CHLORIDE",
            "fr_name": "Chlorure de succinylcholine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00038172",
      "brand_name": "QUELICIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "08223",
      "number_of_ais": "1",
      "ai_group_no": "0105141001"
    },
    "created_date": "2020-04-09T20:30:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00038172",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "M03AB",
    "atc_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
    "anticipated_start_date": "2020-05-08T00:00:00-04:00",
    "actual_end_date": "2020-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-14T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "QUELICIN",
    "en_drug_common_name": "QUELICIN",
    "fr_drug_brand_name": "QUELICIN",
    "fr_drug_common_name": "QUELICIN",
    "en_ingredients": "SUCCINYLCHOLINE CHLORIDE",
    "fr_ingredients": "Chlorure de succinylcholine",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "25 x 10mL vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111785,
    "drug": {
      "current_status": "MARKETED",
      "id": 4982,
      "drug_code": 2866,
      "updated_date": "2025-05-15T02:30:28-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250464,
          "ingredient": {
            "id": 1306,
            "ingredient_code": 8566,
            "en_name": "RIFAMPIN",
            "fr_name": "Rifampine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00393444",
      "brand_name": "ROFACT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "51695",
      "number_of_ais": "1",
      "ai_group_no": "0105824002"
    },
    "created_date": "2020-04-09T21:54:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00393444",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "J04AB",
    "atc_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
    "anticipated_start_date": "2020-04-24T00:00:00-04:00",
    "actual_end_date": "2020-04-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-04-23T19:53:48-04:00",
    "status": "avoided_shortage",
    "en_comments": "currently on manual allocation",
    "en_drug_brand_name": "ROFACT",
    "en_drug_common_name": "ROFACT",
    "fr_drug_brand_name": "ROFACT",
    "fr_drug_common_name": "ROFACT",
    "en_ingredients": "RIFAMPIN",
    "fr_ingredients": "Rifampine",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111790,
    "drug": {
      "current_status": "MARKETED",
      "id": 4418,
      "drug_code": 2138,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250362,
          "ingredient": {
            "id": 22,
            "ingredient_code": 6311,
            "en_name": "FLUOROURACIL",
            "fr_name": "Fluorouracil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00330582",
      "brand_name": "EFUDEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "47716",
      "number_of_ais": "1",
      "ai_group_no": "0107505001"
    },
    "created_date": "2020-04-09T21:58:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00330582",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "actual_start_date": "2020-04-03T00:00:00-04:00",
    "actual_end_date": "2020-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-05-01T20:34:47-04:00",
    "status": "resolved",
    "en_comments": "delay in production",
    "fr_comments": "délai en production",
    "en_drug_brand_name": "EFUDEX",
    "en_drug_common_name": "EFUDEX",
    "fr_drug_brand_name": "EFUDEX",
    "fr_drug_common_name": "EFUDEX",
    "en_ingredients": "FLUOROURACIL",
    "fr_ingredients": "Fluorouracil",
    "drug_strength": "5%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "40g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111803,
    "drug": {
      "current_status": "MARKETED",
      "id": 30366,
      "drug_code": 9242,
      "updated_date": "2025-12-03T00:30:26-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251137,
          "ingredient": {
            "id": 1600,
            "ingredient_code": 4182,
            "en_name": "CARBAMAZEPINE",
            "fr_name": "Carbamazépine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00782718",
      "brand_name": "TEVA-CARBAMAZEPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68169",
      "number_of_ais": "1",
      "ai_group_no": "0108674001"
    },
    "created_date": "2020-04-10T17:10:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00782718",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AF",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-01T17:22:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CARBAMAZEPINE",
    "en_drug_common_name": "CARBAMAZEPINE 200MG TAB",
    "fr_drug_brand_name": "TEVA-CARBAMAZEPINE 200MG TAB",
    "fr_drug_common_name": "CARBAMAZEPINE 200MG TAB",
    "en_ingredients": "CARBAMAZEPINE",
    "fr_ingredients": "Carbamazépine",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111807,
    "drug": {
      "current_status": "MARKETED",
      "id": 66087,
      "drug_code": 95113,
      "updated_date": "2025-05-15T02:35:51-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262461,
          "ingredient": {
            "id": 3624,
            "ingredient_code": 13238,
            "en_name": "EVEROLIMUS",
            "fr_name": "Évérolimus"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02463229",
      "brand_name": "TEVA-EVEROLIMUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152682003"
    },
    "created_date": "2020-04-10T17:11:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02463229",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01XE",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-14T18:10:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-EVEROLIMUS",
    "en_drug_common_name": "EVEROLIMUS 2.5MG TAB",
    "fr_drug_brand_name": "TEVA-EVEROLIMUS 2.5MG TAB",
    "fr_drug_common_name": "EVEROLIMUS 2.5MG TAB",
    "en_ingredients": "EVEROLIMUS",
    "fr_ingredients": "Évérolimus",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111810,
    "drug": {
      "current_status": "MARKETED",
      "id": 50254,
      "drug_code": 92856,
      "updated_date": "2025-12-03T00:32:52-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261346,
          "ingredient": {
            "id": 3096,
            "ingredient_code": 13026,
            "en_name": "ATAZANAVIR",
            "fr_name": "Atazanavir (Sulfate d'atazanavir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443813",
      "brand_name": "TEVA-ATAZANAVIR",
      "brand_name_fr": "TEVA-ATAZANAVIR",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149741003"
    },
    "created_date": "2020-04-10T17:12:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443813",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J05AE",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-23T18:31:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ATAZANAVIR",
    "en_drug_common_name": "ATAZANAVIR SULF 200MG CAPSULE",
    "fr_drug_brand_name": "TEVA-ATAZANAVIR SULF 200MG CAPSULE",
    "fr_drug_common_name": "ATAZANAVIR SULF 200MG CAPSULE",
    "en_ingredients": "ATAZANAVIR",
    "fr_ingredients": "ATAZANAVIR SULF",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111813,
    "drug": {
      "current_status": "MARKETED",
      "id": 50256,
      "drug_code": 92857,
      "updated_date": "2025-12-03T00:32:52-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261347,
          "ingredient": {
            "id": 3096,
            "ingredient_code": 13026,
            "en_name": "ATAZANAVIR",
            "fr_name": "Atazanavir (Sulfate d'atazanavir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443821",
      "brand_name": "TEVA-ATAZANAVIR",
      "brand_name_fr": "TEVA-ATAZANAVIR",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149741004"
    },
    "created_date": "2020-04-10T17:14:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443821",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J05AE",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2020-07-31T00:00:00-04:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-07-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-07-23T14:04:00-04:00",
    "status": "resolved",
    "en_comments": "Allocating to 100% of our market.",
    "fr_comments": "Allocating to 100% of our market.",
    "en_drug_brand_name": "TEVA-ATAZANAVIR",
    "en_drug_common_name": "ATAZANAVIR SULF 300MG CAPSULE",
    "fr_drug_brand_name": "TEVA-ATAZANAVIR SULF 300MG CAPSULE",
    "fr_drug_common_name": "ATAZANAVIR SULF 300MG CAPSULE",
    "en_ingredients": "ATAZANAVIR",
    "fr_ingredients": "ATAZANAVIR SULF",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111816,
    "drug": {
      "current_status": "MARKETED",
      "id": 18384,
      "drug_code": 79653,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256441,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310910",
      "brand_name": "TEVA-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055003"
    },
    "created_date": "2020-04-10T17:32:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310910",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-16T19:06:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN 40MG FC TABLET",
    "fr_drug_brand_name": "TEVA-ATORVASTATIN 40MG FC TABLET",
    "fr_drug_common_name": "ATORVASTATIN 40MG FC TABLET",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111819,
    "drug": {
      "current_status": "MARKETED",
      "id": 6076,
      "drug_code": 4254,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250613,
          "ingredient": {
            "id": 1222,
            "ingredient_code": 10127,
            "en_name": "PROPRANOLOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propranolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00496480",
      "brand_name": "TEVA-PROPRANOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57110",
      "number_of_ais": "1",
      "ai_group_no": "0101831003"
    },
    "created_date": "2020-04-10T17:41:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00496480",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-16T19:07:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PROPRANOLOL",
    "en_drug_common_name": "PROPRANOLOL 10MG TABLET",
    "fr_drug_brand_name": "TEVA-PROPRANOLOL 10MG TABLET",
    "fr_drug_common_name": "PROPRANOLOL 10MG TABLET",
    "en_ingredients": "PROPRANOLOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propanolol",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's & 1000's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111823,
    "drug": {
      "current_status": "MARKETED",
      "id": 25644,
      "drug_code": 88053,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259262,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395444",
      "brand_name": "TEVA-QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858006"
    },
    "created_date": "2020-04-10T17:50:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395444",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-05-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-29T19:03:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-QUETIAPINE XR",
    "en_drug_common_name": "QUETIAPINE XR 50MG TABLET",
    "fr_drug_brand_name": "TEVA-QUETIAPINE XR 50MG TABLET",
    "fr_drug_common_name": "QUETIAPINE XR 50MG TABLET",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111826,
    "drug": {
      "current_status": "MARKETED",
      "id": 25652,
      "drug_code": 88057,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259266,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395487",
      "brand_name": "TEVA-QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858007"
    },
    "created_date": "2020-04-10T17:51:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395487",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-04T18:50:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-QUETIAPINE XR",
    "en_drug_common_name": "QUETIAPINE XR 400MG TAB",
    "fr_drug_brand_name": "TEVA-QUETIAPINE XR 400MG TAB",
    "fr_drug_common_name": "QUETIAPINE XR 400MG TAB",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111829,
    "drug": {
      "current_status": "MARKETED",
      "id": 7976,
      "drug_code": 5184,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250713,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00482323",
      "brand_name": "NOVO-GESIC FORTE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59859",
      "number_of_ais": "1",
      "ai_group_no": "0102009002"
    },
    "created_date": "2020-04-10T17:53:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00482323",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02BE",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-04T18:50:47-04:00",
    "status": "resolved",
    "en_comments": "Allocating to 100% of our market.",
    "fr_comments": "Allocating to 100% of our market.",
    "en_drug_brand_name": "NOVO-GESIC FORTE",
    "en_drug_common_name": "GESIC 500MG CAPLET",
    "fr_drug_brand_name": "NOVO-GESIC 500MG CAPLET",
    "fr_drug_common_name": "GESIC 500MG CAPLET",
    "en_ingredients": "ACETAMINOPHEN",
    "fr_ingredients": "Acétaminophène",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111832,
    "drug": {
      "current_status": "MARKETED",
      "id": 23514,
      "drug_code": 86097,
      "updated_date": "2025-05-15T02:33:05-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258481,
          "ingredient": {
            "id": 2882,
            "ingredient_code": 12126,
            "en_name": "ENTACAPONE",
            "fr_name": "Entacapone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02375559",
      "brand_name": "TEVA-ENTACAPONE",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143623001"
    },
    "created_date": "2020-04-10T17:54:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02375559",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N04BX",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-23T18:32:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ENTACAPONE",
    "en_drug_common_name": "ENTACAPONE 200MG TABLET",
    "fr_drug_brand_name": "TEVA-ENTACAPONE 200MG TABLET",
    "fr_drug_common_name": "ENTACAPONE 200MG TABLET",
    "en_ingredients": "ENTACAPONE",
    "fr_ingredients": "Entacapone",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111835,
    "drug": {
      "current_status": "MARKETED",
      "id": 6078,
      "drug_code": 4255,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250614,
          "ingredient": {
            "id": 1222,
            "ingredient_code": 10127,
            "en_name": "PROPRANOLOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propranolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00496499",
      "brand_name": "TEVA-PROPRANOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57111",
      "number_of_ais": "1",
      "ai_group_no": "0101831004"
    },
    "created_date": "2020-04-10T17:56:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00496499",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-05-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-21T18:50:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PROPRANOLOL",
    "en_drug_common_name": "PROPRANOLOL 40MG TABLET",
    "fr_drug_brand_name": "TEVA-PROPRANOLOL 40MG TABLET",
    "fr_drug_common_name": "PROPRANOLOL 40MG TABLET",
    "en_ingredients": "PROPRANOLOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propanolol",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111838,
    "drug": {
      "current_status": "MARKETED",
      "id": 18908,
      "drug_code": 80162,
      "updated_date": "2025-05-15T02:32:14-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256603,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02316099",
      "brand_name": "ACT QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858002"
    },
    "created_date": "2020-04-10T17:57:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02316099",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2021-01-31T00:00:00-05:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-22T17:05:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE 100MG FC TABLET",
    "fr_drug_brand_name": "ACT-QUETIAPINE 100MG FC TABLET",
    "fr_drug_common_name": "QUETIAPINE 100MG FC TABLET",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111841,
    "drug": {
      "current_status": "MARKETED",
      "id": 5228,
      "drug_code": 3344,
      "updated_date": "2025-12-03T00:30:21-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250503,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00452130",
      "brand_name": "NOVAMOXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "53941",
      "number_of_ais": "1",
      "ai_group_no": "0131314003"
    },
    "created_date": "2020-04-10T17:58:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00452130",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01CA",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-23T18:32:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NOVAMOXIN",
    "en_drug_common_name": "AMOXICILLIN SUS 250MG/5ML",
    "fr_drug_brand_name": "TEVA-AMOXICILLIN SUS 250MG/5ML",
    "fr_drug_common_name": "AMOXICILLIN SUS 250MG/5ML",
    "en_ingredients": "AMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "250MG",
    "drug_dosage_form": "GRANULES FOR SUSPENSION",
    "drug_dosage_form_fr": "Granules pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100ml & 150ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111846,
    "drug": {
      "current_status": "MARKETED",
      "id": 9882,
      "drug_code": 64054,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253776,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240484",
      "brand_name": "TEVA-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417001"
    },
    "created_date": "2020-04-10T18:04:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240484",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-05-20T00:00:00-04:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-09-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-03T15:08:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SERTRALINE",
    "en_drug_common_name": "SERTRALINE 50MG CAPSULE",
    "fr_drug_brand_name": "TEVA-SERTRALINE 50MG CAPSULE",
    "fr_drug_common_name": "SERTRALINE 50MG CAPSULE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111851,
    "drug": {
      "current_status": "MARKETED",
      "id": 2098,
      "drug_code": 14445,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251963,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00849650",
      "brand_name": "TEVA-TOPILENE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76063",
      "number_of_ais": "1",
      "ai_group_no": "0106299002"
    },
    "created_date": "2020-04-10T18:05:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00849650",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-23T18:32:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TOPILENE",
    "en_drug_common_name": "TOPILENE 0.05% CREAM",
    "fr_drug_brand_name": "TEVA-TOPILENE 0.05% CREAM",
    "fr_drug_common_name": "TOPILENE 0.05% CREAM",
    "en_ingredients": "BETAMETHASONE",
    "fr_ingredients": "Bétaméthasone",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "50g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111854,
    "drug": {
      "current_status": "MARKETED",
      "id": 22220,
      "drug_code": 84626,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257953,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02361205",
      "brand_name": "TEVA-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121005"
    },
    "created_date": "2020-04-10T18:06:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02361205",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2020-07-31T00:00:00-04:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-23T18:33:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PREGABALIN",
    "en_drug_common_name": "PREGABALIN 150MG CAPSULE",
    "fr_drug_brand_name": "TEVA-PREGABALIN 150MG CAPSULE",
    "fr_drug_common_name": "PREGABALIN 150MG CAPSULE",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111857,
    "drug": {
      "current_status": "MARKETED",
      "id": 18254,
      "drug_code": 79517,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256403,
          "ingredient": {
            "id": 510,
            "ingredient_code": 7572,
            "en_name": "CYPROTERONE ACETATE",
            "fr_name": "Acétate de cyprotérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256402,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.035",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02309556",
      "brand_name": "TEVA-CYPROTERONE / ETHINYL ESTRADIOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0232337001"
    },
    "created_date": "2020-04-10T18:07:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02309556",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G03HB",
    "atc_description": "ANTIANDROGENS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-05-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-29T19:04:00-04:00",
    "status": "resolved",
    "en_comments": "Allocating to 100% of our market.",
    "fr_comments": "Allocating to 100% of our market.",
    "en_drug_brand_name": "TEVA-CYPROTERONE / ETHINYL ESTRADIOL",
    "en_drug_common_name": "CYPROTERONE/E EST 2/0.035MG",
    "fr_drug_brand_name": "TEVA-CYPROTERONE/E EST 2/0.035MG",
    "fr_drug_common_name": "CYPROTERONE/E EST 2/0.035MG",
    "en_ingredients": "CYPROTERONE ACETATE\r\nETHINYL ESTRADIOL",
    "fr_ingredients": "Acétate de cyprotérone\r\nÉthinylestradiol",
    "drug_strength": "2MG\r\n0.035MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 21",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111862,
    "drug": {
      "current_status": "MARKETED",
      "id": 18736,
      "drug_code": 80011,
      "updated_date": "2025-05-15T02:32:13-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256550,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02314584",
      "brand_name": "TEVA-ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434004"
    },
    "created_date": "2020-04-10T18:13:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314584",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2021-04-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-04-15T19:07:12-04:00",
    "status": "resolved",
    "en_comments": "Allocating to 100% of our market.",
    "fr_comments": "Allocating to 100% of our market.",
    "en_drug_brand_name": "TEVA-ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE 40MG CAP",
    "fr_drug_brand_name": "TEVA-ATOMOXETINE 40MG CAP",
    "fr_drug_common_name": "ATOMOXETINE 40MG CAP",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "ATOMOXETINE",
    "drug_strength": "40MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "PP 30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111865,
    "drug": {
      "current_status": "MARKETED",
      "id": 20190,
      "drug_code": 81626,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257162,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257161,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02330539",
      "brand_name": "TEVA-IRBESARTAN HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086003"
    },
    "created_date": "2020-04-10T18:14:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330539",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2021-07-31T00:00:00-04:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2021-03-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-03-04T16:08:08-05:00",
    "status": "resolved",
    "en_comments": "Allocating to 100% of our market to end or risk period",
    "en_drug_brand_name": "TEVA-IRBESARTAN HCTZ",
    "en_drug_common_name": "IRBESARTAN/HCTZ 300/25MG TAB",
    "fr_drug_brand_name": "TEVA-IRBESARTAN/HCTZ 300/25MG TAB",
    "fr_drug_common_name": "IRBESARTAN/HCTZ 300/25MG TAB",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "25MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111868,
    "drug": {
      "current_status": "MARKETED",
      "id": 19864,
      "drug_code": 812,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250194,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00021482",
      "brand_name": "TEVA-HYDROCHLOROTHIAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "30012",
      "number_of_ais": "1",
      "ai_group_no": "0101048001"
    },
    "created_date": "2020-04-10T18:15:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00021482",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C03AA",
    "atc_description": "LOW-CEILING DIURETICS, THIAZIDES",
    "estimated_end_date": "2020-12-31T00:00:00-05:00",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-08T19:42:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-HYDROCHLOROTHIAZIDE",
    "en_drug_common_name": "HYDROCHLOROTHIAZIDE 50MG TAB",
    "fr_drug_brand_name": "TEVA-HYDROCHLOROTHIAZIDE 50MG TAB",
    "fr_drug_common_name": "HYDROCHLOROTHIAZIDE 50MG TAB",
    "en_ingredients": "HYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111871,
    "drug": {
      "current_status": "DORMANT",
      "id": 30184,
      "drug_code": 92233,
      "updated_date": "2025-05-15T06:55:54-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369267,
          "ingredient": {
            "id": 1076,
            "ingredient_code": 8209,
            "en_name": "PROPOFOL",
            "fr_name": "Propofol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02437961",
      "brand_name": "TEVA-PROPOFOL",
      "brand_name_fr": "",
      "descriptor": "20ML/50ML/100ML SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121833001"
    },
    "created_date": "2020-04-10T18:17:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02437961",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N01AX",
    "atc_description": "ANESTHETICS, GENERAL",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-14T17:51:43-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "TEVA-PROPOFOL",
    "en_drug_common_name": "PROPOFOL 10MG/ML INJ",
    "fr_drug_brand_name": "TEVA PROPOFOL 10MG/ML INJ",
    "fr_drug_common_name": "PROPOFOL 10MG/ML INJ",
    "en_ingredients": "PROPOFOL",
    "fr_ingredients": "Propofol",
    "drug_strength": "10MG",
    "drug_dosage_form": "EMULSION",
    "drug_dosage_form_fr": "Émulsion",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "20, 50, & 100ml vial",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111874,
    "drug": {
      "current_status": "MARKETED",
      "id": 14012,
      "drug_code": 73989,
      "updated_date": "2025-05-15T02:31:36-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255062,
          "ingredient": {
            "id": 1002,
            "ingredient_code": 11385,
            "en_name": "TERBINAFINE",
            "fr_name": "Terbinafine (Chlorhydrate de terbinafine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02254727",
      "brand_name": "TEVA-TERBINAFINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132855002"
    },
    "created_date": "2020-04-10T18:18:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02254727",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D01BA",
    "atc_description": "ANTIFUNGALS FOR SYSTEMIC USE",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2020-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-10-03T19:13:59-04:00",
    "status": "resolved",
    "en_comments": "Item is under review to be discontinued - Transitioned",
    "en_drug_brand_name": "ACT TERBINAFINE",
    "en_drug_common_name": "TERBINAFINE 250MG TABLET",
    "fr_drug_brand_name": "CO-TERBINAFINE 250MG TABLET",
    "fr_drug_common_name": "TERBINAFINE 250MG TABLET",
    "en_ingredients": "TERBINAFINE",
    "fr_ingredients": "Terbinafine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111877,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22956,
      "drug_code": 85518,
      "updated_date": "2025-12-03T01:29:12-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8350401,
          "ingredient": {
            "id": 3006,
            "ingredient_code": 11241,
            "en_name": "PIPERACILLIN",
            "fr_name": "Pipéracilline (Pipéracilline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8350400,
          "ingredient": {
            "id": 3416,
            "ingredient_code": 11242,
            "en_name": "TAZOBACTAM",
            "fr_name": "Tazobactam (Tazobactam sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.375",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02370166",
      "brand_name": "PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "FOR I.V. INFUSION ONLY. SINGLE-DOSE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0225919005"
    },
    "created_date": "2020-04-10T18:19:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02370166",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01CR",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "actual_start_date": "2020-04-08T00:00:00-04:00",
    "actual_end_date": "2022-03-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-10-04T19:26:40-04:00",
    "status": "resolved",
    "en_comments": "Item is discontinued",
    "en_drug_brand_name": "PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION",
    "en_drug_common_name": "PIPERACILLIN/TAZOBACTAM 3/0.375G",
    "fr_drug_brand_name": "PIPERACILLIN/TAZOBACTAM 3/0.375G",
    "fr_drug_common_name": "PIPERACILLIN/TAZOBACTAM 3/0.375G",
    "en_ingredients": "PIPERACILLIN\r\nTAZOBACTAM",
    "fr_ingredients": "PIPERACILLIN/TAZOBACTAM",
    "drug_strength": "3G\r\n0.375G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10pk",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111885,
    "drug": {
      "current_status": "MARKETED",
      "id": 31732,
      "drug_code": 94130,
      "updated_date": "2025-05-15T02:35:23-04:00",
      "company": {
        "id": 16915,
        "created_date": "2020-07-07T01:47:04-04:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 9360,
        "mfr_code": "",
        "name": "LABORATOIRE AGUETTANT",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1, RUE ALEXANDER FLEMING",
        "province": "RHÔNE",
        "country": "FRANCE",
        "city": "LYON",
        "postal_code": "69007",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261925,
          "ingredient": {
            "id": 78,
            "ingredient_code": 10258,
            "en_name": "PHENYLEPHRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de phényléphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02454599",
      "brand_name": "PHENYLEPHRINE HYDROCHLORIDE INJECTION",
      "brand_name_fr": "INJECTION DE CHLORHYDRATE DE PHÉNYLÉPHRINE",
      "descriptor": "SINGLE USE PRE-FILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100662011"
    },
    "created_date": "2020-04-13T00:39:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02454599",
    "company_name": "BIOSYENT PHARMA INC",
    "atc_number": "C01CA",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "anticipated_start_date": "2020-05-02T00:00:00-04:00",
    "estimated_end_date": "2020-05-29T00:00:00-04:00",
    "actual_end_date": "2020-05-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-05-29T14:30:04-04:00",
    "status": "resolved",
    "en_comments": "COVID 19 has caused unprecedented drug demand and a potential risk of drug shortage",
    "en_drug_brand_name": "PHENYLEPHRINE HYDROCHLORIDE INJECTION",
    "en_drug_common_name": "phenylephrine hydrochloride injection",
    "fr_drug_brand_name": "INJECTION DE CHLORHYDRATE DE PHÉNYLÉPHRINE",
    "fr_drug_common_name": "INJECTION DE CHLORHYDRATE DE PHÉNYLÉPHRINE",
    "en_ingredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de phényléphrine",
    "drug_strength": "50MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 syringes per box",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111888,
    "drug": {
      "current_status": "MARKETED",
      "id": 29038,
      "drug_code": 91086,
      "updated_date": "2025-12-03T00:32:35-05:00",
      "company": {
        "id": 16915,
        "created_date": "2020-07-07T01:47:04-04:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 9360,
        "mfr_code": "",
        "name": "LABORATOIRE AGUETTANT",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1, RUE ALEXANDER FLEMING",
        "province": "RHÔNE",
        "country": "FRANCE",
        "city": "LYON",
        "postal_code": "69007",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260538,
          "ingredient": {
            "id": 558,
            "ingredient_code": 8970,
            "en_name": "ATROPINE SULFATE",
            "fr_name": "Sulfate d'atropine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02426269",
      "brand_name": "ATROPINE SULFATE INJECTION",
      "brand_name_fr": "SULFATE D'ATROPINE INJECTABLE",
      "descriptor": "SINGLE-USE PREFILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104748003"
    },
    "created_date": "2020-04-13T00:55:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02426269",
    "company_name": "BIOSYENT PHARMA INC",
    "atc_number": "A03BA",
    "atc_description": "BELLADONNAAND DERIVATIVES, PLAIN",
    "anticipated_start_date": "2020-07-16T00:00:00-04:00",
    "actual_end_date": "2020-07-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-07-17T18:27:04-04:00",
    "status": "resolved",
    "en_comments": "COVID 19 has caused unprecedented drug demand and a potential risk of drug shortage.",
    "en_drug_brand_name": "ATROPINE SULFATE INJECTION",
    "en_drug_common_name": "ATROPINE SULFATE INJECTION",
    "fr_drug_brand_name": "ATROPINE SULFATE INJECTION",
    "fr_drug_common_name": "ATROPINE SULFATE INJECTION",
    "en_ingredients": "ATROPINE SULFATE",
    "fr_ingredients": "Sulfate d'atropine",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nSous-cutanée\r\nIntramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "10 syringes per box",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111892,
    "drug": {
      "current_status": "MARKETED",
      "id": 22602,
      "drug_code": 85127,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8258144,
          "ingredient": {
            "id": 172,
            "ingredient_code": 1299,
            "en_name": "LORATADINE",
            "fr_name": "Loratadine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02366444",
      "brand_name": "LORATADINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0120416001"
    },
    "created_date": "2020-04-13T12:26:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02366444",
    "company_name": "APOTEX INC",
    "atc_number": "R06AX",
    "atc_description": "ANTIHISTAMINES FOR SYSTEMIC USE",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-19T13:17:42-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LORATADINE",
    "en_drug_common_name": "LORATADINE",
    "fr_drug_brand_name": "APC-LORATADINE",
    "fr_drug_common_name": "LORATADINE",
    "en_ingredients": "LORATADINE",
    "fr_ingredients": "Loratadine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS/ 100 btl",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111895,
    "drug": {
      "current_status": "DORMANT",
      "id": 22534,
      "drug_code": 85026,
      "updated_date": "2025-12-03T02:32:28-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368557,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02365359",
      "brand_name": "APO-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220002"
    },
    "created_date": "2020-04-13T12:30:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02365359",
    "company_name": "APOTEX INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-10-16T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-19T12:48:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "APO-CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111898,
    "drug": {
      "current_status": "MARKETED",
      "id": 61188,
      "drug_code": 95756,
      "updated_date": "2025-12-03T00:33:34-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262795,
          "ingredient": {
            "id": 3466,
            "ingredient_code": 20301,
            "en_name": "DABIGATRAN ETEXILATE",
            "fr_name": "Dabigatran étexilate (Mésilate de dabigatran étexilate)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02468913",
      "brand_name": "APO-DABIGATRAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152467003"
    },
    "created_date": "2020-04-13T12:35:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02468913",
    "company_name": "APOTEX INC",
    "atc_number": "B01AE",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2021-01-22T00:00:00-05:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2021-01-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-01-26T14:56:19-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DABIGATRAN",
    "en_drug_common_name": "DABIGATRAN",
    "fr_drug_brand_name": "APO-DABIGATRAN",
    "fr_drug_common_name": "DABIGATRAN",
    "en_ingredients": "DABIGATRAN ETEXILATE",
    "fr_ingredients": "DABIGATRAN",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111901,
    "drug": {
      "current_status": "MARKETED",
      "id": 51287,
      "drug_code": 94919,
      "updated_date": "2025-05-15T02:35:45-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262353,
          "ingredient": {
            "id": 3356,
            "ingredient_code": 20022,
            "en_name": "DEFERASIROX",
            "fr_name": "Déférasirox"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461552",
      "brand_name": "APO-DEFERASIROX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151733002"
    },
    "created_date": "2020-04-13T12:41:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02461552",
    "company_name": "APOTEX INC",
    "atc_number": "V03AC",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2020-05-22T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-05-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-22T13:34:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DEFERASIROX",
    "en_drug_common_name": "DEFERASIROX",
    "fr_drug_brand_name": "APO-DEFERASIROX DISP",
    "fr_drug_common_name": "DEFERASIROX",
    "en_ingredients": "DEFERASIROX",
    "fr_ingredients": "Déférasirox",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET FOR SUSPENSION",
    "drug_dosage_form_fr": "Comprimé pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111909,
    "drug": {
      "current_status": "MARKETED",
      "id": 17022,
      "drug_code": 78035,
      "updated_date": "2025-05-15T02:31:55-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256002,
          "ingredient": {
            "id": 3198,
            "ingredient_code": 13585,
            "en_name": "ESCITALOPRAM",
            "fr_name": "Escitalopram (Oxalate d'escitalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295024",
      "brand_name": "APO-ESCITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150435004"
    },
    "created_date": "2020-04-13T13:50:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295024",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-06-01T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-19T15:52:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ESCITALOPRAM",
    "en_drug_common_name": "ESCITALOPRAM",
    "fr_drug_brand_name": "APO-ESCITALOPRAM",
    "fr_drug_common_name": "ESCITALOPRAM",
    "en_ingredients": "ESCITALOPRAM",
    "fr_ingredients": "Escitalopram",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111918,
    "drug": {
      "current_status": "MARKETED",
      "id": 16784,
      "drug_code": 77741,
      "updated_date": "2025-05-15T02:31:53-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255931,
          "ingredient": {
            "id": 1474,
            "ingredient_code": 156,
            "en_name": "FAMCICLOVIR",
            "fr_name": "Famciclovir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292041",
      "brand_name": "APO-FAMCICLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127885001"
    },
    "created_date": "2020-04-13T13:55:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292041",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2020-05-05T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-04T13:33:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FAMCICLOVIR",
    "en_drug_common_name": "FAMCICLOVIR",
    "fr_drug_brand_name": "APO-FAMCICLOVIR",
    "fr_drug_common_name": "FAMCICLOVIR",
    "en_ingredients": "FAMCICLOVIR",
    "fr_ingredients": "Famciclovir",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111921,
    "drug": {
      "current_status": "MARKETED",
      "id": 16410,
      "drug_code": 77206,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255850,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02286610",
      "brand_name": "APO-MIRTAZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928001"
    },
    "created_date": "2020-04-13T14:09:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02286610",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-05-01T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-27T12:18:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MIRTAZAPINE",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "APO-MIRTAZAPINE",
    "fr_drug_common_name": "MIRTAZAPINE",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111925,
    "drug": {
      "current_status": "MARKETED",
      "id": 20358,
      "drug_code": 81866,
      "updated_date": "2025-12-03T00:31:29-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257208,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02333015",
      "brand_name": "APO-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783006"
    },
    "created_date": "2020-04-13T14:18:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02333015",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-10-30T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-05-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-02T12:44:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "20.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111928,
    "drug": {
      "current_status": "MARKETED",
      "id": 22182,
      "drug_code": 84559,
      "updated_date": "2025-12-03T00:31:42-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257941,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02360624",
      "brand_name": "APO-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2020-04-13T14:22:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02360624",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2021-01-04T00:00:00-05:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-12-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-21T13:30:46-05:00",
    "status": "resolved",
    "en_comments": "limited inventory is available",
    "fr_comments": "limited inventory is available",
    "en_drug_brand_name": "APO-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111931,
    "drug": {
      "current_status": "MARKETED",
      "id": 22180,
      "drug_code": 84558,
      "updated_date": "2025-12-03T00:31:42-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257940,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02360616",
      "brand_name": "APO-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783003"
    },
    "created_date": "2020-04-13T14:27:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02360616",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2021-01-04T00:00:00-05:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-12-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-12-21T13:29:20-05:00",
    "status": "resolved",
    "en_comments": "Limited inventory available",
    "fr_comments": "limited inventory available",
    "en_drug_brand_name": "APO-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111934,
    "drug": {
      "current_status": "MARKETED",
      "id": 32178,
      "drug_code": 9892,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8251241,
          "ingredient": {
            "id": 568,
            "ingredient_code": 253,
            "en_name": "AMYLASE",
            "fr_name": "Amylase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251240,
          "ingredient": {
            "id": 570,
            "ingredient_code": 648,
            "en_name": "PROTEASE",
            "fr_name": "Protéase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251239,
          "ingredient": {
            "id": 572,
            "ingredient_code": 649,
            "en_name": "LIPASE",
            "fr_name": "Lipase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00821373",
      "brand_name": "COTAZYM ECS 20",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69249",
      "number_of_ais": "3",
      "ai_group_no": "0302964026"
    },
    "created_date": "2020-04-13T14:30:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00821373",
    "company_name": "MERCK CANADA INC",
    "atc_number": "A09AA",
    "atc_description": "DIGESTIVES, INCL ENZYMES",
    "anticipated_start_date": "2020-05-08T00:00:00-04:00",
    "estimated_end_date": "2020-05-22T00:00:00-04:00",
    "actual_end_date": "2020-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-04-30T15:06:58-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "COTAZYM ECS 20",
    "en_drug_common_name": "PANCRELIPASE DELAYED-RELEASE CAPSULES",
    "fr_drug_brand_name": "COTAZYM E.C.S.",
    "fr_drug_common_name": "CAPSULES DE PANCRÉLIPASE À LIBÉRATION RETARDÉE",
    "en_ingredients": "LIPASE\r\nAMYLASE\r\nPROTEASE",
    "fr_ingredients": "Lipase\r\nAmylase\r\nProtéase",
    "drug_strength": "25000UNIT\r\n100000UNIT\r\n100000UNIT",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100CAP",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111936,
    "drug": {
      "current_status": "MARKETED",
      "id": 10028,
      "drug_code": 64499,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253820,
          "ingredient": {
            "id": 1004,
            "ingredient_code": 11340,
            "en_name": "PAROXETINE",
            "fr_name": "Paroxétine (Chlorhydrate de paroxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240908",
      "brand_name": "APO-PAROXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123131002"
    },
    "created_date": "2020-04-13T14:32:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240908",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-04-26T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-27T12:20:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PAROXETINE",
    "en_drug_common_name": "PAROXETINE",
    "fr_drug_brand_name": "APO-PAROXETINE",
    "fr_drug_common_name": "PAROXETINE",
    "en_ingredients": "PAROXETINE",
    "fr_ingredients": "PAROXETINE",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111939,
    "drug": {
      "current_status": "MARKETED",
      "id": 5808,
      "drug_code": 3891,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8250580,
          "ingredient": {
            "id": 570,
            "ingredient_code": 648,
            "en_name": "PROTEASE",
            "fr_name": "Protéase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "45000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250579,
          "ingredient": {
            "id": 568,
            "ingredient_code": 253,
            "en_name": "AMYLASE",
            "fr_name": "Amylase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "42000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250578,
          "ingredient": {
            "id": 572,
            "ingredient_code": 649,
            "en_name": "LIPASE",
            "fr_name": "Lipase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10800",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00502790",
      "brand_name": "COTAZYM ECS 8",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "55867",
      "number_of_ais": "3",
      "ai_group_no": "0302964031"
    },
    "created_date": "2020-04-13T14:36:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00502790",
    "company_name": "MERCK CANADA INC",
    "atc_number": "A09AA",
    "atc_description": "DIGESTIVES, INCL ENZYMES",
    "anticipated_start_date": "2020-05-15T00:00:00-04:00",
    "estimated_end_date": "2020-07-03T00:00:00-04:00",
    "actual_start_date": "2020-04-30T00:00:00-04:00",
    "actual_end_date": "2020-06-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-06-27T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "COTAZYM ECS 8",
    "en_drug_common_name": "PANCRELIPASE DELAYED-RELEASE CAPSULES",
    "fr_drug_brand_name": "COTAZYM E.C.S. 8",
    "fr_drug_common_name": "CAPSULES DE PANCRÉLIPASE À LIBÉRATION RETARDÉE",
    "en_ingredients": "LIPASE\r\nAMYLASE\r\nPROTEASE",
    "fr_ingredients": "Lipase\r\nAmylase\r\nProtéase",
    "drug_strength": "10800UNIT\r\n42000UNIT\r\n45000UNIT",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500CAP",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111943,
    "drug": {
      "current_status": "MARKETED",
      "id": 10032,
      "drug_code": 64500,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253821,
          "ingredient": {
            "id": 1004,
            "ingredient_code": 11340,
            "en_name": "PAROXETINE",
            "fr_name": "Paroxétine (Chlorhydrate de paroxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240909",
      "brand_name": "APO-PAROXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123131001"
    },
    "created_date": "2020-04-13T14:40:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240909",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-04-27T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-27T12:22:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PAROXETINE",
    "en_drug_common_name": "PAROXETINE",
    "fr_drug_brand_name": "APO-PAROXETINE",
    "fr_drug_common_name": "PAROXETINE",
    "en_ingredients": "PAROXETINE",
    "fr_ingredients": "PAROXETINE",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111946,
    "drug": {
      "current_status": "MARKETED",
      "id": 308,
      "drug_code": 10828,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251400,
          "ingredient": {
            "id": 236,
            "ingredient_code": 11108,
            "en_name": "PRAZOSIN",
            "fr_name": "Prazosine (Chlorhydrate de prazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00882801",
      "brand_name": "APO-PRAZO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70921",
      "number_of_ais": "1",
      "ai_group_no": "0111527001"
    },
    "created_date": "2020-04-13T14:44:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00882801",
    "company_name": "APOTEX INC",
    "atc_number": "C02CA",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "estimated_end_date": "2020-07-03T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-06-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-22T13:26:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PRAZO TAB 1MG",
    "en_drug_common_name": "PRAZO",
    "fr_drug_brand_name": "APO-PRAZO",
    "fr_drug_common_name": "PRAZO",
    "en_ingredients": "PRAZOSIN",
    "fr_ingredients": "PRAZO",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111951,
    "drug": {
      "current_status": "DORMANT",
      "id": 13278,
      "drug_code": 72853,
      "updated_date": "2025-05-15T06:55:31-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367658,
          "ingredient": {
            "id": 584,
            "ingredient_code": 11161,
            "en_name": "QUINAPRIL",
            "fr_name": "Quinapril (Chlorhydrate de quinapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248501",
      "brand_name": "APO-QUINAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123206003"
    },
    "created_date": "2020-04-13T14:48:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248501",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2020-06-26T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-06-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-22T13:33:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-QUINAPRIL",
    "en_drug_common_name": "QUINAPRIL",
    "fr_drug_brand_name": "APO-QUINAPRIL",
    "fr_drug_common_name": "QUINAPRIL",
    "en_ingredients": "QUINAPRIL",
    "fr_ingredients": "QUINAPRIL",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111954,
    "drug": {
      "current_status": "MARKETED",
      "id": 27100,
      "drug_code": 89354,
      "updated_date": "2025-12-03T00:32:19-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259769,
          "ingredient": {
            "id": 584,
            "ingredient_code": 11161,
            "en_name": "QUINAPRIL",
            "fr_name": "Quinapril (Chlorhydrate de quinapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259768,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02408783",
      "brand_name": "APO-QUINAPRIL/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0231789003"
    },
    "created_date": "2020-04-13T14:54:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02408783",
    "company_name": "APOTEX INC",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2020-09-11T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-08-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-09-01T19:10:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-QUINAPRIL/HCTZ",
    "en_drug_common_name": "QUINAPRIL",
    "fr_drug_brand_name": "APO-QUINAPRIL/HCTZ",
    "fr_drug_common_name": "QUINAPRIL",
    "en_ingredients": "QUINAPRIL\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "20MG\r\n25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111957,
    "drug": {
      "current_status": "MARKETED",
      "id": 56740,
      "drug_code": 90451,
      "updated_date": "2025-05-15T02:34:12-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260267,
          "ingredient": {
            "id": 3368,
            "ingredient_code": 20097,
            "en_name": "VARENICLINE",
            "fr_name": "Varénicline (Tartrate de varénicline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02419890",
      "brand_name": "APO-VARENICLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152190002"
    },
    "created_date": "2020-04-13T14:58:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02419890",
    "company_name": "APOTEX INC",
    "atc_number": "N07BA",
    "atc_description": "DRUGS USED IN ADDICTIVE DISORDERS",
    "estimated_end_date": "2020-05-29T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-19T18:21:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-VARENICLINE",
    "en_drug_common_name": "APO-VARENICLINE",
    "fr_drug_brand_name": "APO-VARENICLINE",
    "fr_drug_common_name": "VARENICLINE",
    "en_ingredients": "VARENICLINE",
    "fr_ingredients": "VARENICLINE",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "56 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111960,
    "drug": {
      "current_status": "MARKETED",
      "id": 60206,
      "drug_code": 96087,
      "updated_date": "2025-05-15T02:36:14-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262989,
          "ingredient": {
            "id": 3124,
            "ingredient_code": 13311,
            "en_name": "VARDENAFIL",
            "fr_name": "Vardénafil (Chlorhydrate de vardénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02471655",
      "brand_name": "APO-VARDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150003002"
    },
    "created_date": "2020-04-13T15:03:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02471655",
    "company_name": "APOTEX INC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2020-05-08T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-11T12:24:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-VARDENAFIL",
    "en_drug_common_name": "VARDENAFIL",
    "fr_drug_brand_name": "APO-VARDENAFIL",
    "fr_drug_common_name": "VARDENAFIL",
    "en_ingredients": "VARDENAFIL",
    "fr_ingredients": "VARDENAFIL",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111963,
    "drug": {
      "current_status": "MARKETED",
      "id": 57148,
      "drug_code": 92001,
      "updated_date": "2025-05-15T02:34:37-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260877,
          "ingredient": {
            "id": 3368,
            "ingredient_code": 20097,
            "en_name": "VARENICLINE",
            "fr_name": "Varénicline (Tartrate de varénicline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8260876,
          "ingredient": {
            "id": 3368,
            "ingredient_code": 20097,
            "en_name": "VARENICLINE",
            "fr_name": "Varénicline (Tartrate de varénicline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02435675",
      "brand_name": "APO-VARENICLINE",
      "brand_name_fr": "",
      "descriptor": "STARTER PACK (COMBOPACK)",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252269001"
    },
    "created_date": "2020-04-13T15:06:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02435675",
    "company_name": "APOTEX INC",
    "atc_number": "N07BA",
    "atc_description": "DRUGS USED IN ADDICTIVE DISORDERS",
    "estimated_end_date": "2020-05-29T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-19T18:24:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-VARENICLINE",
    "en_drug_common_name": "VARENICLINE",
    "fr_drug_brand_name": "APO-VARENICLINE",
    "fr_drug_common_name": "VARENICLINE",
    "en_ingredients": "VARENICLINE\r\nVARENICLINE",
    "fr_ingredients": "VARENICLINE",
    "drug_strength": "0.5MG\r\n1MG",
    "drug_dosage_form": "KIT\r\nTABLET",
    "drug_dosage_form_fr": "Trousse\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "53 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111966,
    "drug": {
      "current_status": "MARKETED",
      "id": 10870,
      "drug_code": 66766,
      "updated_date": "2025-12-03T00:30:46-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254103,
          "ingredient": {
            "id": 704,
            "ingredient_code": 9054,
            "en_name": "WARFARIN SODIUM",
            "fr_name": "Warfarine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242928",
      "brand_name": "APO-WARFARIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104597001"
    },
    "created_date": "2020-04-13T15:11:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242928",
    "company_name": "APOTEX INC",
    "atc_number": "B01AA",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2020-05-26T00:00:00-04:00",
    "actual_start_date": "2020-04-06T00:00:00-04:00",
    "actual_end_date": "2020-05-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-28T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-WARFARIN",
    "en_drug_common_name": "WARFARIN",
    "fr_drug_brand_name": "APO-WARFARIN",
    "fr_drug_common_name": "WARFARIN",
    "en_ingredients": "WARFARIN SODIUM",
    "fr_ingredients": "Warfarine sodique",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111990,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12978,
      "drug_code": 72226,
      "updated_date": "2025-12-03T01:22:12-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8338627,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247917",
      "brand_name": "PMS-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858004"
    },
    "created_date": "2020-04-13T19:30:04-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02247917",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2020-04-13T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-04-13T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-27T16:55:36-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL",
    "fr_drug_brand_name": "PMS-RAMIPRIL",
    "fr_drug_common_name": "RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111993,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12978,
      "drug_code": 72226,
      "updated_date": "2025-12-03T01:22:12-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8338627,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247917",
      "brand_name": "PMS-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858004"
    },
    "created_date": "2020-04-13T19:31:02-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02247917",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2020-04-13T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-04-13T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-27T16:56:35-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL",
    "fr_drug_brand_name": "PMS-RAMIPRIL",
    "fr_drug_common_name": "RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 111996,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12978,
      "drug_code": 72226,
      "updated_date": "2025-12-03T01:22:12-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8338627,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247917",
      "brand_name": "PMS-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858004"
    },
    "created_date": "2020-04-13T19:33:09-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02247917",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "discontinuation_date": "2020-04-13T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-04-13T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2021-10-27T16:57:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL",
    "fr_drug_brand_name": "PMS-RAMIPRIL",
    "fr_drug_common_name": "RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112001,
    "drug": {
      "current_status": "MARKETED",
      "id": 10902,
      "drug_code": 66824,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 598,
        "created_date": "2017-03-09T13:22:57-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11314,
        "mfr_code": "TPT08",
        "name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254108,
          "ingredient": {
            "id": 2848,
            "ingredient_code": 7509,
            "en_name": "HYDROCORTISONE VALERATE",
            "fr_name": "Valérate d'hydrocortisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242984",
      "brand_name": "HYDROVAL CREAM 0.2%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112513001"
    },
    "created_date": "2020-04-13T21:26:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242984",
    "company_name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
    "atc_number": "D07AA",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2020-04-24T00:00:00-04:00",
    "actual_start_date": "2020-04-13T00:00:00-04:00",
    "actual_end_date": "2020-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-21T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HYDROVAL CREAM 0.2%",
    "en_drug_common_name": "HYDROVAL CREAM 0.2%",
    "fr_drug_brand_name": "HYDROVAL CREAM 0.2%",
    "fr_drug_common_name": "HYDROVAL CREAM 0.2%",
    "en_ingredients": "HYDROCORTISONE VALERATE",
    "fr_ingredients": "Valérate d'hydrocortisone",
    "drug_strength": "0.2%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "60 g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112004,
    "drug": {
      "current_status": "MARKETED",
      "id": 30708,
      "drug_code": 9276,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 598,
        "created_date": "2017-03-09T13:22:57-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 11314,
        "mfr_code": "TPT08",
        "name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251141,
          "ingredient": {
            "id": 478,
            "ingredient_code": 7579,
            "en_name": "FLUOCINONIDE",
            "fr_name": "Fluocinonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "00716863",
      "brand_name": "LYDERM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68229",
      "number_of_ais": "1",
      "ai_group_no": "0106313001"
    },
    "created_date": "2020-04-13T21:28:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00716863",
    "company_name": "TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2020-06-12T00:00:00-04:00",
    "actual_start_date": "2020-04-13T00:00:00-04:00",
    "actual_end_date": "2020-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-02T05:00:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LYDERM CREAM 0.05%",
    "en_drug_common_name": "LYDERM CREAM 0.05%",
    "fr_drug_brand_name": "LYDERM CREAM 0.05%",
    "fr_drug_common_name": "LYDERM CREAM 0.05%",
    "en_ingredients": "FLUOCINONIDE",
    "fr_ingredients": "Fluocinonide",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "60 g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112033,
    "drug": {
      "current_status": "MARKETED",
      "id": 53023,
      "drug_code": 94455,
      "updated_date": "2025-05-15T02:35:34-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262118,
          "ingredient": {
            "id": 2586,
            "ingredient_code": 11787,
            "en_name": "CAPECITABINE",
            "fr_name": "Capécitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457504",
      "brand_name": "TARO-CAPECITABINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134120002"
    },
    "created_date": "2020-04-13T21:34:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457504",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "estimated_end_date": "2020-07-17T00:00:00-04:00",
    "actual_start_date": "2020-04-13T00:00:00-04:00",
    "actual_end_date": "2020-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-27T10:33:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CAPECITABINE",
    "en_drug_common_name": "CAPECITABINE",
    "fr_drug_brand_name": "TARO-CAPECITABINE",
    "fr_drug_common_name": "CAPECITABINE",
    "en_ingredients": "CAPECITABINE",
    "fr_ingredients": "Capécitabine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "120 blister",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112036,
    "drug": {
      "current_status": "MARKETED",
      "id": 856,
      "drug_code": 11893,
      "updated_date": "2025-05-15T02:30:52-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251586,
          "ingredient": {
            "id": 210,
            "ingredient_code": 2375,
            "en_name": "CLOTRIMAZOLE",
            "fr_name": "Clotrimazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00812382",
      "brand_name": "CLOTRIMADERM TOPICAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72833",
      "number_of_ais": "1",
      "ai_group_no": "0110231001"
    },
    "created_date": "2020-04-13T21:35:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00812382",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D01AC",
    "atc_description": "ANTIFUNGALS FOR TOPICAL USE",
    "estimated_end_date": "2020-05-29T00:00:00-04:00",
    "actual_start_date": "2020-04-13T00:00:00-04:00",
    "actual_end_date": "2020-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-27T10:34:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CLOTRIMADERM CREAM 1%",
    "en_drug_common_name": "CLOTRIMADERM CREAM 1%",
    "fr_drug_brand_name": "CLOTRIMADERM CREAM 1%",
    "fr_drug_common_name": "CLOTRIMADERM CREAM 1%",
    "en_ingredients": "CLOTRIMAZOLE",
    "fr_ingredients": "Clotrimazole",
    "drug_strength": "1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "30 g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112059,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17290,
      "drug_code": 78339,
      "updated_date": "2025-05-15T04:12:49-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8344406,
          "ingredient": {
            "id": 2884,
            "ingredient_code": 12149,
            "en_name": "RABEPRAZOLE SODIUM",
            "fr_name": "Rabéprazole sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02298082",
      "brand_name": "TARO-RABEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143681002"
    },
    "created_date": "2020-04-13T21:45:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02298082",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2020-07-17T00:00:00-04:00",
    "actual_start_date": "2020-04-13T00:00:00-04:00",
    "actual_end_date": "2020-08-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-08-29T00:51:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-RABEPRAZOLE",
    "en_drug_common_name": "RABEPRAZOLE",
    "fr_drug_brand_name": "RAN-RABEPRAZOLE",
    "fr_drug_common_name": "RABEPRAZOLE",
    "en_ingredients": "RABEPRAZOLE SODIUM",
    "fr_ingredients": "Rabéprazole sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112062,
    "drug": {
      "current_status": "MARKETED",
      "id": 23936,
      "drug_code": 86591,
      "updated_date": "2025-05-15T02:33:13-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258617,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02380072",
      "brand_name": "TARO-VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294002"
    },
    "created_date": "2020-04-13T21:46:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02380072",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-07-03T00:00:00-04:00",
    "actual_start_date": "2020-04-13T00:00:00-04:00",
    "actual_end_date": "2020-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-08-29T01:25:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-VENLAFAXINE XR",
    "en_drug_common_name": "VENLAFAXINE XR",
    "fr_drug_brand_name": "RAN-VENLAFAXINE XR",
    "fr_drug_common_name": "VENLAFAXINE XR",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "VENLAFAXINE",
    "drug_strength": "37.5MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112065,
    "drug": {
      "current_status": "MARKETED",
      "id": 23936,
      "drug_code": 86591,
      "updated_date": "2025-05-15T02:33:13-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258617,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02380072",
      "brand_name": "TARO-VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294002"
    },
    "created_date": "2020-04-13T21:47:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02380072",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-07-03T00:00:00-04:00",
    "actual_start_date": "2020-04-13T00:00:00-04:00",
    "actual_end_date": "2020-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-08-29T01:24:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-VENLAFAXINE XR",
    "en_drug_common_name": "VENLAFAXINE XR",
    "fr_drug_brand_name": "RAN-VENLAFAXINE XR",
    "fr_drug_common_name": "VENLAFAXINE XR",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "VENLAFAXINE",
    "drug_strength": "37.5MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112068,
    "drug": {
      "current_status": "MARKETED",
      "id": 23938,
      "drug_code": 86592,
      "updated_date": "2025-05-15T02:33:13-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258618,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02380080",
      "brand_name": "TARO-VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294001"
    },
    "created_date": "2020-04-13T21:49:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02380080",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-07-03T00:00:00-04:00",
    "actual_start_date": "2020-04-13T00:00:00-04:00",
    "actual_end_date": "2020-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-08-29T01:24:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-VENLAFAXINE XR",
    "en_drug_common_name": "VENLAFAXINE XR",
    "fr_drug_brand_name": "RAN-VENLAFAXINE XR",
    "fr_drug_common_name": "VENLAFAXINE XR",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "VENLAFAXINE",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112172,
    "drug": {
      "current_status": "MARKETED",
      "id": 10050,
      "drug_code": 64599,
      "updated_date": "2025-12-03T00:30:43-05:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8253824,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8253823,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02241007",
      "brand_name": "HYZAAR DS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168002"
    },
    "created_date": "2020-04-14T14:09:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241007",
    "company_name": "MERCK CANADA INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "anticipated_start_date": "2020-06-19T00:00:00-04:00",
    "estimated_end_date": "2020-07-03T00:00:00-04:00",
    "actual_start_date": "2020-06-04T00:00:00-04:00",
    "actual_end_date": "2020-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-07-04T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HYZAAR DS 100/25 MG",
    "en_drug_common_name": "losartan potassium and hydrochlorothiazide tablets",
    "fr_drug_brand_name": "HYZAAR",
    "fr_drug_common_name": "comprimés de losartan potassique et d’hydrochlorothiazide",
    "en_ingredients": "LOSARTAN POTASSIUM\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Losartan potassique\r\nHydrochlorothiazide",
    "drug_strength": "100MG\r\n25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112189,
    "drug": {
      "current_status": "MARKETED",
      "id": 16786,
      "drug_code": 77742,
      "updated_date": "2025-05-15T02:31:53-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255932,
          "ingredient": {
            "id": 1474,
            "ingredient_code": 156,
            "en_name": "FAMCICLOVIR",
            "fr_name": "Famciclovir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02292068",
      "brand_name": "APO-FAMCICLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127885002"
    },
    "created_date": "2020-04-15T12:13:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292068",
    "company_name": "APOTEX INC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2020-05-03T00:00:00-04:00",
    "actual_start_date": "2020-04-13T00:00:00-04:00",
    "actual_end_date": "2020-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-04T13:34:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FAMCICLOVIR",
    "en_drug_common_name": "FAMCICLOVIR",
    "fr_drug_brand_name": "APO-FAMCICLOVIR",
    "fr_drug_common_name": "FAMCICLOVIR",
    "en_ingredients": "FAMCICLOVIR",
    "fr_ingredients": "Famciclovir",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112192,
    "drug": {
      "current_status": "MARKETED",
      "id": 312,
      "drug_code": 10830,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251402,
          "ingredient": {
            "id": 236,
            "ingredient_code": 11108,
            "en_name": "PRAZOSIN",
            "fr_name": "Prazosine (Chlorhydrate de prazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00882836",
      "brand_name": "APO-PRAZO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70923",
      "number_of_ais": "1",
      "ai_group_no": "0111527003"
    },
    "created_date": "2020-04-15T12:17:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00882836",
    "company_name": "APOTEX INC",
    "atc_number": "C02CA",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "estimated_end_date": "2020-07-03T00:00:00-04:00",
    "actual_start_date": "2020-04-13T00:00:00-04:00",
    "actual_end_date": "2020-06-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-22T13:28:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PRAZO TAB 5MG",
    "en_drug_common_name": "PRAZO",
    "fr_drug_brand_name": "APO-PRAZO",
    "fr_drug_common_name": "PRAZO",
    "en_ingredients": "PRAZOSIN",
    "fr_ingredients": "PRAZOSIN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112195,
    "drug": {
      "current_status": "MARKETED",
      "id": 9050,
      "drug_code": 61677,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253563,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02238281",
      "brand_name": "APO-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417001"
    },
    "created_date": "2020-04-15T12:20:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238281",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-05-10T00:00:00-04:00",
    "actual_start_date": "2020-04-13T00:00:00-04:00",
    "actual_end_date": "2020-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-11T20:42:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "APO-SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "250 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112198,
    "drug": {
      "current_status": "MARKETED",
      "id": 60208,
      "drug_code": 96088,
      "updated_date": "2025-05-15T02:36:14-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262990,
          "ingredient": {
            "id": 3124,
            "ingredient_code": 13311,
            "en_name": "VARDENAFIL",
            "fr_name": "Vardénafil (Chlorhydrate de vardénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02471663",
      "brand_name": "APO-VARDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150003003"
    },
    "created_date": "2020-04-15T12:24:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02471663",
    "company_name": "APOTEX INC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2020-05-08T00:00:00-04:00",
    "actual_start_date": "2020-04-13T00:00:00-04:00",
    "actual_end_date": "2020-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-11T12:26:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-VARDENAFIL",
    "en_drug_common_name": "VARDENAFIL",
    "fr_drug_brand_name": "APO-VARDENAFIL",
    "fr_drug_common_name": "VARDENAFIL",
    "en_ingredients": "VARDENAFIL",
    "fr_ingredients": "VARDENAFIL",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112203,
    "drug": {
      "current_status": "MARKETED",
      "id": 2248,
      "drug_code": 15,
      "updated_date": "2025-05-15T02:30:25-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250109,
          "ingredient": {
            "id": 1112,
            "ingredient_code": 11121,
            "en_name": "NORTRIPTYLINE",
            "fr_name": "Nortriptyline (Chlorhydrate de nortriptyline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00015229",
      "brand_name": "AVENTYL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "00226",
      "number_of_ais": "1",
      "ai_group_no": "0102630002"
    },
    "created_date": "2020-04-15T12:57:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00015229",
    "company_name": "AA PHARMA INC",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-04-30T00:00:00-04:00",
    "actual_start_date": "2020-04-15T00:00:00-04:00",
    "actual_end_date": "2020-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-24T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AVENTYL",
    "en_drug_common_name": "Aventyl",
    "fr_drug_brand_name": "Aventyl",
    "fr_drug_common_name": "Aventyl",
    "en_ingredients": "NORTRIPTYLINE",
    "fr_ingredients": "HYDROCHLORURE NORTRIPTYLINE",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112208,
    "drug": {
      "current_status": "MARKETED",
      "id": 10862,
      "drug_code": 66762,
      "updated_date": "2025-12-03T00:30:46-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254099,
          "ingredient": {
            "id": 704,
            "ingredient_code": 9054,
            "en_name": "WARFARIN SODIUM",
            "fr_name": "Warfarine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02242924",
      "brand_name": "APO-WARFARIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104597002"
    },
    "created_date": "2020-04-15T13:13:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242924",
    "company_name": "APOTEX INC",
    "atc_number": "B01AA",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2020-05-13T00:00:00-04:00",
    "actual_start_date": "2020-04-13T00:00:00-04:00",
    "actual_end_date": "2020-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-11T20:50:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-WARFARIN",
    "en_drug_common_name": "WARFARIN",
    "fr_drug_brand_name": "APO-WARFARIN",
    "fr_drug_common_name": "WARFARIN",
    "en_ingredients": "WARFARIN SODIUM",
    "fr_ingredients": "Warfarine sodique",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112220,
    "drug": {
      "current_status": "MARKETED",
      "id": 14756,
      "drug_code": 75097,
      "updated_date": "2025-12-03T00:31:02-05:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8255301,
          "ingredient": {
            "id": 1318,
            "ingredient_code": 238,
            "en_name": "LAMOTRIGINE",
            "fr_name": "Lamotrigine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02265516",
      "brand_name": "MYLAN-LAMOTRIGINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127134006"
    },
    "created_date": "2020-04-15T13:25:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02265516",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2020-05-27T00:00:00-04:00",
    "estimated_end_date": "2020-06-16T00:00:00-04:00",
    "actual_end_date": "2020-05-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-26T11:34:45-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MYLAN-LAMOTRIGINE",
    "en_drug_common_name": "LAMOTRIGINE",
    "fr_drug_brand_name": "MYLAN-LAMOTRIGINE",
    "fr_drug_common_name": "LAMOTRIGINE",
    "en_ingredients": "LAMOTRIGINE",
    "fr_ingredients": "Lamotrigine",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112223,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14724,
      "drug_code": 75035,
      "updated_date": "2025-05-15T04:10:04-04:00",
      "company": {
        "id": 264,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7259,
        "mfr_code": "JSO08",
        "name": "JANSSEN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "19 GREEN BELT DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M3C 1L9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8341016,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8341015,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02264846",
      "brand_name": "TRAMACET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250601001"
    },
    "created_date": "2020-04-15T13:37:50-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02264846",
    "company_name": "JANSSEN INC",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2020-09-17T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-09-17T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-09-18T05:00:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TRAMACET",
    "en_drug_common_name": "Tramadol",
    "fr_drug_brand_name": "TRAMACET* 37.5mg 6x10 Comprimes",
    "fr_drug_common_name": "Tramadol",
    "en_ingredients": "ACETAMINOPHEN\r\nTRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Acétaminophène\r\nChlorhydrate de tramadol",
    "drug_strength": "325MG\r\n37.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6x10",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112226,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21130,
      "drug_code": 83476,
      "updated_date": "2025-05-15T04:16:53-04:00",
      "company": {
        "id": 264,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7259,
        "mfr_code": "JSO08",
        "name": "JANSSEN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "19 GREEN BELT DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M3C 1L9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348779,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02349469",
      "brand_name": "ULTRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151694006"
    },
    "created_date": "2020-04-15T13:41:40-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02349469",
    "company_name": "JANSSEN INC",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2020-09-25T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-09-25T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-09-26T05:00:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ULTRAM",
    "en_drug_common_name": "ULTRAM* 50mg Tablets 100's",
    "fr_drug_brand_name": "ULTRAM",
    "fr_drug_common_name": "ULTRAM* 50mg comprimés 100/flacon",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tramadol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112229,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3764,
      "drug_code": 19250,
      "updated_date": "2025-05-15T03:45:25-04:00",
      "company": {
        "id": 264,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7259,
        "mfr_code": "JSO08",
        "name": "JANSSEN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "19 GREEN BELT DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M3C 1L9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8302772,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8302771,
          "ingredient": {
            "id": 98,
            "ingredient_code": 9131,
            "en_name": "CODEINE PHOSPHATE",
            "fr_name": "Phosphate de codéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02163918",
      "brand_name": "TYLENOL WITH CODEINE NO. 4",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81541",
      "number_of_ais": "2",
      "ai_group_no": "0211376001"
    },
    "created_date": "2020-04-15T13:44:34-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02163918",
    "company_name": "JANSSEN INC",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2020-09-21T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-09-22T05:00:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TYLENOL WITH CODEINE NO. 4",
    "en_drug_common_name": "TYLENOL* NO. 4 TAB 100",
    "fr_drug_brand_name": "Tylenol",
    "fr_drug_common_name": "TYLENOL* NO. 4 TAB 100",
    "en_ingredients": "ACETAMINOPHEN\r\nCODEINE PHOSPHATE",
    "fr_ingredients": "Acétaminophène\r\nPhosphate de codéine",
    "drug_strength": "300MG\r\n60MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112235,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3762,
      "drug_code": 19249,
      "updated_date": "2025-05-15T03:45:25-04:00",
      "company": {
        "id": 264,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7259,
        "mfr_code": "JSO08",
        "name": "JANSSEN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "19 GREEN BELT DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M3C 1L9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8302770,
          "ingredient": {
            "id": 100,
            "ingredient_code": 9358,
            "en_name": "CAFFEINE",
            "fr_name": "Caféine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8302769,
          "ingredient": {
            "id": 98,
            "ingredient_code": 9131,
            "en_name": "CODEINE PHOSPHATE",
            "fr_name": "Phosphate de codéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8302768,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02163926",
      "brand_name": "TYLENOL WITH CODEINE NO. 3 - TAB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81540",
      "number_of_ais": "3",
      "ai_group_no": "0311391005"
    },
    "created_date": "2020-04-15T13:47:43-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02163926",
    "company_name": "JANSSEN INC",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2020-09-25T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-09-26T05:00:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TYLENOL WITH CODEINE NO. 3 - TAB",
    "en_drug_common_name": "TYLENOL* #3 TABLET 500",
    "fr_drug_brand_name": "TYLENOL #3",
    "fr_drug_common_name": "TYLENOL* #3 TABLET 500",
    "en_ingredients": "ACETAMINOPHEN\r\nCODEINE PHOSPHATE\r\nCAFFEINE",
    "fr_ingredients": "Acétaminophène\r\nPhosphate de codéine\r\nCaféine",
    "drug_strength": "300MG\r\n30MG\r\n15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112238,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3760,
      "drug_code": 19248,
      "updated_date": "2025-05-15T03:45:25-04:00",
      "company": {
        "id": 264,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7259,
        "mfr_code": "JSO08",
        "name": "JANSSEN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "19 GREEN BELT DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M3C 1L9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8302767,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8302766,
          "ingredient": {
            "id": 98,
            "ingredient_code": 9131,
            "en_name": "CODEINE PHOSPHATE",
            "fr_name": "Phosphate de codéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8302765,
          "ingredient": {
            "id": 100,
            "ingredient_code": 9358,
            "en_name": "CAFFEINE",
            "fr_name": "Caféine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02163934",
      "brand_name": "TYLENOL WITH CODEINE NO. 2 - TAB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81539",
      "number_of_ais": "3",
      "ai_group_no": "0311391001"
    },
    "created_date": "2020-04-15T13:51:01-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02163934",
    "company_name": "JANSSEN INC",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "discontinuation_date": "2020-09-25T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-09-26T05:00:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TYLENOL WITH CODEINE NO. 2 - TAB",
    "en_drug_common_name": "TYLENOL* #2 TABLET 500",
    "fr_drug_brand_name": "TYLENOL #2 CODEINE",
    "fr_drug_common_name": "TYLENOL* #2 TABLET 500",
    "en_ingredients": "ACETAMINOPHEN\r\nCODEINE PHOSPHATE\r\nCAFFEINE",
    "fr_ingredients": "Acétaminophène\r\nPhosphate de codéine\r\nCaféine",
    "drug_strength": "300MG\r\n15MG\r\n15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112263,
    "drug": {
      "current_status": "MARKETED",
      "id": 25108,
      "drug_code": 87622,
      "updated_date": "2025-05-15T02:33:39-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259098,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02390825",
      "brand_name": "SANDOZ PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121002"
    },
    "created_date": "2020-04-15T18:29:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390825",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2020-04-24T00:00:00-04:00",
    "actual_start_date": "2020-04-10T00:00:00-04:00",
    "actual_end_date": "2020-04-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-04-27T13:48:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ PREGABALIN",
    "en_drug_common_name": "SANDOZ PREGABALIN",
    "fr_drug_brand_name": "SANDOZ PREGABALIN",
    "fr_drug_common_name": "SANDOZ PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 HGC",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112293,
    "drug": {
      "current_status": "MARKETED",
      "id": 64936,
      "drug_code": 97578,
      "updated_date": "2025-12-03T00:34:13-05:00",
      "company": {
        "id": 1952,
        "created_date": "2017-03-09T13:26:33-05:00",
        "updated_date": "2025-05-15T02:30:24-04:00",
        "company_code": 15890,
        "mfr_code": "",
        "name": "STERINOVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3005 AVENUE JOSE-MARIA ROSELL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HYACINTHE",
        "postal_code": "J2S 0J9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263895,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02485540",
      "brand_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "0.4 MG/ML",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698020"
    },
    "created_date": "2020-04-15T20:48:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02485540",
    "company_name": "STERINOVA INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2020-04-17T00:00:00-04:00",
    "estimated_end_date": "2020-08-31T00:00:00-04:00",
    "actual_start_date": "2020-04-17T00:00:00-04:00",
    "actual_end_date": "2020-08-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-09-03T16:03:55-04:00",
    "status": "resolved",
    "en_comments": "Resolved",
    "fr_comments": "Augmentation importante de la demande causée par la pandémie de la COVID-19 pour le format 40mg/100mL. Un format alternatif (20mg/50mL) demeure disponible.",
    "en_drug_brand_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "Hydromorphone Hydrochloride Injection USP",
    "fr_drug_brand_name": "CHLORHYDRATE D’HYDROMORPHONE INJECTABLE USP",
    "fr_drug_common_name": "CHLORHYDRATE D’HYDROMORPHONE INJECTABLE USP",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "40MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "Box of 30 x 100 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112303,
    "drug": {
      "current_status": "MARKETED",
      "id": 4606,
      "drug_code": 23261,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252746,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01964976",
      "brand_name": "PMS-DEXAMETHASONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "E4122",
      "number_of_ais": "1",
      "ai_group_no": "0106303001"
    },
    "created_date": "2020-04-16T13:40:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01964976",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "estimated_end_date": "2020-10-07T00:00:00-04:00",
    "actual_start_date": "2020-04-15T00:00:00-04:00",
    "actual_end_date": "2020-10-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-10-13T20:17:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS DEXAMETHASONE TAB 0.5MG USP",
    "en_drug_common_name": "DEXAMETHASONE",
    "fr_drug_brand_name": "PMS DEXAMETHASONE TAB 0.5MG USP",
    "fr_drug_common_name": "DEXAMETHASONE",
    "en_ingredients": "DEXAMETHASONE",
    "fr_ingredients": "Dexaméthasone",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112364,
    "drug": {
      "current_status": "MARKETED",
      "id": 5182,
      "drug_code": 3263,
      "updated_date": "2025-12-03T00:30:21-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250497,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00406716",
      "brand_name": "NOVAMOXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "53653",
      "number_of_ais": "1",
      "ai_group_no": "0131314006"
    },
    "created_date": "2020-04-16T19:15:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00406716",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01CA",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-15T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-08T19:42:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NOVAMOXIN",
    "en_drug_common_name": "AMOXICILLIN 500MG CAPS",
    "fr_drug_brand_name": "TEVA-AMOXICILLIN 500MG CAPS",
    "fr_drug_common_name": "AMOXICILLIN 500MG CAPS",
    "en_ingredients": "AMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "500MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112367,
    "drug": {
      "current_status": "MARKETED",
      "id": 18380,
      "drug_code": 79651,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256439,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310899",
      "brand_name": "TEVA-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055001"
    },
    "created_date": "2020-04-16T19:17:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310899",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-15T00:00:00-04:00",
    "actual_end_date": "2020-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-23T18:33:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN 10 MG FC TAB",
    "fr_drug_brand_name": "TEVA-ATORVASTATIN 10 MG FC TAB",
    "fr_drug_common_name": "ATORVASTATIN 10 MG FC TAB",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112370,
    "drug": {
      "current_status": "MARKETED",
      "id": 51681,
      "drug_code": 87876,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259215,
          "ingredient": {
            "id": 3254,
            "ingredient_code": 16516,
            "en_name": "EMTRICITABINE",
            "fr_name": "Emtricitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259214,
          "ingredient": {
            "id": 3020,
            "ingredient_code": 12251,
            "en_name": "TENOFOVIR DISOPROXIL FUMARATE",
            "fr_name": "Fumarate de ténofovir disoproxil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259213,
          "ingredient": {
            "id": 2676,
            "ingredient_code": 11857,
            "en_name": "EFAVIRENZ",
            "fr_name": "Éfavirenz"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02393549",
      "brand_name": "TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "3",
      "ai_group_no": "0352327001"
    },
    "created_date": "2020-04-16T19:19:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02393549",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J05AR",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-15T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-08T19:43:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR",
    "en_drug_common_name": "EFAVIR/EMTRICIT/TENOF 600/200/300MG",
    "fr_drug_brand_name": "TEVA-EFAVIR/EMTRICIT/TENOF 600/200/300MG",
    "fr_drug_common_name": "EFAVIR/EMTRICIT/TENOF 600/200/300MG",
    "en_ingredients": "EFAVIRENZ\r\nEMTRICITABINE\r\nTENOFOVIR DISOPROXIL FUMARATE",
    "fr_ingredients": "Éfavirenz\r\nEmtricitabine\r\nFumarate de ténofovir disoproxil",
    "drug_strength": "600MG\r\n200MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112373,
    "drug": {
      "current_status": "MARKETED",
      "id": 1596,
      "drug_code": 13438,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251766,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01910299",
      "brand_name": "TEVA-CLOBETASOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74825",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2020-04-16T19:20:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01910299",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2020-08-31T00:00:00-04:00",
    "actual_start_date": "2020-04-15T00:00:00-04:00",
    "actual_end_date": "2020-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-04T18:51:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CLOBETASOL",
    "en_drug_common_name": "CLOBETASOL 0.05% LOTION",
    "fr_drug_brand_name": "TEVA-CLOBETASOL 0.05% LOTION",
    "fr_drug_common_name": "CLOBETASOL 0.05% LOTION",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "LOTION",
    "drug_dosage_form_fr": "Lotion",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "20ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112376,
    "drug": {
      "current_status": "MARKETED",
      "id": 9684,
      "drug_code": 6346,
      "updated_date": "2025-05-15T02:30:36-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250877,
          "ingredient": {
            "id": 100,
            "ingredient_code": 9358,
            "en_name": "CAFFEINE",
            "fr_name": "Caféine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250876,
          "ingredient": {
            "id": 98,
            "ingredient_code": 9131,
            "en_name": "CODEINE PHOSPHATE",
            "fr_name": "Phosphate de codéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250875,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00653276",
      "brand_name": "TEVA-LENOLTEC NO. 3",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62837",
      "number_of_ais": "3",
      "ai_group_no": "0311391005"
    },
    "created_date": "2020-04-16T19:23:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00653276",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2020-07-31T00:00:00-04:00",
    "actual_start_date": "2020-04-15T00:00:00-04:00",
    "actual_end_date": "2020-07-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-07-30T16:55:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-LENOLTEC NO. 3",
    "en_drug_common_name": "LENOLTEC NO.3 TAB",
    "fr_drug_brand_name": "TEVA-LENOLTEC NO.3 TAB",
    "fr_drug_common_name": "LENOLTEC NO.3 TAB",
    "en_ingredients": "CAFFEINE\r\nCODEINE PHOSPHATE\r\nACETAMINOPHEN",
    "fr_ingredients": "Caféine\r\nPhosphate de codéine\r\nAcétaminophène",
    "drug_strength": "15MG\r\n30MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112379,
    "drug": {
      "current_status": "MARKETED",
      "id": 19116,
      "drug_code": 80371,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256697,
          "ingredient": {
            "id": 3198,
            "ingredient_code": 13585,
            "en_name": "ESCITALOPRAM",
            "fr_name": "Escitalopram (Oxalate d'escitalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02318202",
      "brand_name": "TEVA-ESCITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150435004"
    },
    "created_date": "2020-04-16T19:25:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02318202",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2020-04-15T00:00:00-04:00",
    "actual_end_date": "2020-06-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-18T13:49:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ESCITALOPRAM",
    "en_drug_common_name": "ESCITALOPRAM 20MG TAB",
    "fr_drug_brand_name": "TEVA-ESCITALOPRAM 20MG TAB",
    "fr_drug_common_name": "ESCITALOPRAM 20MG TAB",
    "en_ingredients": "ESCITALOPRAM",
    "fr_ingredients": "Escitalopram",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112382,
    "drug": {
      "current_status": "MARKETED",
      "id": 4692,
      "drug_code": 2447,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250414,
          "ingredient": {
            "id": 564,
            "ingredient_code": 10091,
            "en_name": "FUROSEMIDE",
            "fr_name": "Furosémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00337749",
      "brand_name": "TEVA-FUROSEMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "49660",
      "number_of_ais": "1",
      "ai_group_no": "0101944001"
    },
    "created_date": "2020-04-16T19:30:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00337749",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C03CA",
    "atc_description": "HIGH-CEILING DIURETICS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-15T00:00:00-04:00",
    "actual_end_date": "2020-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-23T18:34:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FUROSEMIDE",
    "en_drug_common_name": "FUROSEMIDE 40MG TAB",
    "fr_drug_brand_name": "TEVA-FUROSEMIDE 40MG TAB",
    "fr_drug_common_name": "FUROSEMIDE 40MG TAB",
    "en_ingredients": "FUROSEMIDE",
    "fr_ingredients": "Furosémide",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112385,
    "drug": {
      "current_status": "MARKETED",
      "id": 3200,
      "drug_code": 18189,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252258,
          "ingredient": {
            "id": 946,
            "ingredient_code": 1939,
            "en_name": "TRAZODONE HYDROCHLORIDE",
            "fr_name": "Chlohydrate de trazodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02144298",
      "brand_name": "TEVA-TRAZODONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80411",
      "number_of_ais": "1",
      "ai_group_no": "0115713003"
    },
    "created_date": "2020-04-16T19:31:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02144298",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-15T00:00:00-04:00",
    "actual_end_date": "2020-05-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-21T18:51:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TRAZODONE",
    "en_drug_common_name": "TRAZODONE 150MG COMP TAB",
    "fr_drug_brand_name": "TEVA-TRAZODONE 150MG COMP TAB",
    "fr_drug_common_name": "TRAZODONE 150MG COMP TAB",
    "en_ingredients": "TRAZODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlohydrate de trazodone",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112388,
    "drug": {
      "current_status": "MARKETED",
      "id": 1066,
      "drug_code": 12453,
      "updated_date": "2025-05-15T02:30:52-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251630,
          "ingredient": {
            "id": 236,
            "ingredient_code": 11108,
            "en_name": "PRAZOSIN",
            "fr_name": "Prazosine (Chlorhydrate de prazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01934228",
      "brand_name": "TEVA-PRAZOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73558",
      "number_of_ais": "1",
      "ai_group_no": "0111527003"
    },
    "created_date": "2020-04-16T19:32:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01934228",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C02CA",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "estimated_end_date": "2020-08-31T00:00:00-04:00",
    "actual_start_date": "2020-04-15T00:00:00-04:00",
    "actual_end_date": "2020-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-08-19T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PRAZOSIN",
    "en_drug_common_name": "PRAZOSIN 5MG TAB",
    "fr_drug_brand_name": "TEVA-PRAZOSIN 5MG TAB",
    "fr_drug_common_name": "PRAZOSIN 5MG TAB",
    "en_ingredients": "PRAZOSIN",
    "fr_ingredients": "PRAZOSIN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112391,
    "drug": {
      "current_status": "MARKETED",
      "id": 434,
      "drug_code": 10950,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251452,
          "ingredient": {
            "id": 284,
            "ingredient_code": 2144,
            "en_name": "PINDOLOL",
            "fr_name": "Pindolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00869015",
      "brand_name": "TEVA-PINDOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71112",
      "number_of_ais": "1",
      "ai_group_no": "0112362003"
    },
    "created_date": "2020-04-16T19:33:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00869015",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2020-04-15T00:00:00-04:00",
    "actual_end_date": "2021-06-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-06-03T18:43:51-04:00",
    "status": "resolved",
    "en_comments": "Allocating to 100% of our market.",
    "fr_comments": "Allocating to 100% of our market.",
    "en_drug_brand_name": "TEVA-PINDOLOL",
    "en_drug_common_name": "PINDOLOL 10MG TAB",
    "fr_drug_brand_name": "TEVA-PINDOLOL 10MG TAB",
    "fr_drug_common_name": "PINDOLOL 10MG TAB",
    "en_ingredients": "PINDOLOL",
    "fr_ingredients": "Pindolol",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112394,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25440,
      "drug_code": 87880,
      "updated_date": "2025-05-15T04:20:34-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352045,
          "ingredient": {
            "id": 2350,
            "ingredient_code": 2071,
            "en_name": "NABILONE",
            "fr_name": "Nabilone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02393581",
      "brand_name": "ACT NABILONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115009002"
    },
    "created_date": "2020-04-16T19:36:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02393581",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "A04AD",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "actual_start_date": "2020-04-15T00:00:00-04:00",
    "actual_end_date": "2020-08-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-09-23T17:30:34-04:00",
    "status": "resolved",
    "en_comments": "Item is discontinued",
    "en_drug_brand_name": "ACT NABILONE",
    "en_drug_common_name": "NABILONE 0.5MG CAP",
    "fr_drug_brand_name": "ACT-NABILONE 0.5MG CAP",
    "fr_drug_common_name": "NABILONE 0.5MG CAP",
    "en_ingredients": "NABILONE",
    "fr_ingredients": "Nabilone",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112397,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 16332,
      "drug_code": 77118,
      "updated_date": "2025-05-15T04:11:42-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8343195,
          "ingredient": {
            "id": 108,
            "ingredient_code": 4991,
            "en_name": "FOLIC ACID",
            "fr_name": "Acide folique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02285673",
      "brand_name": "SANDOZ FOLIC ACID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108418001"
    },
    "created_date": "2020-04-16T19:44:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02285673",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B03BB",
    "atc_description": "VITAMIN B12 AND FOLIC ACID",
    "estimated_end_date": "2020-05-08T00:00:00-04:00",
    "actual_start_date": "2020-04-10T00:00:00-04:00",
    "actual_end_date": "2020-04-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-05-04T13:44:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ FOLIC ACID",
    "en_drug_common_name": "SANDOZ FOLIC ACID",
    "fr_drug_brand_name": "SANDOZ FOLIC",
    "fr_drug_common_name": "SANDOZ FOLIC",
    "en_ingredients": "FOLIC ACID",
    "fr_ingredients": "Acide folique",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000 TAB BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112404,
    "drug": {
      "current_status": "MARKETED",
      "id": 12504,
      "drug_code": 71198,
      "updated_date": "2025-12-03T00:30:52-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254599,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02246969",
      "brand_name": "SANDOZ ESTRADIOL DERM 100",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106457037"
    },
    "created_date": "2020-04-16T19:53:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246969",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G03CA",
    "atc_description": "ESTROGENS",
    "estimated_end_date": "2020-04-24T00:00:00-04:00",
    "actual_start_date": "2020-04-10T00:00:00-04:00",
    "actual_end_date": "2020-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-04-27T13:28:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ESTRADIOL DERM 100",
    "en_drug_common_name": "SANDOZ ESTRADIOL",
    "fr_drug_brand_name": "SANDOZ ESTRADIOL",
    "fr_drug_common_name": "SANDOZ ESTRADIOL",
    "en_ingredients": "ESTRADIOL",
    "fr_ingredients": "Estradiol",
    "drug_strength": "100MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "8TTS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112407,
    "drug": {
      "current_status": "MARKETED",
      "id": 19932,
      "drug_code": 81245,
      "updated_date": "2025-05-15T02:32:25-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256968,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02327139",
      "brand_name": "SANDOZ FENTANYL PATCH",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302016"
    },
    "created_date": "2020-04-16T19:55:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327139",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2020-04-24T00:00:00-04:00",
    "actual_start_date": "2020-04-10T00:00:00-04:00",
    "actual_end_date": "2020-04-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-04-27T13:29:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ FENTANYL PATCH",
    "en_drug_common_name": "SANDOZ FENTANYL",
    "fr_drug_brand_name": "SANDOZ FENTANYL",
    "fr_drug_common_name": "SANDOZ FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "37MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5 TTSS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112410,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 16528,
      "drug_code": 77344,
      "updated_date": "2025-05-15T04:11:48-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8343394,
          "ingredient": {
            "id": 2190,
            "ingredient_code": 1381,
            "en_name": "FENOFIBRATE",
            "fr_name": "Fénofibrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02288052",
      "brand_name": "SANDOZ FENOFIBRATE S",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118895004"
    },
    "created_date": "2020-04-16T19:58:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02288052",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AB",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "hc_updated_date": "2023-11-17T18:15:26-05:00",
    "actual_start_date": "2020-04-10T00:00:00-04:00",
    "actual_end_date": "2020-04-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2023-11-17T18:15:28-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "SANDOZ FENOFIBRATE S",
    "en_drug_common_name": "SANDOZ FENOFIBRATE S",
    "fr_drug_brand_name": "SANDOZ FENOFIBRATE S",
    "fr_drug_common_name": "SANDOZ FENOFIBRATE S",
    "en_ingredients": "FENOFIBRATE",
    "fr_ingredients": "Fénofibrate",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90 FCT BO",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112413,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18682,
      "drug_code": 79952,
      "updated_date": "2025-05-15T04:13:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8345806,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02314002",
      "brand_name": "SANDOZ QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858002"
    },
    "created_date": "2020-04-16T20:00:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02314002",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2020-04-10T00:00:00-04:00",
    "actual_end_date": "2020-06-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-06-29T14:39:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ QUETIAPINE",
    "en_drug_common_name": "SANDOZ QUETIAPINE",
    "fr_drug_brand_name": "SANDOZ QUETIAPINE",
    "fr_drug_common_name": "SANDOZ QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 FCT BO",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112426,
    "drug": {
      "current_status": "MARKETED",
      "id": 17338,
      "drug_code": 78388,
      "updated_date": "2025-05-15T02:31:59-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8256109,
          "ingredient": {
            "id": 3406,
            "ingredient_code": 20155,
            "en_name": "FLUTICASONE FUROATE",
            "fr_name": "Furoate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "27.5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02298589",
      "brand_name": "AVAMYS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152271001"
    },
    "created_date": "2020-04-17T14:29:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02298589",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R01AD",
    "atc_description": "DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",
    "estimated_end_date": "2020-05-01T00:00:00-04:00",
    "actual_start_date": "2020-04-15T00:00:00-04:00",
    "actual_end_date": "2020-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-04-24T18:59:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AVAMYS",
    "en_drug_common_name": "fluticasone furoate nasal spray",
    "fr_drug_brand_name": "AVAMYS",
    "fr_drug_common_name": "furoate de fluticasone en vaporisateur nasal",
    "en_ingredients": "FLUTICASONE FUROATE",
    "fr_ingredients": "Furoate de fluticasone",
    "drug_strength": "27.5MCG",
    "drug_dosage_form": "SPRAY, METERED DOSE",
    "drug_dosage_form_fr": "Pulvérisation, à dose mesurée",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "120",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112431,
    "drug": {
      "current_status": "MARKETED",
      "id": 23488,
      "drug_code": 86078,
      "updated_date": "2025-05-15T02:33:05-04:00",
      "company": {
        "id": 1652,
        "created_date": "2017-03-09T13:25:05-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 17112,
        "mfr_code": "",
        "name": "SERB S.A.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "480 AVENUE LOUISE",
        "province": "BRUSSELS CAPITAL REGION",
        "country": "BELGIUM",
        "city": "BRUSSELS",
        "postal_code": "1050",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258477,
          "ingredient": {
            "id": 1952,
            "ingredient_code": 4971,
            "en_name": "HYDROXOCOBALAMIN",
            "fr_name": "Hydroxocobalamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02375370",
      "brand_name": "CYANOKIT",
      "brand_name_fr": "",
      "descriptor": "LYOPHILIZED POWDER FOR SOLUTION FOR INFUSION. SINGLE-USE VIAL.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108455004"
    },
    "created_date": "2020-04-17T18:18:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02375370",
    "company_name": "SERB S.A.",
    "atc_number": "V03AB",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2020-04-20T00:00:00-04:00",
    "estimated_end_date": "2020-04-30T00:00:00-04:00",
    "actual_end_date": "2020-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-05-01T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Please contact Methapharm Inc. at 1-800-287-7686 or by email at sales@methapharm.com for any specific questions.",
    "fr_comments": "Veuillez contacter Methapharm Inc. au 1-800-287-7686 ou par courriel à sales@methapharm.com pour toute question spécifique.",
    "en_drug_brand_name": "CYANOKIT",
    "en_drug_common_name": "Hydroxocobalamin Powder for Infusion",
    "fr_drug_brand_name": "CYANOKIT",
    "fr_drug_common_name": "Hydroxocobalamin Powder for Infusion",
    "en_ingredients": "HYDROXOCOBALAMIN",
    "fr_ingredients": "Hydroxocobalamine",
    "drug_strength": "5G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5 g / vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112475,
    "drug": {
      "id": 10848,
      "drug_code": 66736,
      "updated_date": "2025-12-03T00:30:46-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254095,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242904",
      "brand_name": "MIDAZOLAM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "MUTI-DOSE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935002"
    },
    "created_date": "2020-04-20T12:48:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242904",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "estimated_end_date": "2020-07-17T00:00:00-04:00",
    "actual_start_date": "2020-05-01T00:00:00-04:00",
    "actual_end_date": "2020-07-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-07-07T05:00:06-04:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of our Midazolam Injection, 1 mg/mL, MD Vial, 5 mL will be available at all distribution centres today, July 6th, 2020. Please note this product will remain on allocation. Contract customers will be allocated 100% of their historical average monthly volumes.",
    "fr_comments": "Au nom de Fresenius Kabi Canada Ltée, j’ai le plaisir d’annoncer que nous avons reconstitué nos stocks de Midazolam injectable à 1 mg/mL en fioles DM de 5 mL et que cette présentation du produit est disponible auprès de tous nos centres de distribution, et ce, aujourd’hui même le 6 juillet 2020. Veuillez noter que ce produit demeurera sous allocation. Les clients contractuels s’en verront attribuer 100 % de leurs volumes mensuels moyens historiques.",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "Midazolam Injection",
    "fr_drug_brand_name": "Midazolam injectable",
    "fr_drug_common_name": "Midazolam injectable",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nIntramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "1 mg/mL MD Vial 5 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112478,
    "drug": {
      "current_status": "MARKETED",
      "id": 10850,
      "drug_code": 66737,
      "updated_date": "2025-12-03T00:30:46-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254096,
          "ingredient": {
            "id": 2690,
            "ingredient_code": 11188,
            "en_name": "MIDAZOLAM",
            "fr_name": "Midazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242905",
      "brand_name": "MIDAZOLAM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "MULTI-DOSE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119935001"
    },
    "created_date": "2020-04-20T12:51:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242905",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "estimated_end_date": "2020-06-01T00:00:00-04:00",
    "actual_start_date": "2020-05-01T00:00:00-04:00",
    "actual_end_date": "2020-05-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-18T12:58:50-04:00",
    "status": "resolved",
    "en_comments": "On 110% Allocation",
    "fr_comments": "Sous allocation à 110 %",
    "en_drug_brand_name": "MIDAZOLAM INJECTION",
    "en_drug_common_name": "Midazolam injectable",
    "fr_drug_brand_name": "Midazolam injectable",
    "fr_drug_common_name": "Midazolam injectable",
    "en_ingredients": "MIDAZOLAM",
    "fr_ingredients": "Midazolam",
    "drug_strength": "5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse\r\nIntramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "5 mg/mL, fioles DUM de 1 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112481,
    "drug": {
      "current_status": "MARKETED",
      "id": 16382,
      "drug_code": 77176,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255836,
          "ingredient": {
            "id": 2932,
            "ingredient_code": 11343,
            "en_name": "MITOXANTRONE",
            "fr_name": "Mitoxantrone (Chlorhydrate de mitoxantrone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02286300",
      "brand_name": "MITOXANTRONE INJECTION",
      "brand_name_fr": "MITOXANTRONE INJECTABLE",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116465001"
    },
    "created_date": "2020-04-20T12:52:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02286300",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "L01DB",
    "atc_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
    "estimated_end_date": "2020-04-30T00:00:00-04:00",
    "actual_start_date": "2020-04-17T00:00:00-04:00",
    "actual_end_date": "2020-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-06T13:19:01-04:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of our MitoXANTRONE Injection,\r\n2 mg/mL, SD Vial, 10 mL will be available at all distribution centres today, Thursday, April 30th, 2020",
    "fr_comments": "Au nom de Fresenius Kabi Canada Ltée, j’ai le plaisir d’annoncer que nous avons reconstitué nos stocks de MitoXANTRONE injectable à 2 mg/mL en fioles DU de 10 mL et que cette présentation est disponible auprès de tous nos centres de distribution dès aujourd’hui, jeudi 30 avril 2020.",
    "en_drug_brand_name": "MITOXANTRONE INJECTION",
    "en_drug_common_name": "MitoXANTRONE Injection",
    "fr_drug_brand_name": "MitoXANTRONE injectable",
    "fr_drug_common_name": "MitoXANTRONE injectable",
    "en_ingredients": "MITOXANTRONE",
    "fr_ingredients": "MitoXANTRONE injectable",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "2 mg/mL SD Vial 10 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112518,
    "drug": {
      "current_status": "MARKETED",
      "id": 21470,
      "drug_code": 83849,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257670,
          "ingredient": {
            "id": 3128,
            "ingredient_code": 12378,
            "en_name": "CICLOPIROX",
            "fr_name": "Ciclopirox"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02353288",
      "brand_name": "TARO-CICLOPIROX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150022001"
    },
    "created_date": "2020-04-20T17:37:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353288",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D01AE",
    "atc_description": "ANTIFUNGALS FOR TOPICAL USE",
    "estimated_end_date": "2020-06-05T00:00:00-04:00",
    "actual_start_date": "2020-04-20T00:00:00-04:00",
    "actual_end_date": "2020-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-02T05:00:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CICLOPIROX",
    "en_drug_common_name": "CICLOPIROX",
    "fr_drug_brand_name": "TARO-CICLOPIROX",
    "fr_drug_common_name": "CICLOPIROX",
    "en_ingredients": "CICLOPIROX",
    "fr_ingredients": "Ciclopirox",
    "drug_strength": "8%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "6 g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112531,
    "drug": {
      "current_status": "MARKETED",
      "id": 18660,
      "drug_code": 79925,
      "updated_date": "2025-05-15T02:32:13-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256533,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313758",
      "brand_name": "TARO-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055004"
    },
    "created_date": "2020-04-20T18:13:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313758",
    "company_name": "SUN PHARMA CANADA INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2020-09-11T00:00:00-04:00",
    "actual_start_date": "2020-04-20T00:00:00-04:00",
    "actual_end_date": "2020-09-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-08T13:04:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "TARO-ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112534,
    "drug": {
      "current_status": "MARKETED",
      "id": 55349,
      "drug_code": 93530,
      "updated_date": "2025-05-15T02:35:09-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261620,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261619,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02449463",
      "brand_name": "TARO-RAMIPRIL HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251649004"
    },
    "created_date": "2020-04-20T18:14:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02449463",
    "company_name": "SUN PHARMA CANADA INC",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2020-05-22T00:00:00-04:00",
    "actual_start_date": "2020-04-20T00:00:00-04:00",
    "actual_end_date": "2020-05-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-27T11:30:40-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-RAMIPRIL HCTZ",
    "en_drug_common_name": "RAMIPRIL HCTZ",
    "fr_drug_brand_name": "TARO-RAMIPRIL HCTZ",
    "fr_drug_common_name": "RAMIPRIL HCTZ",
    "en_ingredients": "RAMIPRIL\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Ramipril\r\nHydrochlorothiazide",
    "drug_strength": "5MG\r\n25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112537,
    "drug": {
      "current_status": "MARKETED",
      "id": 1674,
      "drug_code": 13591,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8251786,
          "ingredient": {
            "id": 924,
            "ingredient_code": 11177,
            "en_name": "LODOXAMIDE",
            "fr_name": "Lodoxamide (Trométhamine de lodoxamide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "00893560",
      "brand_name": "ALOMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75012",
      "number_of_ais": "1",
      "ai_group_no": "0122561001"
    },
    "created_date": "2020-04-20T18:16:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00893560",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01GX",
    "atc_description": "DECONGESTANTS AND ANTIALLERGICS",
    "estimated_end_date": "2020-09-07T00:00:00-04:00",
    "actual_start_date": "2020-03-04T00:00:00-05:00",
    "actual_end_date": "2020-09-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-09-08T20:23:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ALOMIDE",
    "en_drug_common_name": "ALOMIDE SOLUTION 10ML",
    "fr_drug_brand_name": "ALOMIDE",
    "fr_drug_common_name": "ALOMIDE SOLN 10ML",
    "en_ingredients": "LODOXAMIDE",
    "fr_ingredients": "LODOXAMIDE",
    "drug_strength": "0.1%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "10ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112544,
    "drug": {
      "current_status": "DORMANT",
      "id": 24670,
      "drug_code": 87251,
      "updated_date": "2025-05-15T06:55:46-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8368797,
          "ingredient": {
            "id": 1368,
            "ingredient_code": 1988,
            "en_name": "TRANEXAMIC ACID",
            "fr_name": "Acide tranexamique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02386933",
      "brand_name": "TRANEXAMIC ACID INJECTION BP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114760002"
    },
    "created_date": "2020-04-20T19:26:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02386933",
    "company_name": "STERIMAX INC",
    "atc_number": "B02AA",
    "atc_description": "ANTIFIBRINOLYTICS",
    "actual_start_date": "2020-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-09-09T15:15:25-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "TRANEXAMIC ACID INJECTION BP",
    "en_drug_common_name": "TRANEXAMIC ACID INJECTION BP",
    "fr_drug_brand_name": "ACIDE TRANEXAMIQUE POUR INJECTION BP",
    "fr_drug_common_name": "ACIDE TRANEXAMIQUE POUR INJECTION BP",
    "en_ingredients": "TRANEXAMIC ACID",
    "fr_ingredients": "Acide tranexamique",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 VIALS - 10 ML",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112579,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1264,
      "drug_code": 12818,
      "updated_date": "2025-05-15T03:39:03-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8290530,
          "ingredient": {
            "id": 704,
            "ingredient_code": 9054,
            "en_name": "WARFARIN SODIUM",
            "fr_name": "Warfarine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01918311",
      "brand_name": "COUMADIN TAB 1MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74038",
      "number_of_ais": "1",
      "ai_group_no": "0104597002"
    },
    "created_date": "2020-04-20T20:58:18-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "01918311",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "B01AA",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "discontinuation_date": "2020-08-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2020-09-01T05:00:18-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "COUMADIN TAB 1MG",
    "en_drug_common_name": "Warfarin",
    "fr_drug_brand_name": "COUMADIN TAB 1MG",
    "fr_drug_common_name": "Warfarine",
    "en_ingredients": "WARFARIN SODIUM",
    "fr_ingredients": "Warfarine sodique",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1 BTL x 100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112584,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1586,
      "drug_code": 13419,
      "updated_date": "2025-05-15T03:39:39-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8291452,
          "ingredient": {
            "id": 704,
            "ingredient_code": 9054,
            "en_name": "WARFARIN SODIUM",
            "fr_name": "Warfarine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01918346",
      "brand_name": "COUMADIN TAB 2.5MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74802",
      "number_of_ais": "1",
      "ai_group_no": "0104597005"
    },
    "created_date": "2020-04-20T21:03:17-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "01918346",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "B01AA",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "discontinuation_date": "2020-08-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-07-15T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2020-09-01T05:00:18-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "COUMADIN TAB 2.5MG",
    "en_drug_common_name": "Warfarin",
    "fr_drug_brand_name": "COUMADIN TAB 2.5MG",
    "fr_drug_common_name": "Warfarine",
    "en_ingredients": "WARFARIN SODIUM",
    "fr_ingredients": "Warfarine sodique",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1 BTL x 250",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112593,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1266,
      "drug_code": 12819,
      "updated_date": "2025-05-15T03:39:03-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8290531,
          "ingredient": {
            "id": 704,
            "ingredient_code": 9054,
            "en_name": "WARFARIN SODIUM",
            "fr_name": "Warfarine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01918354",
      "brand_name": "COUMADIN TAB 5MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74039",
      "number_of_ais": "1",
      "ai_group_no": "0104597001"
    },
    "created_date": "2020-04-20T21:10:04-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "01918354",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "B01AA",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "discontinuation_date": "2020-08-10T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2020-08-11T05:00:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "COUMADIN TAB 5MG",
    "en_drug_common_name": "Warfarin",
    "fr_drug_brand_name": "COUMADIN TAB 5MG",
    "fr_drug_common_name": "Warfarine",
    "en_ingredients": "WARFARIN SODIUM",
    "fr_ingredients": "Warfarine sodique",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1 BTL x 100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112596,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1584,
      "drug_code": 13418,
      "updated_date": "2025-05-15T03:39:39-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8291451,
          "ingredient": {
            "id": 704,
            "ingredient_code": 9054,
            "en_name": "WARFARIN SODIUM",
            "fr_name": "Warfarine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01918362",
      "brand_name": "COUMADIN TAB 10MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74801",
      "number_of_ais": "1",
      "ai_group_no": "0104597004"
    },
    "created_date": "2020-04-20T21:12:11-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "01918362",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "B01AA",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "discontinuation_date": "2020-06-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2020-06-02T05:00:21-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "COUMADIN TAB 10MG",
    "en_drug_common_name": "Warfarin",
    "fr_drug_brand_name": "COUMADIN TAB 10MG",
    "fr_drug_common_name": "Warfarine",
    "en_ingredients": "WARFARIN SODIUM",
    "fr_ingredients": "Warfarine sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1 BTL x 100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112600,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9752,
      "drug_code": 63732,
      "updated_date": "2025-05-15T03:59:23-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8329157,
          "ingredient": {
            "id": 704,
            "ingredient_code": 9054,
            "en_name": "WARFARIN SODIUM",
            "fr_name": "Warfarine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240206",
      "brand_name": "COUMADIN TAB 6 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104597008"
    },
    "created_date": "2020-04-20T21:14:30-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02240206",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "B01AA",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "discontinuation_date": "2020-07-10T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2020-07-11T05:00:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "COUMADIN TAB 6 MG",
    "en_drug_common_name": "warfarin",
    "fr_drug_brand_name": "COUMADIN TAB 6 MG",
    "fr_drug_common_name": "Warfarine",
    "en_ingredients": "WARFARIN SODIUM",
    "fr_ingredients": "Warfarine sodique",
    "drug_strength": "6MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1BTL x 100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112606,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1560,
      "drug_code": 13375,
      "updated_date": "2025-05-15T03:39:36-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8291375,
          "ingredient": {
            "id": 704,
            "ingredient_code": 9054,
            "en_name": "WARFARIN SODIUM",
            "fr_name": "Warfarine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02007959",
      "brand_name": "COUMADIN TAB 4MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74739",
      "number_of_ais": "1",
      "ai_group_no": "0104597003"
    },
    "created_date": "2020-04-20T21:17:29-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02007959",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "B01AA",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "discontinuation_date": "2020-06-15T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2020-06-16T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "COUMADIN TAB 4MG",
    "en_drug_common_name": "Warfarin",
    "fr_drug_brand_name": "COUMADIN TAB 4MG",
    "fr_drug_common_name": "Warfarine",
    "en_ingredients": "WARFARIN SODIUM",
    "fr_ingredients": "Warfarine sodique",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1 BTL x 100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112609,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1644,
      "drug_code": 13536,
      "updated_date": "2025-05-15T03:39:46-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8291719,
          "ingredient": {
            "id": 704,
            "ingredient_code": 9054,
            "en_name": "WARFARIN SODIUM",
            "fr_name": "Warfarine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01918338",
      "brand_name": "COUMADIN TAB 2MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74945",
      "number_of_ais": "1",
      "ai_group_no": "0104597006"
    },
    "created_date": "2020-04-20T21:30:11-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "01918338",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "B01AA",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "discontinuation_date": "2020-08-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-06-15T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2020-09-01T05:00:18-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "COUMADIN TAB 2MG",
    "en_drug_common_name": "Warfarin",
    "fr_drug_brand_name": "COUMADIN TAB 2MG",
    "fr_drug_common_name": "Warfarine",
    "en_ingredients": "WARFARIN SODIUM",
    "fr_ingredients": "Warfarine sodique",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1 BTL x 100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112614,
    "drug": {
      "current_status": "MARKETED",
      "id": 25614,
      "drug_code": 88027,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259251,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "900",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02395150",
      "brand_name": "0.9% SODIUM CHLORIDE INJECTION",
      "brand_name_fr": "CHLORURE DE SODIUM À 0,9 % POUR PERFUSION",
      "descriptor": "SINGLE USE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2020-04-20T23:15:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395150",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2020-04-20T00:00:00-04:00",
    "estimated_end_date": "2020-06-05T00:00:00-04:00",
    "actual_start_date": "2020-04-20T00:00:00-04:00",
    "actual_end_date": "2020-05-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-05-27T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SODIUM CHLORIDE 0.9% INJECTION",
    "en_drug_common_name": "Sodium Chloride 0,9% 250ml  (FFX+)",
    "fr_drug_brand_name": "Sodium Chloride 0,9% INJ",
    "fr_drug_common_name": "Sodium Chloride 0,9% 250ml (FFX+)",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "900MG",
    "drug_dosage_form": "SOLUTION\r\nSOLUTION",
    "drug_dosage_form_fr": "Solution\r\nSolution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "250 ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112668,
    "drug": {
      "current_status": "MARKETED",
      "id": 20304,
      "drug_code": 81805,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257194,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02332396",
      "brand_name": "SANDOZ AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072003"
    },
    "created_date": "2020-04-21T16:00:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02332396",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2020-05-15T00:00:00-04:00",
    "actual_start_date": "2020-04-17T00:00:00-04:00",
    "actual_end_date": "2020-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-05-19T14:21:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ AZITHROMYCIN",
    "en_drug_common_name": "SANDOZ AZITHROMYCIN",
    "fr_drug_brand_name": "SANDOZ AZITHROMYCIN",
    "fr_drug_common_name": "SANDOZ AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "200MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "37,5 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112671,
    "drug": {
      "current_status": "MARKETED",
      "id": 16808,
      "drug_code": 77765,
      "updated_date": "2025-05-15T02:31:54-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255939,
          "ingredient": {
            "id": 3122,
            "ingredient_code": 11309,
            "en_name": "CEFTRIAXONE",
            "fr_name": "Ceftriaxone (Ceftriaxone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02292297",
      "brand_name": "CEFTRIAXONE SODIUM FOR INJECTION BP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0117292008"
    },
    "created_date": "2020-04-21T16:02:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292297",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01DD",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2020-05-22T00:00:00-04:00",
    "actual_start_date": "2020-04-17T00:00:00-04:00",
    "actual_end_date": "2020-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-05-28T17:59:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CEFTRIAXONE SODIUM FOR INJECTION BP",
    "en_drug_common_name": "CEFTRIAXONE",
    "fr_drug_brand_name": "CEFTRIAXONE SODIUM FOR INJECTION BP",
    "fr_drug_common_name": "CEFTRIAXONE",
    "en_ingredients": "CEFTRIAXONE",
    "fr_ingredients": "CEFTRIAXONE",
    "drug_strength": "10G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1PSOIJ",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112678,
    "drug": {
      "current_status": "DORMANT",
      "id": 61740,
      "drug_code": 95649,
      "updated_date": "2025-12-03T02:32:41-05:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369476,
          "ingredient": {
            "id": 602,
            "ingredient_code": 1200,
            "en_name": "ZOPICLONE",
            "fr_name": "Zopiclone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02468115",
      "brand_name": "MAR-ZOPICLONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122562003"
    },
    "created_date": "2020-04-21T16:05:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02468115",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N05CF",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "anticipated_start_date": "2020-04-20T00:00:00-04:00",
    "actual_start_date": "2020-04-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-04-21T16:05:38-04:00",
    "status": "active_confirmed",
    "en_comments": "Business reasons",
    "fr_comments": "Business reasons",
    "en_drug_brand_name": "MAR-ZOPICLONE",
    "en_drug_common_name": "Zopiclone",
    "fr_drug_brand_name": "Mar-Zopiclone",
    "fr_drug_common_name": "Zopiclone",
    "en_ingredients": "ZOPICLONE",
    "fr_ingredients": "Zopiclone",
    "drug_strength": "3.75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 Tablet",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112691,
    "drug": {
      "current_status": "MARKETED",
      "id": 9428,
      "drug_code": 62731,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253676,
          "ingredient": {
            "id": 2414,
            "ingredient_code": 11443,
            "en_name": "TRANDOLAPRIL",
            "fr_name": "Trandolapril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239267",
      "brand_name": "MAVIK",
      "brand_name_fr": "",
      "descriptor": "4MG",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131524004"
    },
    "created_date": "2020-04-21T17:47:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239267",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2020-05-05T00:00:00-04:00",
    "actual_start_date": "2020-04-17T00:00:00-04:00",
    "actual_end_date": "2020-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2020-04-29T14:02:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAVIK",
    "en_drug_common_name": "TRANDOLAPRIL",
    "fr_drug_brand_name": "MAVIK",
    "fr_drug_common_name": "TRANDOLAPRIL",
    "en_ingredients": "TRANDOLAPRIL",
    "fr_ingredients": "Trandolapril",
    "drug_strength": "4MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112694,
    "drug": {
      "current_status": "MARKETED",
      "id": 1522,
      "drug_code": 13302,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251750,
          "ingredient": {
            "id": 572,
            "ingredient_code": 649,
            "en_name": "LIPASE",
            "fr_name": "Lipase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251749,
          "ingredient": {
            "id": 570,
            "ingredient_code": 648,
            "en_name": "PROTEASE",
            "fr_name": "Protéase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1600",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251748,
          "ingredient": {
            "id": 568,
            "ingredient_code": 253,
            "en_name": "AMYLASE",
            "fr_name": "Amylase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25500",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01985205",
      "brand_name": "CREON MINIMICROSPHERES 25",
      "brand_name_fr": "CREON MINIMICROSPHERES 25",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74650",
      "number_of_ais": "3",
      "ai_group_no": "0302964041"
    },
    "created_date": "2020-04-21T18:03:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01985205",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "A09AA",
    "atc_description": "DIGESTIVES, INCL ENZYMES",
    "anticipated_start_date": "2020-05-29T00:00:00-04:00",
    "estimated_end_date": "2020-06-02T00:00:00-04:00",
    "actual_end_date": "2020-05-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2020-05-26T11:30:38-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "CREON MINIMICROSPHERES 25",
    "en_drug_common_name": "CREON MINIMICROSPHERES 25",
    "fr_drug_brand_name": "CREON MINIMICROSPHERES 25",
    "fr_drug_common_name": "CREON MINIMICROSPHERES 25",
    "en_ingredients": "LIPASE\r\nAMYLASE\r\nPROTEASE",
    "fr_ingredients": "Lipase\r\nAmylase\r\nProtéase",
    "drug_strength": "25000UNIT\r\n25500UNIT\r\n1600UNIT",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "25",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112725,
    "drug": {
      "current_status": "MARKETED",
      "id": 13610,
      "drug_code": 73429,
      "updated_date": "2025-05-15T02:31:34-04:00",
      "company": {
        "id": 448,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 13687,
        "mfr_code": "",
        "name": "TAKEDA PHARMACEUTICALS AMERICA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "500 KENDALL STREET",
        "province": "MASSACHUSETTS",
        "country": "UNITED STATES",
        "city": "CAMBRIDGE",
        "postal_code": "02142",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254918,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02249464",
      "brand_name": "PREVACID FASTAB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666002"
    },
    "created_date": "2020-04-22T11:33:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02249464",
    "company_name": "TAKEDA PHARMACEUTICALS AMERICA INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "actual_start_date": "2020-04-16T00:00:00-04:00",
    "actual_end_date": "2020-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-04-29T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PREVACID FASTAB",
    "en_drug_common_name": "LANSOPRAZOLE",
    "fr_drug_brand_name": "PREVACID FASTAB",
    "fr_drug_common_name": "LANSOPRAZOLE",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "Lansoprazole",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30x10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112738,
    "drug": {
      "current_status": "MARKETED",
      "id": 722,
      "drug_code": 11626,
      "updated_date": "2025-12-03T00:30:30-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251557,
          "ingredient": {
            "id": 330,
            "ingredient_code": 6436,
            "en_name": "HYDRALAZINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydralazine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00441627",
      "brand_name": "APO-HYDRALAZINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72441",
      "number_of_ais": "1",
      "ai_group_no": "0107444002"
    },
    "created_date": "2020-04-22T14:37:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00441627",
    "company_name": "APOTEX INC",
    "atc_number": "C02DB",
    "atc_description": "ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",
    "estimated_end_date": "2020-05-15T00:00:00-04:00",
    "actual_start_date": "2020-04-20T00:00:00-04:00",
    "actual_end_date": "2020-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-20T13:08:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-HYDRALAZINE",
    "en_drug_common_name": "HYDRALAZINE",
    "fr_drug_brand_name": "APO-HYDRALAZINE",
    "fr_drug_common_name": "HYDRALAZINE",
    "en_ingredients": "HYDRALAZINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydralazine",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112741,
    "drug": {
      "current_status": "MARKETED",
      "id": 63372,
      "drug_code": 95700,
      "updated_date": "2025-05-15T02:36:07-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262765,
          "ingredient": {
            "id": 4138,
            "ingredient_code": 16100,
            "en_name": "PERINDOPRIL ARGININE",
            "fr_name": "Périndopril arginine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8262764,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02468573",
      "brand_name": "APO-PERINDOPRIL/AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0257790002"
    },
    "created_date": "2020-04-22T14:42:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02468573",
    "company_name": "APOTEX INC",
    "atc_number": "C09BB",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2020-04-27T00:00:00-04:00",
    "actual_start_date": "2020-04-20T00:00:00-04:00",
    "actual_end_date": "2020-04-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-04-28T17:53:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PERINDOPRIL/AMLODIPINE",
    "en_drug_common_name": "PERINDOPRIL",
    "fr_drug_brand_name": "APO-PERINDOPRIL/AMLODIPINE",
    "fr_drug_common_name": "PERINDOPRIL",
    "en_ingredients": "PERINDOPRIL ARGININE\r\nAMLODIPINE",
    "fr_ingredients": "PERINDOPRIL ARGININE AMLODIPINE",
    "drug_strength": "7MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112745,
    "drug": {
      "current_status": "MARKETED",
      "id": 30248,
      "drug_code": 92309,
      "updated_date": "2025-05-15T02:34:43-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8261052,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02438690",
      "brand_name": "ASMANEX TWISTHALER",
      "brand_name_fr": "",
      "descriptor": "FOR ORAL INHALATION ONLY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732007"
    },
    "created_date": "2020-04-22T15:05:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02438690",
    "company_name": "MERCK CANADA INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2020-12-11T00:00:00-05:00",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-12-11T06:00:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ASMANEX TWISTHALER",
    "en_drug_common_name": "mometasone furoate dry powder inhaler",
    "fr_drug_brand_name": "ASMANEX TWISTHALER",
    "fr_drug_common_name": "furoate de mométasone inhalateur de poudre sèche",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "100MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "30dose",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112752,
    "drug": {
      "current_status": "DORMANT",
      "id": 5954,
      "drug_code": 41869,
      "updated_date": "2025-12-03T02:32:16-05:00",
      "company": {
        "id": 3128,
        "created_date": "2017-08-17T01:15:06-04:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 16816,
        "mfr_code": "",
        "name": "KNIGHT THERAPEUTICS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 ALEXIS-NIHON BLVD., SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367189,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00875988",
      "brand_name": "TEMPRA INFANT DROPS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "M2011",
      "number_of_ais": "1",
      "ai_group_no": "0102009003"
    },
    "created_date": "2020-04-22T18:36:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00875988",
    "company_name": "PALADIN LABS INC",
    "atc_number": "N02BE",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2020-04-17T00:00:00-04:00",
    "actual_end_date": "2020-06-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-06-11T17:20:50-04:00",
    "status": "resolved",
    "en_comments": "Inventory on allocation based on historical demand",
    "fr_comments": "Inventaire sur allocation basée sur l'historique de la demande",
    "en_drug_brand_name": "TEMPRA INFANT DROPS",
    "en_drug_common_name": "TEMPRA BANANA & TEMPRA CHERRY",
    "fr_drug_brand_name": "TEMPRA ENFANT GOUTTES",
    "fr_drug_common_name": "TEMPRA BANANE ET CERISE",
    "en_ingredients": "ACETAMINOPHEN",
    "fr_ingredients": "Acétaminophène",
    "drug_strength": "80MG",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "15mL & 24mL bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112759,
    "drug": {
      "current_status": "DORMANT",
      "id": 5952,
      "drug_code": 41867,
      "updated_date": "2025-12-03T02:32:16-05:00",
      "company": {
        "id": 3128,
        "created_date": "2017-08-17T01:15:06-04:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 16816,
        "mfr_code": "",
        "name": "KNIGHT THERAPEUTICS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 ALEXIS-NIHON BLVD., SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367188,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00884553",
      "brand_name": "TEMPRA CHILDREN'S SYRUP",
      "brand_name_fr": "TEMPRA SIROP POUR ENFANTS",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "M2008",
      "number_of_ais": "1",
      "ai_group_no": "0102009004"
    },
    "created_date": "2020-04-22T18:41:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00884553",
    "company_name": "PALADIN LABS INC",
    "atc_number": "N02BE",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2020-04-17T00:00:00-04:00",
    "actual_end_date": "2020-06-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-06-11T17:22:28-04:00",
    "status": "resolved",
    "en_comments": "Inventory on allocation based on historical demand",
    "fr_comments": "Inventaire sur allocation basée sur l'historique de la demande",
    "en_drug_brand_name": "TEMPRA CHILDREN'S SYRUP",
    "en_drug_common_name": "TEMPRA CHERRY",
    "fr_drug_brand_name": "TEMPRA SIROP ENFANTS",
    "fr_drug_common_name": "TEMPRA CERSE",
    "en_ingredients": "ACETAMINOPHEN",
    "fr_ingredients": "Acétaminophène",
    "drug_strength": "80MG",
    "drug_dosage_form": "SYRUP",
    "drug_dosage_form_fr": "Sirop",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100mL bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112764,
    "drug": {
      "current_status": "DORMANT",
      "id": 6004,
      "drug_code": 42066,
      "updated_date": "2025-12-03T02:32:16-05:00",
      "company": {
        "id": 3128,
        "created_date": "2017-08-17T01:15:06-04:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 16816,
        "mfr_code": "",
        "name": "KNIGHT THERAPEUTICS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 ALEXIS-NIHON BLVD., SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367190,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00875996",
      "brand_name": "TEMPRA DOUBLE STRENGTH CHILDREN'S SYRUP",
      "brand_name_fr": "TEMPRA SIROP POUR ENFANTS CONCENTRATION DOUBLE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "M2264",
      "number_of_ais": "1",
      "ai_group_no": "0102009005"
    },
    "created_date": "2020-04-22T18:46:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00875996",
    "company_name": "PALADIN LABS INC",
    "atc_number": "N02BE",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2020-04-17T00:00:00-04:00",
    "actual_end_date": "2020-06-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-06-11T17:22:50-04:00",
    "status": "resolved",
    "en_comments": "Inventory on allocation based on historical demand",
    "fr_comments": "Inventaire sur allocation basée sur l'historique de la demande",
    "en_drug_brand_name": "TEMPRA DOUBLE STRENGTH CHILDREN'S SYRUP",
    "en_drug_common_name": "TEMPRA BANANA & TEMPRA CHERRY",
    "fr_drug_brand_name": "TEMPRA EXTRA FORT SIROP ENFANTS",
    "fr_drug_common_name": "TEMPRA BANANE ET TEMPRA CERISE",
    "en_ingredients": "ACETAMINOPHEN",
    "fr_ingredients": "Acétaminophène",
    "drug_strength": "160MG",
    "drug_dosage_form": "SYRUP",
    "drug_dosage_form_fr": "Sirop",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100mL bottle - Flacon 100mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112771,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24290,
      "drug_code": 86882,
      "updated_date": "2025-05-15T04:20:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351454,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02383039",
      "brand_name": "MYLAN-ESOMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145162001"
    },
    "created_date": "2020-04-22T19:04:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02383039",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "hc_updated_date": "2021-05-17T16:01:07-04:00",
    "actual_start_date": "2020-03-30T00:00:00-04:00",
    "actual_end_date": "2020-06-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-05-17T16:01:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-ESOMEPRAZOLE",
    "en_drug_common_name": "ESOMEPRAZOLE",
    "fr_drug_brand_name": "MYLAN-ESOMEPRAZOLE",
    "fr_drug_common_name": "ESOMEPRAZOLE",
    "en_ingredients": "ESOMEPRAZOLE",
    "fr_ingredients": "ESOMEPRAZOLE",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112783,
    "drug": {
      "current_status": "MARKETED",
      "id": 11502,
      "drug_code": 68258,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8254279,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02244291",
      "brand_name": "FLOVENT HFA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124685001"
    },
    "created_date": "2020-04-22T20:35:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244291",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-06-03T14:26:34-04:00",
    "status": "resolved",
    "en_comments": "Re-supply is ongoing with  inventory allocated to 100% of regular demand.",
    "fr_comments": "Un réapprovisionnement est en cours avec une allocation des stocks à 100 % de la demande régulière.",
    "en_drug_brand_name": "FLOVENT HFA",
    "en_drug_common_name": "fluticasone propionate inhalation aerosol",
    "fr_drug_brand_name": "FLOVENT HFA",
    "fr_drug_common_name": "propionate de fluticasone en aérosol pour inhalation",
    "en_ingredients": "FLUTICASONE PROPIONATE",
    "fr_ingredients": "Propionate de fluticasone",
    "drug_strength": "50MCG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "INHALATION\r\nORAL\r\nINHALATION\r\nORAL",
    "drug_route_fr": "Inhalation\r\nOrale\r\nInhalation\r\nOrale",
    "drug_package_quantity": "1x120",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112786,
    "drug": {
      "current_status": "MARKETED",
      "id": 6278,
      "drug_code": 43104,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253030,
          "ingredient": {
            "id": 124,
            "ingredient_code": 2585,
            "en_name": "SALBUTAMOL",
            "fr_name": "Salbutamol (Sulfate de salbutamol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02213451",
      "brand_name": "VENTOLIN I.V. INFUSION SOLUTION 5.0MG SALBUTAMOL IN 5ML (1000MCG/ML)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9396",
      "number_of_ais": "1",
      "ai_group_no": "0108887007"
    },
    "created_date": "2020-04-22T20:40:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02213451",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03CC",
    "atc_description": "ADRENERGICS FOR SYSTEMIC USE",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-06-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-06-24T17:59:42-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VENTOLIN I.V. INFUSION SOLUTION 5.0MG SALBUTAMOL IN 5ML (1000MCG/ML)",
    "en_drug_common_name": "salbutamol sulfate for injection",
    "fr_drug_brand_name": "VENTOLIN I.V. INFUSION SOLUTION 5.0MG SULBUTAMOL IN 5ML (1000MCG/ML)",
    "fr_drug_common_name": "sulfate de salbutamol pour injection",
    "en_ingredients": "SALBUTAMOL",
    "fr_ingredients": "Salbutamol",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5 x 5mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112805,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9750,
      "drug_code": 63731,
      "updated_date": "2025-05-15T03:59:23-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8329156,
          "ingredient": {
            "id": 704,
            "ingredient_code": 9054,
            "en_name": "WARFARIN SODIUM",
            "fr_name": "Warfarine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240205",
      "brand_name": "COUMADIN TAB 3MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104597007"
    },
    "created_date": "2020-04-22T20:54:58-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02240205",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "B01AA",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "discontinuation_date": "2020-08-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-08-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 3,
      "en_reason": "Manufacturing issues",
      "fr_reason": "Problèmes de fabrication",
      "active": true
    },
    "updated_date": "2020-09-01T05:00:18-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "COUMADIN TAB 3MG",
    "en_drug_common_name": "Warfarin",
    "fr_drug_brand_name": "COUMADIN TAB 3MG",
    "fr_drug_common_name": "Warfarine",
    "en_ingredients": "WARFARIN SODIUM",
    "fr_ingredients": "Warfarine sodique",
    "drug_strength": "3MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1 BTL x 100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112809,
    "drug": {
      "current_status": "MARKETED",
      "id": 16602,
      "drug_code": 77486,
      "updated_date": "2025-05-15T02:31:51-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8255891,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "320",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02289504",
      "brand_name": "DIOVAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885004"
    },
    "created_date": "2020-04-22T20:59:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02289504",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2020-04-30T00:00:00-04:00",
    "actual_start_date": "2020-03-13T00:00:00-04:00",
    "actual_end_date": "2020-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-05-05T18:14:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DIOVAN",
    "en_drug_common_name": "DIOVAN FCT 320MG 2X14",
    "fr_drug_brand_name": "DIOVAN",
    "fr_drug_common_name": "DIOVAN FCT 320MG 2X14",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "320MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "2 X 14",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112812,
    "drug": {
      "current_status": "MARKETED",
      "id": 15126,
      "drug_code": 75588,
      "updated_date": "2025-05-15T02:31:41-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8255400,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02270528",
      "brand_name": "DIOVAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885003"
    },
    "created_date": "2020-04-22T21:02:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02270528",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2020-05-07T00:00:00-04:00",
    "estimated_end_date": "2020-05-25T00:00:00-04:00",
    "actual_end_date": "2020-05-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-05-21T20:15:46-04:00",
    "status": "resolved",
    "en_comments": "Limited inventory",
    "fr_comments": "Inventaire limite",
    "en_drug_brand_name": "DIOVAN",
    "en_drug_common_name": "DIOVAN FCT 40MG 2X14",
    "fr_drug_brand_name": "DIOVAN",
    "fr_drug_common_name": "DIOVAN FCT 40MG 2X14",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "2X14",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112822,
    "drug": {
      "current_status": "MARKETED",
      "id": 10994,
      "drug_code": 66984,
      "updated_date": "2025-12-03T00:30:46-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8254133,
          "ingredient": {
            "id": 124,
            "ingredient_code": 2585,
            "en_name": "SALBUTAMOL",
            "fr_name": "Salbutamol (Sulfate de salbutamol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02243115",
      "brand_name": "VENTOLIN DISKUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108887005"
    },
    "created_date": "2020-04-22T21:40:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243115",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03AC",
    "atc_description": "ADRENERGICS, INHALANTS",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-06-03T14:41:52-04:00",
    "status": "resolved",
    "en_comments": "Re-supply is ongoing with  inventory allocated to 100% of regular demand.",
    "fr_comments": "Un réapprovisionnement est en cours avec une allocation des stocks à 100 % de la demande régulière.",
    "en_drug_brand_name": "VENTOLIN DISKUS",
    "en_drug_common_name": "salbutamol sulfate dry powder for inhalation",
    "fr_drug_brand_name": "VENTOLIN DISKUS",
    "fr_drug_common_name": "sulfate de salbutamol en poudre sèche pour inhalation",
    "en_ingredients": "SALBUTAMOL",
    "fr_ingredients": "Salbutamol",
    "drug_strength": "200MCG",
    "drug_dosage_form": "POWDER",
    "drug_dosage_form_fr": "Poudre",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "1x60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112859,
    "drug": {
      "current_status": "MARKETED",
      "id": 2570,
      "drug_code": 16164,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252093,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01976168",
      "brand_name": "SENSORCAINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77950",
      "number_of_ais": "1",
      "ai_group_no": "0108896004"
    },
    "created_date": "2020-04-23T14:25:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01976168",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2020-04-23T00:00:00-04:00",
    "estimated_end_date": "2020-05-07T00:00:00-04:00",
    "actual_end_date": "2020-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-05-09T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SENSORCAINE",
    "en_drug_common_name": "SENSORCAINE",
    "fr_drug_brand_name": "SENSORCAINE 5MG/ML LIQ AMP 50X10ML",
    "fr_drug_common_name": "SENSORCAINE",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nEPIDURAL\r\nBLOCK/INFILTRATION\r\nEPIDURAL",
    "drug_route_fr": "Bloc/Infiltration\r\nÉpidurale\r\nBloc/Infiltration\r\nÉpidurale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112862,
    "drug": {
      "current_status": "MARKETED",
      "id": 24886,
      "drug_code": 87408,
      "updated_date": "2025-05-15T02:33:33-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8259000,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388553",
      "brand_name": "AURO-ALENDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2020-04-23T14:35:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388553",
    "company_name": "AURO PHARMA INC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-05-23T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-ALENDRONATE",
    "en_drug_common_name": "Alendronic Acid",
    "fr_drug_brand_name": "AURO-ALENDRONATE",
    "fr_drug_common_name": "Alendronate monosodique",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "Alendronate monosodique",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1x4",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112865,
    "drug": {
      "current_status": "MARKETED",
      "id": 57687,
      "drug_code": 94735,
      "updated_date": "2025-05-15T02:35:43-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8262253,
          "ingredient": {
            "id": 3528,
            "ingredient_code": 20435,
            "en_name": "ARIPIPRAZOLE",
            "fr_name": "Aripiprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02460068",
      "brand_name": "AURO-ARIPIPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152514003"
    },
    "created_date": "2020-04-23T14:43:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02460068",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-08-19T18:51:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-ARIPIPRAZOLE",
    "en_drug_common_name": "Aripiprazole",
    "fr_drug_brand_name": "AURO-ARIPIPRAZOLE",
    "fr_drug_common_name": "Aripiprazole",
    "en_ingredients": "ARIPIPRAZOLE",
    "fr_ingredients": "Aripiprazole",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 & 100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112874,
    "drug": {
      "current_status": "MARKETED",
      "id": 25126,
      "drug_code": 87631,
      "updated_date": "2025-05-15T02:33:39-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8259106,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02390922",
      "brand_name": "AURO-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417002"
    },
    "created_date": "2020-04-23T14:58:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390922",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-07-07T14:46:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-SERTRALINE",
    "en_drug_common_name": "Sertraline",
    "fr_drug_brand_name": "AURO-SERTRALINE",
    "fr_drug_common_name": "Sertraline",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "Sertraline",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112879,
    "drug": {
      "current_status": "MARKETED",
      "id": 29898,
      "drug_code": 91945,
      "updated_date": "2025-05-15T02:34:36-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8260850,
          "ingredient": {
            "id": 2972,
            "ingredient_code": 12759,
            "en_name": "VALGANCICLOVIR",
            "fr_name": "Valganciclovir (Chlorhydrate de valganciclovir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "450",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02435179",
      "brand_name": "AURO-VALGANCICLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0147203001"
    },
    "created_date": "2020-04-23T15:01:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02435179",
    "company_name": "AURO PHARMA INC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-06-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-06-19T14:42:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-VALGANCICLOVIR",
    "en_drug_common_name": "Valganciclovir",
    "fr_drug_brand_name": "AURO-VALGANCICLOVIR",
    "fr_drug_common_name": "Valganciclovir",
    "en_ingredients": "VALGANCICLOVIR",
    "fr_ingredients": "Valganciclovir",
    "drug_strength": "450MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112884,
    "drug": {
      "current_status": "MARKETED",
      "id": 29786,
      "drug_code": 91825,
      "updated_date": "2025-05-15T02:34:35-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8260798,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02433869",
      "brand_name": "AURO-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121001"
    },
    "created_date": "2020-04-23T15:17:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02433869",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-07-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-07-17T21:17:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-PREGABALIN",
    "en_drug_common_name": "Pregabalin",
    "fr_drug_brand_name": "AURO-PREGABALIN",
    "fr_drug_common_name": "Prégabaline",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 112887,
    "drug": {
      "current_status": "MARKETED",
      "id": 24724,
      "drug_code": 87298,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8258921,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387395",
      "brand_name": "AURO-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858004"
    },
    "created_date": "2020-04-23T15:26:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387395",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2021-03-01T00:00:00-05:00",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2021-02-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2021-03-01T20:34:01-05:00",
    "status": "resolved",
    "en_comments": "Replaceable with 2.5 mg 100's",
    "en_drug_brand_name": "AURO-RAMIPRIL",
    "en_drug_common_name": "Ramipril",
    "fr_drug_brand_name": "AURO-RAMIPRIL",
    "fr_drug_common_name": "Ramipril",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113010,
    "drug": {
      "current_status": "MARKETED",
      "id": 15398,
      "drug_code": 75966,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255512,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02274205",
      "brand_name": "TEVA-LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843003"
    },
    "created_date": "2020-04-23T18:36:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02274205",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2020-08-31T00:00:00-04:00",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-08-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-08-27T18:58:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM 750MG FC TAB",
    "fr_drug_brand_name": "ACT-LEVETIRACETAM 750MG FC TAB",
    "fr_drug_common_name": "LEVETIRACETAM 750MG FC TAB",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113013,
    "drug": {
      "current_status": "MARKETED",
      "id": 15570,
      "drug_code": 76241,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255582,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02276739",
      "brand_name": "TEVA-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783004"
    },
    "created_date": "2020-04-23T18:37:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02276739",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-14T17:11:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE 7.5MG TAB",
    "fr_drug_brand_name": "TEVA-OLANZAPINE 7.5MG TAB",
    "fr_drug_common_name": "OLANZAPINE 7.5MG TAB",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113016,
    "drug": {
      "current_status": "MARKETED",
      "id": 8278,
      "drug_code": 5647,
      "updated_date": "2025-05-15T02:30:34-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250794,
          "ingredient": {
            "id": 1010,
            "ingredient_code": 7408,
            "en_name": "SPIRONOLACTONE",
            "fr_name": "Spironolactone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00613223",
      "brand_name": "TEVA-SPIRONOLACTONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61192",
      "number_of_ais": "1",
      "ai_group_no": "0106462002"
    },
    "created_date": "2020-04-23T18:38:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00613223",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C03DA",
    "atc_description": "POTASSIUM-SPARING AGENTS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-08T19:44:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SPIRONOLACTONE",
    "en_drug_common_name": "SPIRONOLACTONE 100MG TAB",
    "fr_drug_brand_name": "TEVA-SPIRONOLACTONE 100MG TAB",
    "fr_drug_common_name": "SPIRONOLACTONE 100MG TAB",
    "en_ingredients": "SPIRONOLACTONE",
    "fr_ingredients": "Spironolactone",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113019,
    "drug": {
      "current_status": "MARKETED",
      "id": 18674,
      "drug_code": 79948,
      "updated_date": "2025-05-15T02:32:13-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256535,
          "ingredient": {
            "id": 2614,
            "ingredient_code": 11793,
            "en_name": "ZOLMITRIPTAN",
            "fr_name": "Zolmitriptan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313960",
      "brand_name": "TEVA-ZOLMITRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134381001"
    },
    "created_date": "2020-04-23T18:41:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313960",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-08T19:46:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ZOLMITRIPTAN",
    "en_drug_common_name": "ZOLMITRIPTAN 2.5MG TAB",
    "fr_drug_brand_name": "TEVA-ZOLMITRIPTAN 2.5MG TAB",
    "fr_drug_common_name": "ZOLMITRIPTAN 2.5MG TAB",
    "en_ingredients": "ZOLMITRIPTAN",
    "fr_ingredients": "Zolmitriptan",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113022,
    "drug": {
      "current_status": "MARKETED",
      "id": 3312,
      "drug_code": 18421,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252306,
          "ingredient": {
            "id": 24,
            "ingredient_code": 8642,
            "en_name": "DOXYCYCLINE",
            "fr_name": "Doxycycline (Hyclate de doxycycline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02158574",
      "brand_name": "TEVA-DOXYCYCLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80679",
      "number_of_ais": "1",
      "ai_group_no": "0105569001"
    },
    "created_date": "2020-04-23T18:42:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02158574",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01AA",
    "atc_description": "TETRACYCLINES",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-04T18:51:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DOXYCYCLINE",
    "en_drug_common_name": "DOXYCYCLINE 100MG FC TAB",
    "fr_drug_brand_name": "TEVA-DOXYCYCLINE 100MG FC TAB",
    "fr_drug_common_name": "DOXYCYCLINE 100MG FC TAB",
    "en_ingredients": "DOXYCYCLINE",
    "fr_ingredients": "Doxycycline",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113025,
    "drug": {
      "current_status": "MARKETED",
      "id": 16066,
      "drug_code": 76860,
      "updated_date": "2025-05-15T02:31:46-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255736,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02282984",
      "brand_name": "TEVA-FENTANYL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302012"
    },
    "created_date": "2020-04-23T18:43:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02282984",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-05-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-21T18:52:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FENTANYL",
    "en_drug_common_name": "FENTANYL TDS 100MCG/H PATCH",
    "fr_drug_brand_name": "TEVA-FENTANYL TDS 100MCG/H PATCH",
    "fr_drug_common_name": "FENTANYL TDS 100MCG/H PATCH",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "100MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113028,
    "drug": {
      "current_status": "MARKETED",
      "id": 56752,
      "drug_code": 95023,
      "updated_date": "2025-05-15T02:35:47-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262422,
          "ingredient": {
            "id": 6333,
            "ingredient_code": 1915,
            "en_name": "CYCLOSPORINE",
            "fr_name": "Cyclosporine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02462486",
      "brand_name": "TEVA-CYCLOSPORINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115996006"
    },
    "created_date": "2020-04-23T18:45:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02462486",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "S01XA",
    "atc_description": "OTHER OPHTHALMOLOGICALS",
    "estimated_end_date": "2020-05-31T00:00:00-04:00",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-05-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-21T18:52:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CYCLOSPORINE",
    "en_drug_common_name": "CYCLOSPORINE 0.05% OPH SOLN",
    "fr_drug_brand_name": "TEVA-CYCLOSPORINE 0.05% OPH SOLN",
    "fr_drug_common_name": "CYCLOSPORINE 0.05% OPH SOLN",
    "en_ingredients": "CYCLOSPORINE",
    "fr_ingredients": "CYCLOSPORINE",
    "drug_strength": "0.05%",
    "drug_dosage_form": "EMULSION",
    "drug_dosage_form_fr": "Émulsion",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "0.4ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113031,
    "drug": {
      "current_status": "MARKETED",
      "id": 4044,
      "drug_code": 19756,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252566,
          "ingredient": {
            "id": 1604,
            "ingredient_code": 5895,
            "en_name": "VINCRISTINE SULFATE",
            "fr_name": "Sulfate de vincristine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02143305",
      "brand_name": "VINCRISTINE SULFATE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82052",
      "number_of_ais": "1",
      "ai_group_no": "0107646001"
    },
    "created_date": "2020-04-23T18:46:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02143305",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01CA",
    "atc_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
    "estimated_end_date": "2020-08-31T00:00:00-04:00",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-08-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-08-27T18:58:25-04:00",
    "status": "resolved",
    "en_comments": "Allocating to 100% of our market.",
    "fr_comments": "Allocating to 100% of our market.",
    "en_drug_brand_name": "VINCRISTINE SULFATE INJECTION",
    "en_drug_common_name": "VINCRISTINE INJECTION 1MG/ML",
    "fr_drug_brand_name": "VINCRISTINE INJECTION 1MG/ML",
    "fr_drug_common_name": "VINCRISTINE INJECTION 1MG/ML",
    "en_ingredients": "VINCRISTINE SULFATE",
    "fr_ingredients": "Sulfate de vincristine",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "5ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113034,
    "drug": {
      "current_status": "MARKETED",
      "id": 5436,
      "drug_code": 35798,
      "updated_date": "2025-12-03T00:30:35-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252839,
          "ingredient": {
            "id": 136,
            "ingredient_code": 8508,
            "en_name": "NYSTATIN",
            "fr_name": "Nystatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02194201",
      "brand_name": "TEVA-NYSTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H3087",
      "number_of_ais": "1",
      "ai_group_no": "0105858002"
    },
    "created_date": "2020-04-23T18:47:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02194201",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A07AA",
    "atc_description": "INTESTINALANTIINFECTIVES",
    "estimated_end_date": "2020-11-30T00:00:00-05:00",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-11-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-26T21:12:11-05:00",
    "status": "resolved",
    "en_comments": "Allocating to 100% of our market.",
    "fr_comments": "Allocating to 100% of our market.",
    "en_drug_brand_name": "TEVA-NYSTATIN",
    "en_drug_common_name": "NYSTATIN 100MU/ML DROP",
    "fr_drug_brand_name": "TEVA-NYSTATIN 100MU/ML DROP",
    "fr_drug_common_name": "NYSTATIN 100MU/ML DROP",
    "en_ingredients": "NYSTATIN",
    "fr_ingredients": "Nystatine",
    "drug_strength": "100000UNIT",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1L",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113037,
    "drug": {
      "current_status": "MARKETED",
      "id": 30402,
      "drug_code": 92455,
      "updated_date": "2025-05-15T02:34:45-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261107,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02440172",
      "brand_name": "TEVA-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "FOR ON-DEMAND DOSING",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485002"
    },
    "created_date": "2020-04-23T18:49:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02440172",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2020-07-31T00:00:00-04:00",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-07-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-07-23T14:04:24-04:00",
    "status": "resolved",
    "en_comments": "Allocating to 100% of our market.",
    "fr_comments": "Allocating to 100% of our market.",
    "en_drug_brand_name": "TEVA-TADALAFIL",
    "en_drug_common_name": "TADALAFIL 20MG TABLET",
    "fr_drug_brand_name": "TEVA-TADALAFIL 20MG TABLET",
    "fr_drug_common_name": "TADALAFIL 20MG TABLET",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "P Pack 4",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113040,
    "drug": {
      "current_status": "MARKETED",
      "id": 14418,
      "drug_code": 74666,
      "updated_date": "2025-12-03T00:31:02-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255198,
          "ingredient": {
            "id": 2776,
            "ingredient_code": 11980,
            "en_name": "LEFLUNOMIDE",
            "fr_name": "Léflunomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02261278",
      "brand_name": "TEVA-LEFLUNOMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140182002"
    },
    "created_date": "2020-04-23T18:50:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02261278",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2020-08-31T00:00:00-04:00",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-08T19:48:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-LEFLUNOMIDE",
    "en_drug_common_name": "LEFLUNOMIDE 20MG TABLET",
    "fr_drug_brand_name": "TEVA-LEFLUNOMIDE 20MG TABLET",
    "fr_drug_common_name": "LEFLUNOMIDE 20MG TABLET",
    "en_ingredients": "LEFLUNOMIDE",
    "fr_ingredients": "Léflunomide",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113043,
    "drug": {
      "current_status": "MARKETED",
      "id": 30356,
      "drug_code": 92406,
      "updated_date": "2025-12-03T00:32:47-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261094,
          "ingredient": {
            "id": 2566,
            "ingredient_code": 11772,
            "en_name": "BUPROPION HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupropion"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439662",
      "brand_name": "TEVA-BUPROPION XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131140004"
    },
    "created_date": "2020-04-23T18:51:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439662",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2020-04-22T00:00:00-04:00",
    "actual_end_date": "2020-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-05-08T19:52:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT BUPROPION XL",
    "en_drug_common_name": "BUPROPION XL 300MG SR TABLET",
    "fr_drug_brand_name": "ACT-BUPROPION XL 300MG SR TABLET",
    "fr_drug_common_name": "BUPROPION XL 300MG SR TABLET",
    "en_ingredients": "BUPROPION HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupropion",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113046,
    "drug": {
      "current_status": "MARKETED",
      "id": 10162,
      "drug_code": 64989,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253851,
          "ingredient": {
            "id": 2754,
            "ingredient_code": 1747,
            "en_name": "IFOSFAMIDE",
            "fr_name": "Ifosfamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        }
      ],
      "din": "02241357",
      "brand_name": "IFEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0120706002"
    },
    "created_date": "2020-04-23T19:09:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241357",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "L01AA",
    "atc_description": "ALKYLATINGAGENTS",
    "anticipated_start_date": "2020-04-23T00:00:00-04:00",
    "estimated_end_date": "2020-05-12T00:00:00-04:00",
    "actual_start_date": "2020-04-23T00:00:00-04:00",
    "actual_end_date": "2020-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-05-13T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IFEX",
    "en_drug_common_name": "IFEX",
    "fr_drug_brand_name": "IFEX",
    "fr_drug_common_name": "IFEX",
    "en_ingredients": "IFOSFAMIDE",
    "fr_ingredients": "Ifosfamide",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1g Vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113065,
    "drug": {
      "current_status": "MARKETED",
      "id": 1496,
      "drug_code": 1327,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250262,
          "ingredient": {
            "id": 844,
            "ingredient_code": 10227,
            "en_name": "LITHIUM CARBONATE",
            "fr_name": "Carbonate de lithium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00236683",
      "brand_name": "CARBOLITH",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "39051",
      "number_of_ais": "1",
      "ai_group_no": "0101163002"
    },
    "created_date": "2020-04-23T19:51:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00236683",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "N05AN",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2020-04-15T00:00:00-04:00",
    "actual_end_date": "2020-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2020-05-01T20:31:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CARBOLITH",
    "en_drug_common_name": "CARBOLITH",
    "fr_drug_brand_name": "CARBOLITH",
    "fr_drug_common_name": "CARBOLITH",
    "en_ingredients": "LITHIUM CARBONATE",
    "fr_ingredients": "Carbonate de lithium",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113070,
    "drug": {
      "current_status": "DORMANT",
      "id": 8006,
      "drug_code": 52048,
      "updated_date": "2025-12-03T02:32:17-05:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367302,
          "ingredient": {
            "id": 124,
            "ingredient_code": 2585,
            "en_name": "SALBUTAMOL",
            "fr_name": "Salbutamol (Sulfate de salbutamol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02232570",
      "brand_name": "AIROMIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108887003"
    },
    "created_date": "2020-04-23T20:00:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02232570",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "R03AC",
    "atc_description": "ADRENERGICS, INHALANTS",
    "anticipated_start_date": "2020-07-31T00:00:00-04:00",
    "actual_end_date": "2020-07-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-07-02T17:31:42-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "AIROMIR",
    "en_drug_common_name": "AIROMIR",
    "fr_drug_brand_name": "AIROMIR",
    "fr_drug_common_name": "AIROMIR",
    "en_ingredients": "SALBUTAMOL",
    "fr_ingredients": "Salbutamol",
    "drug_strength": "100MCG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "200 dose",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113076,
    "drug": {
      "current_status": "MARKETED",
      "id": 9014,
      "drug_code": 61553,
      "updated_date": "2025-12-03T00:30:41-05:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253555,
          "ingredient": {
            "id": 810,
            "ingredient_code": 9418,
            "en_name": "DIAZEPAM",
            "fr_name": "Diazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02238162",
      "brand_name": "DIASTAT",
      "brand_name_fr": "",
      "descriptor": "PREFILLED RECTAL DELIVERY SYSTEM",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103614001"
    },
    "created_date": "2020-04-23T20:15:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238162",
    "company_name": "VALEANT PHARMACEUTICALS NORTH AMERICA LLC",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "actual_start_date": "2020-04-01T00:00:00-04:00",
    "actual_end_date": "2020-11-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-11-18T18:27:40-05:00",
    "status": "resolved",
    "en_comments": "awaiting import permit",
    "fr_comments": "awaiting import permit",
    "en_drug_brand_name": "DIASTAT",
    "en_drug_common_name": "DIASTAT",
    "fr_drug_brand_name": "DIASTAT",
    "fr_drug_common_name": "DIASTAT",
    "en_ingredients": "DIAZEPAM",
    "fr_ingredients": "Diazépam",
    "drug_strength": "5MG",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "RECTAL\r\nRECTAL",
    "drug_route_fr": "Rectale\r\nRectale",
    "drug_package_quantity": "10mg 2 pk",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113081,
    "drug": {
      "current_status": "MARKETED",
      "id": 280,
      "drug_code": 10767,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8251382,
          "ingredient": {
            "id": 76,
            "ingredient_code": 626,
            "en_name": "CHLORHEXIDINE GLUCONATE",
            "fr_name": "Gluconate de chlorhexidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00658413",
      "brand_name": "BAXEDIN LIQ 20%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70802",
      "number_of_ais": "1",
      "ai_group_no": "0107629002"
    },
    "created_date": "2020-04-23T21:05:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00658413",
    "company_name": "OMEGA LABORATORIES LTD",
    "atc_number": "D08AC",
    "atc_description": "ANTISEPTICS AND DISINFECTANTS",
    "estimated_end_date": "2020-04-30T00:00:00-04:00",
    "actual_start_date": "2020-04-17T00:00:00-04:00",
    "actual_end_date": "2020-05-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-05-19T14:07:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BAXEDIN LIQ 20%",
    "en_drug_common_name": "Baxedin® 20%",
    "fr_drug_brand_name": "Baxedin® 20%",
    "fr_drug_common_name": "Gluconate de chlorhexidine BP 20%",
    "en_ingredients": "CHLORHEXIDINE GLUCONATE",
    "fr_ingredients": "Gluconate de chlorhexidine",
    "drug_strength": "20%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "500 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113084,
    "drug": {
      "current_status": "MARKETED",
      "id": 1508,
      "drug_code": 13290,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8251745,
          "ingredient": {
            "id": 716,
            "ingredient_code": 8881,
            "en_name": "ISOPROPYL ALCOHOL",
            "fr_name": "Alcool isopropylique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251744,
          "ingredient": {
            "id": 76,
            "ingredient_code": 626,
            "en_name": "CHLORHEXIDINE GLUCONATE",
            "fr_name": "Gluconate de chlorhexidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01938983",
      "brand_name": "STANHEXIDINE 4% WITH ISOPROPYL ALCOHOL 4%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74635",
      "number_of_ais": "2",
      "ai_group_no": "0213979003"
    },
    "created_date": "2020-04-23T21:07:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01938983",
    "company_name": "OMEGA LABORATORIES LTD",
    "atc_number": "D08AC",
    "atc_description": "ANTISEPTICS AND DISINFECTANTS",
    "estimated_end_date": "2020-05-15T00:00:00-04:00",
    "actual_start_date": "2020-04-17T00:00:00-04:00",
    "actual_end_date": "2020-06-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-06-16T13:40:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "STANHEXIDINE 4% WITH ISOPROPYL ALCOHOL 4%",
    "en_drug_common_name": "Chlorhexidine Gluconate 4% w/v aqueous with Isopropyl Alcohol 4%",
    "fr_drug_brand_name": "Stanhexidine 4%",
    "fr_drug_common_name": "Gluconate de chlorhexidine 4% p/v aqueux avec 4% d'alcool isopropylique",
    "en_ingredients": "CHLORHEXIDINE GLUCONATE\r\nISOPROPYL ALCOHOL",
    "fr_ingredients": "Gluconate de chlorhexidine\r\nAlcool isopropylique",
    "drug_strength": "4%\r\n4%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "1 x 4L",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113087,
    "drug": {
      "current_status": "MARKETED",
      "id": 5474,
      "drug_code": 36480,
      "updated_date": "2025-05-15T02:31:00-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8252846,
          "ingredient": {
            "id": 304,
            "ingredient_code": 12030,
            "en_name": "DEXAMETHASONE PHOSPHATE",
            "fr_name": "Phosphate de dexaméthasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02204266",
      "brand_name": "DEXAMETHASONE-OMEGA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H3818",
      "number_of_ais": "1",
      "ai_group_no": "0106305003"
    },
    "created_date": "2020-04-23T21:15:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02204266",
    "company_name": "OMEGA LABORATORIES LTD",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "estimated_end_date": "2020-06-30T00:00:00-04:00",
    "actual_start_date": "2020-03-06T00:00:00-05:00",
    "actual_end_date": "2020-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-06-05T19:45:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DEXAMETHASONE-OMEGA",
    "en_drug_common_name": "Dexamethasone Sodium Phosphate Injection USP",
    "fr_drug_brand_name": "Dexamethasone OMEGA",
    "fr_drug_common_name": "Injection de phosphate sodique de dexaméthasone USP",
    "en_ingredients": "DEXAMETHASONE PHOSPHATE",
    "fr_ingredients": "Phosphate de dexaméthasone",
    "drug_strength": "4MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRA-ARTICULAR\r\nINTRALESIONAL\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nSOFT TISSUE INJECTION\r\nINTRA-ARTICULAR\r\nINTRALESIONAL\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nSOFT TISSUE INJECTION",
    "drug_route_fr": "Intra-articulaire\r\nIntralésionnelle\r\nIntramusculaire\r\nIntraveineuse\r\nInjection dans les tissus mous\r\nIntra-articulaire\r\nIntralésionnelle\r\nIntramusculaire\r\nIntraveineuse\r\nInjection dans les tissus mous",
    "drug_package_quantity": "10 x 25mL vial/fiole",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113120,
    "drug": {
      "current_status": "MARKETED",
      "id": 53481,
      "drug_code": 95075,
      "updated_date": "2025-05-15T02:35:48-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8262440,
          "ingredient": {
            "id": 2158,
            "ingredient_code": 41,
            "en_name": "MEROPENEM",
            "fr_name": "Méropénem (Méropénem Trihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02462885",
      "brand_name": "MEROPENEM FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128599001"
    },
    "created_date": "2020-04-24T17:39:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02462885",
    "company_name": "AURO PHARMA INC",
    "atc_number": "J01DH",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "actual_start_date": "2020-04-23T00:00:00-04:00",
    "actual_end_date": "2020-07-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-07-08T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MEROPENEM FOR INJECTION",
    "en_drug_common_name": "Meropenem",
    "fr_drug_brand_name": "MEROPENEM FOR INJECTION",
    "fr_drug_common_name": "Méropénem",
    "en_ingredients": "MEROPENEM",
    "fr_ingredients": "Méropénem",
    "drug_strength": "500MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "box of 10 vials",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113123,
    "drug": {
      "current_status": "MARKETED",
      "id": 53483,
      "drug_code": 95076,
      "updated_date": "2025-05-15T02:35:48-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8262441,
          "ingredient": {
            "id": 2158,
            "ingredient_code": 41,
            "en_name": "MEROPENEM",
            "fr_name": "Méropénem (Méropénem Trihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02462893",
      "brand_name": "MEROPENEM FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128599003"
    },
    "created_date": "2020-04-24T17:44:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02462893",
    "company_name": "AURO PHARMA INC",
    "atc_number": "J01DH",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "actual_start_date": "2020-04-23T00:00:00-04:00",
    "actual_end_date": "2020-07-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-07-08T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MEROPENEM FOR INJECTION",
    "en_drug_common_name": "Meropenem",
    "fr_drug_brand_name": "MEROPENEM FOR INJECTION",
    "fr_drug_common_name": "Méropénem",
    "en_ingredients": "MEROPENEM",
    "fr_ingredients": "Méropénem",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "box of 10 vials",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113128,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24958,
      "drug_code": 87460,
      "updated_date": "2025-05-15T04:20:21-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351805,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389088",
      "brand_name": "MAR-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783003"
    },
    "created_date": "2020-04-24T18:27:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389088",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "hc_updated_date": "2021-10-26T20:21:49-04:00",
    "actual_start_date": "2019-10-01T00:00:00-04:00",
    "actual_end_date": "2019-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-10-26T20:21:51-04:00",
    "status": "resolved",
    "en_comments": "Business reasons",
    "fr_comments": "Business reasons",
    "en_drug_brand_name": "MAR-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE ODT",
    "fr_drug_brand_name": "Mar-Olanzapine ODT",
    "fr_drug_common_name": "Olanzapine ODT",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 Tablets",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113131,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24962,
      "drug_code": 87462,
      "updated_date": "2025-05-15T04:20:21-04:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8351807,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389118",
      "brand_name": "MAR-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783005"
    },
    "created_date": "2020-04-24T18:29:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389118",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "hc_updated_date": "2021-10-26T20:20:48-04:00",
    "actual_start_date": "2019-10-01T00:00:00-04:00",
    "actual_end_date": "2019-10-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2021-10-26T20:20:51-04:00",
    "status": "resolved",
    "en_comments": "Business reasons",
    "fr_comments": "Business reasons",
    "en_drug_brand_name": "MAR-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE ODT",
    "fr_drug_brand_name": "Mar-Olanzapine ODT",
    "fr_drug_common_name": "Olanzapine ODT",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 Tablets",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113155,
    "drug": {
      "current_status": "MARKETED",
      "id": 6770,
      "drug_code": 44255,
      "updated_date": "2025-12-03T00:30:37-05:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8253174,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02182882",
      "brand_name": "COZAAR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9979",
      "number_of_ais": "1",
      "ai_group_no": "0127971002"
    },
    "created_date": "2020-04-24T20:34:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02182882",
    "company_name": "MERCK CANADA INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2020-04-24T00:00:00-04:00",
    "estimated_end_date": "2020-05-01T00:00:00-04:00",
    "actual_start_date": "2020-04-24T00:00:00-04:00",
    "actual_end_date": "2020-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-04-29T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "COZAAR",
    "en_drug_common_name": "losartan potassium tablets",
    "fr_drug_brand_name": "COZAAR",
    "fr_drug_common_name": "comprimés de losartan potassique",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113158,
    "drug": {
      "current_status": "MARKETED",
      "id": 392,
      "drug_code": 10913,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8251442,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251441,
          "ingredient": {
            "id": 272,
            "ingredient_code": 20170,
            "en_name": "ENALAPRIL SODIUM",
            "fr_name": "Énalapril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00657298",
      "brand_name": "VASERETIC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71053",
      "number_of_ais": "2",
      "ai_group_no": "0252326001"
    },
    "created_date": "2020-04-24T21:09:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00657298",
    "company_name": "MERCK CANADA INC",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "anticipated_start_date": "2020-05-20T00:00:00-04:00",
    "estimated_end_date": "2020-05-29T00:00:00-04:00",
    "actual_start_date": "2020-05-20T00:00:00-04:00",
    "actual_end_date": "2020-05-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-05-26T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VASERETIC",
    "en_drug_common_name": "enalapril and hydrochlorothiazide tablets",
    "fr_drug_brand_name": "VASERETIC",
    "fr_drug_common_name": "comprimés d’énalapril et d’hydrochlorothiazide",
    "en_ingredients": "ENALAPRIL SODIUM\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Énalapril sodique\r\nHydrochlorothiazide",
    "drug_strength": "8MG\r\n25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113175,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 53493,
      "drug_code": 95337,
      "updated_date": "2025-05-15T04:25:13-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8357372,
          "ingredient": {
            "id": 2190,
            "ingredient_code": 1381,
            "en_name": "FENOFIBRATE",
            "fr_name": "Fénofibrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "145",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02465167",
      "brand_name": "MINT-FENOFIBRATE E",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118895006"
    },
    "created_date": "2020-04-25T23:09:30-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02465167",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C10AB",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "discontinuation_date": "2020-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-25T23:10:30-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MINT-FENOFIBRATE E",
    "en_drug_common_name": "Fenofibrate",
    "fr_drug_brand_name": "MINT-FENOFIBRATE",
    "fr_drug_common_name": "Fenofibrate",
    "en_ingredients": "FENOFIBRATE",
    "fr_ingredients": "Fénofibrate",
    "drug_strength": "145MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottles",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113184,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28700,
      "drug_code": 90827,
      "updated_date": "2025-05-15T04:22:21-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8354559,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02423553",
      "brand_name": "MINT-CIPROFLOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123207006"
    },
    "created_date": "2020-04-25T23:30:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423553",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "hc_updated_date": "2022-06-06T16:51:04-04:00",
    "estimated_end_date": "2021-06-30T00:00:00-04:00",
    "actual_start_date": "2020-04-24T00:00:00-04:00",
    "actual_end_date": "2022-03-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-06-06T16:51:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-CIPROFLOX",
    "en_drug_common_name": "Ciprofloxacin",
    "fr_drug_brand_name": "Mint-Ciproflox",
    "fr_drug_common_name": "Ciprofloxacin",
    "en_ingredients": "CIPROFLOXACIN",
    "fr_ingredients": "Ciprofloxacine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113187,
    "drug": {
      "current_status": "MARKETED",
      "id": 26756,
      "drug_code": 89051,
      "updated_date": "2025-05-15T02:33:55-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259647,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02405741",
      "brand_name": "MINT-LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971003"
    },
    "created_date": "2020-04-25T23:34:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02405741",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2019-09-27T00:00:00-04:00",
    "actual_end_date": "2024-03-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-05T19:20:53-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-LOSARTAN",
    "en_drug_common_name": "losartan",
    "fr_drug_brand_name": "Mint-losartan",
    "fr_drug_common_name": "Losartan",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "50.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113190,
    "drug": {
      "current_status": "MARKETED",
      "id": 26758,
      "drug_code": 89052,
      "updated_date": "2025-05-15T02:33:55-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259648,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02405768",
      "brand_name": "MINT-LOSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127971002"
    },
    "created_date": "2020-04-25T23:36:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02405768",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2019-09-27T00:00:00-04:00",
    "actual_end_date": "2024-03-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-05T19:21:58-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-LOSARTAN",
    "en_drug_common_name": "losartan",
    "fr_drug_brand_name": "Mint-losartan",
    "fr_drug_common_name": "Losartan",
    "en_ingredients": "LOSARTAN POTASSIUM",
    "fr_ingredients": "Losartan potassique",
    "drug_strength": "100.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113193,
    "drug": {
      "current_status": "MARKETED",
      "id": 25002,
      "drug_code": 87515,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259042,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259041,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389657",
      "brand_name": "MINT-LOSARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168001"
    },
    "created_date": "2020-04-25T23:38:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389657",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2020-09-30T00:00:00-04:00",
    "actual_start_date": "2019-09-27T00:00:00-04:00",
    "actual_end_date": "2020-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-07-13T15:04:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-LOSARTAN/HCTZ",
    "en_drug_common_name": "losartan/HCTZ",
    "fr_drug_brand_name": "Mint- Losartan/HCTZ",
    "fr_drug_common_name": "losartan/hctz",
    "en_ingredients": "LOSARTAN POTASSIUM\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Losartan potassique\r\nHydrochlorothiazide",
    "drug_strength": "50MG\r\n12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113196,
    "drug": {
      "current_status": "MARKETED",
      "id": 19846,
      "drug_code": 81186,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256944,
          "ingredient": {
            "id": 2812,
            "ingredient_code": 12012,
            "en_name": "PIOGLITAZONE",
            "fr_name": "Pioglitazone (Chlorhydrate de pioglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "45",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02326493",
      "brand_name": "MINT-PIOGLITAZONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141541003"
    },
    "created_date": "2020-04-25T23:40:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02326493",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "A10BG",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "hc_updated_date": "2021-08-13T19:55:52-04:00",
    "estimated_end_date": "2021-12-31T00:00:00-05:00",
    "actual_start_date": "2019-09-27T00:00:00-04:00",
    "actual_end_date": "2022-03-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-03T20:26:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-PIOGLITAZONE",
    "en_drug_common_name": "Pioglitazone",
    "fr_drug_brand_name": "Mint-Pioglitazone",
    "fr_drug_common_name": "Pioglitazone",
    "en_ingredients": "PIOGLITAZONE",
    "fr_ingredients": "Pioglitazone",
    "drug_strength": "45MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113199,
    "drug": {
      "current_status": "MARKETED",
      "id": 28262,
      "drug_code": 90415,
      "updated_date": "2025-05-15T02:34:12-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260254,
          "ingredient": {
            "id": 2614,
            "ingredient_code": 11793,
            "en_name": "ZOLMITRIPTAN",
            "fr_name": "Zolmitriptan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02419521",
      "brand_name": "MINT-ZOLMITRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134381001"
    },
    "created_date": "2020-04-25T23:42:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02419521",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "actual_start_date": "2020-04-24T00:00:00-04:00",
    "actual_end_date": "2021-12-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-05T19:54:49-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-ZOLMITRIPTAN",
    "en_drug_common_name": "zolmitriptan",
    "fr_drug_brand_name": "Mint-Zolmitriptan",
    "fr_drug_common_name": "zolmitriptan",
    "en_ingredients": "ZOLMITRIPTAN",
    "fr_ingredients": "Zolmitriptan",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6 count blisters",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113281,
    "drug": {
      "current_status": "MARKETED",
      "id": 29402,
      "drug_code": 91415,
      "updated_date": "2025-05-15T02:34:29-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260668,
          "ingredient": {
            "id": 2658,
            "ingredient_code": 11847,
            "en_name": "CITALOPRAM",
            "fr_name": "Citalopram (Bromhydrate de citalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429705",
      "brand_name": "MINT-CITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136243001"
    },
    "created_date": "2020-04-27T13:56:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429705",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2020-10-30T00:00:00-04:00",
    "actual_start_date": "2020-04-24T00:00:00-04:00",
    "actual_end_date": "2020-10-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-10T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-CITALOPRAM",
    "en_drug_common_name": "Citalopram",
    "fr_drug_brand_name": "Mint-Citalopram",
    "fr_drug_common_name": "Citalopram",
    "en_ingredients": "CITALOPRAM",
    "fr_ingredients": "Citalopram",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113285,
    "drug": {
      "current_status": "MARKETED",
      "id": 29404,
      "drug_code": 91416,
      "updated_date": "2025-05-15T02:34:29-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260669,
          "ingredient": {
            "id": 2658,
            "ingredient_code": 11847,
            "en_name": "CITALOPRAM",
            "fr_name": "Citalopram (Bromhydrate de citalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429713",
      "brand_name": "MINT-CITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136243002"
    },
    "created_date": "2020-04-27T13:59:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429713",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "actual_start_date": "2020-04-24T00:00:00-04:00",
    "actual_end_date": "2020-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-11-11T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-CITALOPRAM",
    "en_drug_common_name": "Citalopram",
    "fr_drug_brand_name": "Mint-Citalopram",
    "fr_drug_common_name": "Citalopram",
    "en_ingredients": "CITALOPRAM",
    "fr_ingredients": "Citalopram",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottles",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113293,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 26154,
      "drug_code": 88494,
      "updated_date": "2025-05-15T04:20:57-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352632,
          "ingredient": {
            "id": 268,
            "ingredient_code": 2072,
            "en_name": "ALPRAZOLAM",
            "fr_name": "Alprazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02400111",
      "brand_name": "JAMP-ALPRAZOLAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115008001"
    },
    "created_date": "2020-04-27T16:43:34-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02400111",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "discontinuation_date": "2019-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-27T16:45:17-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "JAMP-ALPRAZOLAM",
    "en_drug_common_name": "Alprazolam tablets",
    "fr_drug_brand_name": "JAMP-Alprazolam",
    "fr_drug_common_name": "Alprazolam",
    "en_ingredients": "ALPRAZOLAM",
    "fr_ingredients": "Alprazolam",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113296,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 26154,
      "drug_code": 88494,
      "updated_date": "2025-05-15T04:20:57-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352632,
          "ingredient": {
            "id": 268,
            "ingredient_code": 2072,
            "en_name": "ALPRAZOLAM",
            "fr_name": "Alprazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02400111",
      "brand_name": "JAMP-ALPRAZOLAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115008001"
    },
    "created_date": "2020-04-27T16:46:32-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02400111",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "discontinuation_date": "2019-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-27T16:46:57-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "JAMP-ALPRAZOLAM",
    "en_drug_common_name": "Alprazolam",
    "fr_drug_brand_name": "JAMP-Alprazolam",
    "fr_drug_common_name": "Alprazolam",
    "en_ingredients": "ALPRAZOLAM",
    "fr_ingredients": "Alprazolam",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113299,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 26156,
      "drug_code": 88495,
      "updated_date": "2025-05-15T04:20:57-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352633,
          "ingredient": {
            "id": 268,
            "ingredient_code": 2072,
            "en_name": "ALPRAZOLAM",
            "fr_name": "Alprazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02400138",
      "brand_name": "JAMP-ALPRAZOLAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115008002"
    },
    "created_date": "2020-04-27T16:48:26-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02400138",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "discontinuation_date": "2019-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-27T16:49:16-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "JAMP-ALPRAZOLAM",
    "en_drug_common_name": "Alprazolam",
    "fr_drug_brand_name": "JAMP-Alprazolam",
    "fr_drug_common_name": "Alprazolam",
    "en_ingredients": "ALPRAZOLAM",
    "fr_ingredients": "Alprazolam",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113302,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 26156,
      "drug_code": 88495,
      "updated_date": "2025-05-15T04:20:57-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352633,
          "ingredient": {
            "id": 268,
            "ingredient_code": 2072,
            "en_name": "ALPRAZOLAM",
            "fr_name": "Alprazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02400138",
      "brand_name": "JAMP-ALPRAZOLAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115008002"
    },
    "created_date": "2020-04-27T16:51:18-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02400138",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "discontinuation_date": "2019-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-27T16:52:01-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "JAMP-ALPRAZOLAM",
    "en_drug_common_name": "JAMP-Alprazolam",
    "fr_drug_brand_name": "JAMP-Alprazolam",
    "fr_drug_common_name": "Alprazolam",
    "en_ingredients": "ALPRAZOLAM",
    "fr_ingredients": "Alprazolam",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113305,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 26158,
      "drug_code": 88496,
      "updated_date": "2025-05-15T04:20:57-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352634,
          "ingredient": {
            "id": 268,
            "ingredient_code": 2072,
            "en_name": "ALPRAZOLAM",
            "fr_name": "Alprazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02400146",
      "brand_name": "JAMP-ALPRAZOLAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115008003"
    },
    "created_date": "2020-04-27T16:54:11-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02400146",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "discontinuation_date": "2019-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-27T16:54:55-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "JAMP-ALPRAZOLAM",
    "en_drug_common_name": "Alprazolam",
    "fr_drug_brand_name": "JAMP-Alprazolam",
    "fr_drug_common_name": "Alprazolam",
    "en_ingredients": "ALPRAZOLAM",
    "fr_ingredients": "Alprazolam",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113308,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 26160,
      "drug_code": 88497,
      "updated_date": "2025-05-15T04:20:57-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352635,
          "ingredient": {
            "id": 268,
            "ingredient_code": 2072,
            "en_name": "ALPRAZOLAM",
            "fr_name": "Alprazolam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02400154",
      "brand_name": "JAMP-ALPRAZOLAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115008004"
    },
    "created_date": "2020-04-27T17:03:09-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02400154",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "discontinuation_date": "2019-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-27T17:03:47-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "JAMP-ALPRAZOLAM",
    "en_drug_common_name": "Alprazolam",
    "fr_drug_brand_name": "JAMP-Alprazolam",
    "fr_drug_common_name": "Alprazolam",
    "en_ingredients": "ALPRAZOLAM",
    "fr_ingredients": "Alprazolam",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113311,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10094,
      "drug_code": 64716,
      "updated_date": "2025-05-15T04:00:31-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8330851,
          "ingredient": {
            "id": 2742,
            "ingredient_code": 11925,
            "en_name": "ROSIGLITAZONE",
            "fr_name": "Rosiglitazone (Maléate de rosiglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02241112",
      "brand_name": "AVANDIA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138802002"
    },
    "created_date": "2020-04-27T17:08:24-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02241112",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "A10BG",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2020-08-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2020-08-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-09-01T16:09:15-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "AVANDIA",
    "en_drug_common_name": "rosiglitazone (as rosiglitazone maleate) tablets",
    "fr_drug_brand_name": "AVANDIA",
    "fr_drug_common_name": "rosiglitazone (sous forme de maléate de rosiglitazone) comprimés",
    "en_ingredients": "ROSIGLITAZONE",
    "fr_ingredients": "Rosiglitazone (ROSIGLITAZONE MALEATE)",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60's",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113314,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10096,
      "drug_code": 64717,
      "updated_date": "2025-05-15T04:00:31-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8330852,
          "ingredient": {
            "id": 2742,
            "ingredient_code": 11925,
            "en_name": "ROSIGLITAZONE",
            "fr_name": "Rosiglitazone (Maléate de rosiglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02241113",
      "brand_name": "AVANDIA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138802003"
    },
    "created_date": "2020-04-27T17:13:10-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02241113",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "A10BG",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2020-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-12-11T17:48:14-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "AVANDIA",
    "en_drug_common_name": "rosiglitazone (as rosiglitazone maleate) tablets",
    "fr_drug_brand_name": "AVANDIA",
    "fr_drug_common_name": "rosiglitazone (sous forme de maléate de rosiglitazone) comprimés",
    "en_ingredients": "ROSIGLITAZONE",
    "fr_ingredients": "Rosiglitazone (ROSIGLITAZONE MALEATE)",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113317,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10098,
      "drug_code": 64718,
      "updated_date": "2025-05-15T04:00:31-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8330853,
          "ingredient": {
            "id": 2742,
            "ingredient_code": 11925,
            "en_name": "ROSIGLITAZONE",
            "fr_name": "Rosiglitazone (Maléate de rosiglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02241114",
      "brand_name": "AVANDIA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138802004"
    },
    "created_date": "2020-04-27T17:17:40-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02241114",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "A10BG",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2020-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-27T17:21:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "AVANDIA",
    "en_drug_common_name": "rosiglitazone (as rosiglitazone maleate) tablets",
    "fr_drug_brand_name": "AVANDIA",
    "fr_drug_common_name": "rosiglitazone (sous forme de maléate de rosiglitazone) comprimés",
    "en_ingredients": "ROSIGLITAZONE",
    "fr_ingredients": "Rosiglitazone (ROSIGLITAZONE MALEATE)",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60's",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113330,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2406,
      "drug_code": 15625,
      "updated_date": "2025-12-03T01:07:19-05:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8295348,
          "ingredient": {
            "id": 1156,
            "ingredient_code": 11219,
            "en_name": "BETAXOLOL",
            "fr_name": "Bétaxolol (Chlorhydrate de bétaxolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "01908448",
      "brand_name": "BETOPTIC S",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77363",
      "number_of_ais": "1",
      "ai_group_no": "0131365002"
    },
    "created_date": "2020-04-27T18:27:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01908448",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2020-05-04T00:00:00-04:00",
    "estimated_end_date": "2020-05-12T00:00:00-04:00",
    "actual_end_date": "2020-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-05-21T12:49:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BETOPTIC S",
    "en_drug_common_name": "BETOPTIC S 0.25% SUSP 10ML",
    "fr_drug_brand_name": "BETOPTIC S",
    "fr_drug_common_name": "BETOPTIC S 0.25% SUSP 10ML",
    "en_ingredients": "BETAXOLOL",
    "fr_ingredients": "BETAXOLOL",
    "drug_strength": "0.25%",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "10ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113348,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13684,
      "drug_code": 73528,
      "updated_date": "2025-05-15T04:08:23-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8339759,
          "ingredient": {
            "id": 3124,
            "ingredient_code": 13311,
            "en_name": "VARDENAFIL",
            "fr_name": "Vardénafil (Chlorhydrate de vardénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02250489",
      "brand_name": "LEVITRA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150003003"
    },
    "created_date": "2020-04-28T14:32:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02250489",
    "company_name": "BAYER INC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2020-06-15T00:00:00-04:00",
    "actual_start_date": "2020-06-05T00:00:00-04:00",
    "actual_end_date": "2020-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-19T14:07:43-04:00",
    "status": "resolved",
    "en_comments": "Product is available to market.",
    "en_drug_brand_name": "LEVITRA",
    "en_drug_common_name": "VARDENAFIL",
    "fr_drug_brand_name": "LEVITRA",
    "fr_drug_common_name": "Vardénafil",
    "en_ingredients": "VARDENAFIL",
    "fr_ingredients": "Vardénafil",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113394,
    "drug": {
      "current_status": "MARKETED",
      "id": 23432,
      "drug_code": 8602,
      "updated_date": "2025-05-15T02:30:42-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251107,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00751170",
      "brand_name": "APO-METOPROLOL (TYPE L)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "67172",
      "number_of_ais": "1",
      "ai_group_no": "0111923003"
    },
    "created_date": "2020-04-29T12:29:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00751170",
    "company_name": "APOTEX INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2020-08-14T00:00:00-04:00",
    "actual_start_date": "2020-04-27T00:00:00-04:00",
    "actual_end_date": "2020-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-08-05T12:30:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METOPROLOL (TYPE L) TAB 100MG",
    "en_drug_common_name": "METOPROLOL",
    "fr_drug_brand_name": "APO-METOPROLOL (TYPE L) TAB 100MG",
    "fr_drug_common_name": "METOPROLOL",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113424,
    "drug": {
      "current_status": "MARKETED",
      "id": 52259,
      "drug_code": 94902,
      "updated_date": "2025-05-15T02:35:44-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8262341,
          "ingredient": {
            "id": 3254,
            "ingredient_code": 16516,
            "en_name": "EMTRICITABINE",
            "fr_name": "Emtricitabine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8262340,
          "ingredient": {
            "id": 2676,
            "ingredient_code": 11857,
            "en_name": "EFAVIRENZ",
            "fr_name": "Éfavirenz"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8262339,
          "ingredient": {
            "id": 3020,
            "ingredient_code": 12251,
            "en_name": "TENOFOVIR DISOPROXIL FUMARATE",
            "fr_name": "Fumarate de ténofovir disoproxil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461412",
      "brand_name": "MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "3",
      "ai_group_no": "0352327001"
    },
    "created_date": "2020-04-29T13:40:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02461412",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J05AR",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2020-07-08T00:00:00-04:00",
    "estimated_end_date": "2020-09-08T00:00:00-04:00",
    "actual_end_date": "2020-05-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-07-09T13:59:56-04:00",
    "status": "avoided_shortage",
    "en_comments": "short dated inventory",
    "fr_comments": "short dated inventory",
    "en_drug_brand_name": "MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE",
    "en_drug_common_name": "EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE",
    "fr_drug_brand_name": "MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE",
    "fr_drug_common_name": "EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE",
    "en_ingredients": "EFAVIRENZ\r\nEMTRICITABINE\r\nTENOFOVIR DISOPROXIL FUMARATE",
    "fr_ingredients": "Éfavirenz\r\nEmtricitabine\r\nFumarate de ténofovir disoproxil",
    "drug_strength": "600MG\r\n200MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30BT",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113458,
    "drug": {
      "current_status": "MARKETED",
      "id": 22228,
      "drug_code": 8464,
      "updated_date": "2025-05-15T02:30:41-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251093,
          "ingredient": {
            "id": 2870,
            "ingredient_code": 1893,
            "en_name": "PROPAFENONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propafénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00603708",
      "brand_name": "RYTHMOL",
      "brand_name_fr": "RYTHMOL",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "66951",
      "number_of_ais": "1",
      "ai_group_no": "0116258001"
    },
    "created_date": "2020-04-29T14:04:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00603708",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "C01BC",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "estimated_end_date": "2020-05-05T00:00:00-04:00",
    "actual_start_date": "2020-04-21T00:00:00-04:00",
    "actual_end_date": "2020-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-05-06T14:14:47-04:00",
    "status": "resolved",
    "en_comments": "short dated inventory",
    "fr_comments": "short dated inventory",
    "en_drug_brand_name": "RYTHMOL",
    "en_drug_common_name": "PROPAFENONE HYDROCHLORIDE",
    "fr_drug_brand_name": "RYTHMOL",
    "fr_drug_common_name": "PROPAFENONE HYDROCHLORIDE",
    "en_ingredients": "PROPAFENONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propafénone",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113461,
    "drug": {
      "current_status": "MARKETED",
      "id": 22238,
      "drug_code": 8465,
      "updated_date": "2025-05-15T02:30:41-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251094,
          "ingredient": {
            "id": 2870,
            "ingredient_code": 1893,
            "en_name": "PROPAFENONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propafénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00603716",
      "brand_name": "RYTHMOL",
      "brand_name_fr": "RYTHMOL",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "66952",
      "number_of_ais": "1",
      "ai_group_no": "0116258002"
    },
    "created_date": "2020-04-29T14:06:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00603716",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "C01BC",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "estimated_end_date": "2020-05-05T00:00:00-04:00",
    "actual_start_date": "2020-04-13T00:00:00-04:00",
    "actual_end_date": "2020-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-05-06T14:15:13-04:00",
    "status": "resolved",
    "en_comments": "short dated inventory",
    "fr_comments": "short dated inventory",
    "en_drug_brand_name": "RYTHMOL",
    "en_drug_common_name": "PROPAFENONE HYDROCHLORIDE",
    "fr_drug_brand_name": "RYTHMOL",
    "fr_drug_common_name": "PROPAFENONE HYDROCHLORIDE",
    "en_ingredients": "PROPAFENONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propafénone",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113471,
    "drug": {
      "current_status": "MARKETED",
      "id": 14848,
      "drug_code": 75233,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255323,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02266938",
      "brand_name": "TARO-CLINDAMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105830004"
    },
    "created_date": "2020-04-29T14:31:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02266938",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D10AF",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2020-07-03T00:00:00-04:00",
    "actual_start_date": "2019-04-28T00:00:00-04:00",
    "actual_end_date": "2020-08-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-08-28T23:29:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLINDAMYCIN",
    "en_drug_common_name": "CLINDAMYCIN",
    "fr_drug_brand_name": "TARO-CLINDAMYCIN",
    "fr_drug_common_name": "CLINDAMYCIN",
    "en_ingredients": "CLINDAMYCIN",
    "fr_ingredients": "CLINDAMYCIN",
    "drug_strength": "1%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "30 ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113481,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 5552,
      "drug_code": 36949,
      "updated_date": "2025-05-15T03:47:42-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8309397,
          "ingredient": {
            "id": 1414,
            "ingredient_code": 5325,
            "en_name": "LEVOTHYROXINE SODIUM",
            "fr_name": "Lévothyroxine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02213230",
      "brand_name": "ELTROXIN",
      "brand_name_fr": "ELTROXIN",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4375",
      "number_of_ais": "1",
      "ai_group_no": "0107794002"
    },
    "created_date": "2020-04-29T15:56:55-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02213230",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "H03AA",
    "atc_description": "THYROID PREPARATIONS",
    "discontinuation_date": "2018-07-24T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2020-04-29T15:57:28-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "ELTROXIN",
    "en_drug_common_name": "Eltroxin 300 mcg",
    "fr_drug_brand_name": "ELTROXIN",
    "fr_drug_common_name": "Eltroxin 300 mcg",
    "en_ingredients": "LEVOTHYROXINE SODIUM",
    "fr_ingredients": "Lévothyroxine sodique",
    "drug_strength": "300MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 tablets",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113486,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9832,
      "drug_code": 63903,
      "updated_date": "2025-05-15T03:59:38-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8329446,
          "ingredient": {
            "id": 2190,
            "ingredient_code": 1381,
            "en_name": "FENOFIBRATE",
            "fr_name": "Fénofibrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240360",
      "brand_name": "FENO-MICRO-200",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118895001"
    },
    "created_date": "2020-04-29T16:45:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240360",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C10AB",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2020-04-29T00:00:00-04:00",
    "actual_end_date": "2020-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-05-05T05:00:10-04:00",
    "status": "resolved",
    "en_comments": "Looking for an alternate source of supply Recherche d'une source alternative d'approvisionnement",
    "fr_comments": "Looking for an alternate source of supply Recherche d'une source alternative d'approvisionnement",
    "en_drug_brand_name": "FENO-MICRO-200",
    "en_drug_common_name": "FENO MICRO",
    "fr_drug_brand_name": "FENO MICRO 200",
    "fr_drug_common_name": "FENO MICRO",
    "en_ingredients": "FENOFIBRATE",
    "fr_ingredients": "Fénofibrate",
    "drug_strength": "200MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30,100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 113490,
    "drug": {
      "current_status": "MARKETED",
      "id": 9344,
      "drug_code": 62547,
      "updated_date": "2025-12-03T00:30:42-05:00",
      "company": {
        "id": 430,
        "created_date": "2017-03-09T13:22:46-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15812,
        "mfr_code": "",
        "name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ZIEGELHOF 24",
        "province": "MECKLENBURG - WEST POMERANIA",
        "country": "GERMANY",
        "city": "GREIFSWALD",
        "postal_code": "17489",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253642,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239091",
      "brand_name": "ATACAND",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220002"
    },
    "created_date": "2020-04-29T18:10:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239091",
    "company_name": "ASTRAZENECA CANADA INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2020-05-01T00:00:00-04:00",
    "estimated_end_date": "2020-05-20T00:00:00-04:00",
    "actual_start_date": "2020-05-01T00:00:00-04:00",
    "actual_end_date": "2020-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2020-05-14T14:23:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ATACAND TAB 8MG",
    "en_drug_common_name": "candesartan cilexetil",
    "fr_drug_brand_name": "Atacand",
    "fr_drug_common_name": "candésartan cilexétil",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  }
]